
<html lang="en"     class="pb-page"  data-request-id="edd34efc-fac9-456e-b1d2-c80c294629cb"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2020.63.issue-13;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/acs.jmedchem.0c00208;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Preclinical Lead Optimization of a 1,2,4-Triazole Based Tankyrase Inhibitor" /></meta><meta name="dc.Creator" content="Jo  Waaler" /></meta><meta name="dc.Creator" content="Ruben G. G.  Leenders" /></meta><meta name="dc.Creator" content="Sven T.  Sowa" /></meta><meta name="dc.Creator" content="Shoshy  Alam Brinch" /></meta><meta name="dc.Creator" content="Max  Lycke" /></meta><meta name="dc.Creator" content="Piotr  Nieczypor" /></meta><meta name="dc.Creator" content="Sjoerd  Aertssen" /></meta><meta name="dc.Creator" content="Sudarshan  Murthy" /></meta><meta name="dc.Creator" content="Albert  Galera-Prat" /></meta><meta name="dc.Creator" content="Eddy  Damen" /></meta><meta name="dc.Creator" content="Anita  Wegert" /></meta><meta name="dc.Creator" content="Marc  Nazaré" /></meta><meta name="dc.Creator" content="Lari  Lehtiö" /></meta><meta name="dc.Creator" content="Stefan  Krauss" /></meta><meta name="dc.Description" content="Tankyrases 1 and 2 are central biotargets in the WNT/β-catenin signaling and Hippo signaling pathways. We have previously developed tankyrase inhibitors bearing a 1,2,4-triazole moiety and binding ..." /></meta><meta name="Description" content="Tankyrases 1 and 2 are central biotargets in the WNT/β-catenin signaling and Hippo signaling pathways. We have previously developed tankyrase inhibitors bearing a 1,2,4-triazole moiety and binding ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 8, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c00208" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2020 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00208" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c00208" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00208" /></link>
        
    
    

<title>Preclinical Lead Optimization of a 1,2,4-Triazole Based Tankyrase Inhibitor | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c00208" /></meta><meta property="og:title" content="Preclinical Lead Optimization of a 1,2,4-Triazole Based Tankyrase Inhibitor" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00208/20210315/images/large/jm0c00208_0010.jpeg" /></meta><meta property="og:description" content="Tankyrases 1 and 2 are central biotargets in the WNT/β-catenin signaling and Hippo signaling pathways. We have previously developed tankyrase inhibitors bearing a 1,2,4-triazole moiety and binding predominantly to the adenosine binding site of the tankyrase catalytic domain. Here we describe a systematic structure-guided lead optimization approach of these tankyrase inhibitors. The central 1,2,4-triazole template and trans-cyclobutyl linker of the lead compound 1 were left unchanged, while side-group East, West, and South moieties were altered by introducing different building blocks defined as point mutations. The systematic study provided a novel series of compounds reaching picomolar IC50 inhibition in WNT/β-catenin signaling cellular reporter assay. The novel optimized lead 13 resolves previous atropisomerism, solubility, and Caco-2 efflux liabilities. 13 shows a favorable ADME profile, including improved Caco-2 permeability and oral bioavailability in mice, and exhibits antiproliferative efficacy in the colon cancer cell line COLO 320DM in vitro." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c00208"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00208">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c00208&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c00208&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c00208&amp;href=/doi/10.1021/acs.jmedchem.0c00208" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 13</span><span class="cit-fg-pageRange">, 6834-6846</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/13" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c00151" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c00225" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Preclinical Lead Optimization of a 1,2,4-Triazole Based Tankyrase Inhibitor</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Jo Waaler</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jo Waaler</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Hybrid Technology Hub—Centre of Excellence, Institute of Basic Medical Sciences, University of Oslo, P.O. Box 1110 Blindern, 0317 Oslo, Norway</div><div class="loa-info-affiliations-info">Department of Immunology and Transfusion Medicine, Oslo University Hospital, P.O. Box 4950 Nydalen, 0424 Oslo, Norway</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#5b3134752c3a3a373e291b292976293e283e3a293833753534"><span class="__cf_email__" data-cfemail="c3a9acedb4a2a2afa6b183b1b1eeb1a6b0a6a2b1a0abedadac">[email protected]</span></a>. Phone: +47 23 07 90 14.</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jo++Waaler">Jo Waaler</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8501-6225" title="Orcid link">http://orcid.org/0000-0002-8501-6225</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ruben G. G. Leenders</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ruben G. G. Leenders</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Mercachem BV, Kerkenbos 1013, 6546 BB Nijmegen, The Netherlands</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ruben+G.+G.++Leenders">Ruben G. G. Leenders</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sven T. Sowa</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sven T. Sowa</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Faculty of Biochemistry and Molecular Medicine, Biocenter Oulu, University of Oulu, P.O. Box 5400, 90014 Oulu, Finland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sven+T.++Sowa">Sven T. Sowa</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Shoshy Alam Brinch</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shoshy Alam Brinch</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Hybrid Technology Hub—Centre of Excellence, Institute of Basic Medical Sciences, University of Oslo, P.O. Box 1110 Blindern, 0317 Oslo, Norway</div><div class="loa-info-affiliations-info">Department of Immunology and Transfusion Medicine, Oslo University Hospital, P.O. Box 4950 Nydalen, 0424 Oslo, Norway</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shoshy++Alam+Brinch">Shoshy Alam Brinch</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Max Lycke</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Max Lycke</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Hybrid Technology Hub—Centre of Excellence, Institute of Basic Medical Sciences, University of Oslo, P.O. Box 1110 Blindern, 0317 Oslo, Norway</div><div class="loa-info-affiliations-info">Department of Immunology and Transfusion Medicine, Oslo University Hospital, P.O. Box 4950 Nydalen, 0424 Oslo, Norway</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Max++Lycke">Max Lycke</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Piotr Nieczypor</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Piotr Nieczypor</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Mercachem BV, Kerkenbos 1013, 6546 BB Nijmegen, The Netherlands</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Piotr++Nieczypor">Piotr Nieczypor</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sjoerd Aertssen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sjoerd Aertssen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Mercachem BV, Kerkenbos 1013, 6546 BB Nijmegen, The Netherlands</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sjoerd++Aertssen">Sjoerd Aertssen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sudarshan Murthy</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sudarshan Murthy</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Faculty of Biochemistry and Molecular Medicine, Biocenter Oulu, University of Oulu, P.O. Box 5400, 90014 Oulu, Finland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sudarshan++Murthy">Sudarshan Murthy</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Albert Galera-Prat</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Albert Galera-Prat</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Faculty of Biochemistry and Molecular Medicine, Biocenter Oulu, University of Oulu, P.O. Box 5400, 90014 Oulu, Finland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Albert++Galera-Prat">Albert Galera-Prat</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Eddy Damen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Eddy Damen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Mercachem BV, Kerkenbos 1013, 6546 BB Nijmegen, The Netherlands</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Eddy++Damen">Eddy Damen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Anita Wegert</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Anita Wegert</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Mercachem BV, Kerkenbos 1013, 6546 BB Nijmegen, The Netherlands</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Anita++Wegert">Anita Wegert</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Marc Nazaré</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Marc Nazaré</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry, Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Campus Berlin Buch, Robert-Roessle-Straße 10, 13125 Berlin, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Marc++Nazar%C3%A9">Marc Nazaré</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lari Lehtiö</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lari Lehtiö</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Faculty of Biochemistry and Molecular Medicine, Biocenter Oulu, University of Oulu, P.O. Box 5400, 90014 Oulu, Finland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lari++Lehti%C3%B6">Lari Lehtiö</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7250-832X" title="Orcid link">http://orcid.org/0000-0001-7250-832X</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Stefan Krauss</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Stefan Krauss</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Hybrid Technology Hub—Centre of Excellence, Institute of Basic Medical Sciences, University of Oslo, P.O. Box 1110 Blindern, 0317 Oslo, Norway</div><div class="loa-info-affiliations-info">Department of Immunology and Transfusion Medicine, Oslo University Hospital, P.O. Box 4950 Nydalen, 0424 Oslo, Norway</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Stefan++Krauss">Stefan Krauss</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00208&amp;href=/doi/10.1021%2Facs.jmedchem.0c00208" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 13</span><span class="cit-pageRange">, 6834–6846</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 8, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>5 February 2020</li><li><span class="item_label"><b>Published</b> online</span>8 June 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 9 July 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c00208" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00208</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="https://acsopenscience.org/open-access/licensing-options/"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a><span class="article_header-cc-by"><a href="https://creativecommons.org/licenses/by/4.0/"><img src="/pb-assets/images/licensesLogos/OA_Icons_cc-1612971093887.svg" alt="CC: Creative Commons" /></img><span><strong>CC: </strong>Creative Commons</span></a><a href="https://creativecommons.org/licenses/by/4.0/"><img src="/pb-assets/images/licensesLogos/OA_Icons_by-1612971093257.svg" alt="BY: Credit must be given to the creator" /></img><span><strong>BY: </strong>Credit must be given to the creator</span></a></span></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c00208"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2265</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">5</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c00208" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Preclinical Lead Optimization of a 1,2,4-Triazole Based Tankyrase Inhibitor&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Jo&quot;,&quot;last_name&quot;:&quot;Waaler&quot;},{&quot;first_name&quot;:&quot;Ruben&quot;,&quot;last_name&quot;:&quot;G. G. Leenders&quot;},{&quot;first_name&quot;:&quot;Sven&quot;,&quot;last_name&quot;:&quot;T. Sowa&quot;},{&quot;first_name&quot;:&quot;Shoshy&quot;,&quot;last_name&quot;:&quot;Alam Brinch&quot;},{&quot;first_name&quot;:&quot;Max&quot;,&quot;last_name&quot;:&quot;Lycke&quot;},{&quot;first_name&quot;:&quot;Piotr&quot;,&quot;last_name&quot;:&quot;Nieczypor&quot;},{&quot;first_name&quot;:&quot;Sjoerd&quot;,&quot;last_name&quot;:&quot;Aertssen&quot;},{&quot;first_name&quot;:&quot;Sudarshan&quot;,&quot;last_name&quot;:&quot;Murthy&quot;},{&quot;first_name&quot;:&quot;Albert&quot;,&quot;last_name&quot;:&quot;Galera-Prat&quot;},{&quot;first_name&quot;:&quot;Eddy&quot;,&quot;last_name&quot;:&quot;Damen&quot;},{&quot;first_name&quot;:&quot;Anita&quot;,&quot;last_name&quot;:&quot;Wegert&quot;},{&quot;first_name&quot;:&quot;Marc&quot;,&quot;last_name&quot;:&quot;Nazaré&quot;},{&quot;first_name&quot;:&quot;Lari&quot;,&quot;last_name&quot;:&quot;Lehtiö&quot;},{&quot;first_name&quot;:&quot;Stefan&quot;,&quot;last_name&quot;:&quot;Krauss&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;08&quot;,&quot;issue&quot;:&quot;13&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;6834-6846&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c00208&quot;},&quot;abstract&quot;:&quot;Tankyrases 1 and 2 are central biotargets in the WNT/β-catenin signaling and Hippo signaling pathways. We have previously developed tankyrase inhibitors bearing a 1,2,4-triazole moiety and binding predominantly to the adenosine binding site of the tankyrase catalytic domain. Here we describe a systematic structure-guided lead optimization approach of these tankyrase inhibitors. The central 1,2,4-triazole template and trans-cyclobutyl linker of the lead compound 1 were left unchanged, while side-group East, West, and South moieties were altered by introducing different building blocks defined as point mutations. The systematic study provided a novel series of compounds reaching picomolar IC50 inhibition in WNT/β-catenin signaling cellular reporter assay. The novel optimized lead 13 resolves previous atropisomerism, solubility, and Caco-2 efflux liabilities. 13 shows a favorable ADME profile, including improved Caco-2 permeability and oral bioavailability in mice, and exhibits antiproliferative efficacy in the &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00208&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00208" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00208&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00208" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00208&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00208" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00208&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00208&amp;href=/doi/10.1021/acs.jmedchem.0c00208" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c00208" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c00208" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (9 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c00208%26sid%3Dliteratum%253Aachs%26pmid%3D32511917%26genre%3Darticle%26aulast%3DWaaler%26date%3D2020%26atitle%3DPreclinical%2BLead%2BOptimization%2Bof%2Ba%2B1%252C2%252C4-Triazole%2BBased%2BTankyrase%2BInhibitor%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D13%26spage%3D6834%26epage%3D6846%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (3)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291297" title="Cell signaling">Cell signaling</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292304" title="Optimization">Optimization</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291454" title="Solubility">Solubility</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/13" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/jmcmar.2020.63.issue-13/20200709/jmcmar.2020.63.issue-13.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00208/20210315/images/medium/jm0c00208_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00208/20210315/images/large/jm0c00208_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00208&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Tankyrases 1 and 2 are central biotargets in the WNT/β-catenin signaling and Hippo signaling pathways. We have previously developed tankyrase inhibitors bearing a 1,2,4-triazole moiety and binding predominantly to the adenosine binding site of the tankyrase catalytic domain. Here we describe a systematic structure-guided lead optimization approach of these tankyrase inhibitors. The central 1,2,4-triazole template and <i>trans-</i>cyclobutyl linker of the lead compound <b>1</b> were left unchanged, while side-group East, West, and South moieties were altered by introducing different building blocks defined as point mutations. The systematic study provided a novel series of compounds reaching picomolar IC<sub>50</sub> inhibition in WNT/β<i>-</i>catenin signaling cellular reporter assay. The novel optimized lead <b>13</b> resolves previous atropisomerism, solubility, and Caco-2 efflux liabilities. <b>13</b> shows a favorable ADME profile, including improved Caco-2 permeability and oral bioavailability in mice, and exhibits antiproliferative efficacy in the colon cancer cell line COLO 320DM <i>in vitro.</i></p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16166" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16166" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Tankyrase 1 and tankyrase 2 (TNKS1/2) are members of the PARP family of enzymes that control protein activities, interactions, and turnover through mono- or poly-ADP-ribosylation.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> TNKS1/2 regulate a number of target proteins, including AXIN1 and AXIN2 (AXIN1/2) in the β-catenin destruction complex resulting in WNT/β<i>-</i>catenin signaling pathway inhibition, and AMOT proteins in the Hippo signaling pathway resulting in YAP signaling inhibition.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1−3)</a> Tankyrases, through their ankyrin repeat clusters, bind to AXIN1/2, making AXIN1/2 accessible for ADP-ribosylation by the C-terminal TNKS1/2 catalytic domain.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> AXIN1/2 is subsequently targeted for proteasomal degradation through polyubiquitination of E3 ubiquitin ligase RNF146, recognizing the poly-ADP-ribose signal.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> Destabilization of AXIN1/2, being a structural protein in the β<i>-</i>catenin destruction complex, leads to increased β<i>-</i>catenin levels which can be counteracted by inhibition of TNKS1/2 catalytic activity.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> Similarly, TNKS1/2 control the stability of AMOT proteins via RNF146. Stabilization of AMOT proteins by inhibiting TNKS1/2 activity sequesters YAP to the cytoplasm and prevents target gene expression driven by YAP in the nucleus.<a onclick="showRef(event, 'ref1 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref3">(1,3)</a> TNKS1/2 catalytic activities also interfere with other biological mechanisms and cell signaling pathways such as vesicle transport, energy metabolism, telomere homeostasis, and mitotic spindle formation and affect components in AKT/PI3K and AMPK signaling pathways.<a onclick="showRef(event, 'ref1 ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref1 ref4 ref5 ref6">(1,4−6)</a></div><div class="NLM_p">Several groups of chemical substances have been identified that inhibit TNKS1/2 by binding to the substrate NAD<sup>+</sup> binding site either by occupying a nicotinamide pocket, adenosine binding pocket or by addressing both of them.<a onclick="showRef(event, 'ref2 ref7 ref8 ref9 ref10 ref11 ref12 ref13 ref14 ref15 ref16 ref17 ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref2 ref7 ref8 ref9 ref10 ref11 ref12 ref13 ref14 ref15 ref16 ref17 ref18 ref19 ref20">(2,7−20)</a> Although the catalytic domains of 17 human ARTD/PARP enzymes are homologous, unique features in the TNKS1/2 catalytic domain allow the development of tankyrase-selective chemical inhibitors.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Despite this progress, there is currently no viable selective TNKS1/2 inhibitor in clinical testing or practice for any application including targeting the WNT/β<i>-</i>catenin and YAP signaling pathways in cancer therapy.<a onclick="showRef(event, 'ref17 ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref17 ref21 ref22 ref23">(17,21−23)</a></div><div class="NLM_p">It has been shown that TNKS1/2 inhibitors can exhibit anticancer efficacy in mouse models, either as monotherapy against colorectal cancer<a onclick="showRef(event, 'ref8 ref24'); return false;" href="javascript:void(0);" class="ref ref8 ref24">(8,24)</a> and osteosarcoma<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> or in combination therapies together with PI3K and EGFR inhibitors against colorectal cancer<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> or with PD-1 inhibition against melanoma.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><div class="NLM_p">Two reports indicate intestinal toxicity<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and bone loss<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> in mouse models upon treatment with early lead-stage tankyrase inhibitors, while other reports do not document signs of toxicity, intestinal injury, or body weight changes.<a onclick="showRef(event, 'ref8 ref26 ref27 ref29'); return false;" href="javascript:void(0);" class="ref ref8 ref26 ref27 ref29">(8,26,27,29)</a> Hence, there is a continued need for the development of safe drugs directed toward TNKS1/2 and the WNT/β<i>-</i>catenin signaling pathway with improved chemical and biophysical properties.<a onclick="showRef(event, 'ref17 ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref17 ref21 ref22 ref23">(17,21−23)</a></div><div class="NLM_p last">The compound optimization described here is based on the understanding of the structure–activity relationship, crystallography, and physicochemical properties of our previous 1,2,4-triazole analogue series JW74,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> G007-LK,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> and OD336 (<b>1</b>).<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> The optimization focused especially on the solubility and atropisomerism liabilities of the former G007-LK and <b>1</b> compounds, respectively. In our work we developed a novel series of compounds reaching picomolar IC<sub>50</sub> activity in a cellular WNT/β<i>-</i>catenin signaling reporter assay. Lead compound OM-1700 (<b>13</b>) within the novel series displays high potency and specificity and has overall favorable ADME properties compared to benchmark tankyrase inhibitors.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30225" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30225" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemistry</h3><div class="NLM_p">For the synthesis of novel structures in the optimization campaign, we embraced a building block approach (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). Herein we were able to prepare all compounds following the same synthetic route, simplifying synthesis efforts (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Cyclic amide/urea/carbamate East modifications, however, required a different route (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). Since the 1,2,4-triazole as a central scaffold was well established in our previous research,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> it was left unchanged in the present lead optimization process. In the linker area between the 1,2,4-triazole and the East moieties, we synthesized a series of analogues with a bicyclo[1.1.1]pentane configuration and one compound with a <i>cis</i>-cyclobutane setup. These linker variations were synthesized according to the same scheme as for the default <i>trans</i> linker. For further optimization, the <i>trans-</i>cyclobutyl linker was left unchanged for the majority of the target molecules as it proved to be superior to the tested alternative linker iterations.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00208/20210315/images/medium/jm0c00208_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00208/20210315/images/large/jm0c00208_0001.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Lead compound <b>1</b> and the building blocks defined as West (red), South (blue), East (green), and linker (pink).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00208/20210315/images/large/jm0c00208_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00208&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00208/20210315/images/medium/jm0c00208_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00208/20210315/images/large/jm0c00208_0006.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. (a, Left) Synthesis of Targets with South and West Variations and (b, Right) Synthesis of Targets with East Variations</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00208/20210315/images/large/jm0c00208_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00208&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00208/20210315/images/medium/jm0c00208_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00208/20210315/images/large/jm0c00208_0007.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of <b>18</b> and <b>51</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00208/20210315/images/large/jm0c00208_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00208&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">For compounds having the benzimidazolone West moiety of <b>1</b>, synthesis was performed as depicted in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>a and described in our previous work.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> For East-side variations, a slightly different route enabling East variations in the last step departing from amine <b>G</b> was used (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>b).</div><div class="NLM_p">As a first iteration, we replaced the East benzimidazolone group as in our experience this group can result in unwanted solubility, permeability, and efflux properties. When suitable East-amides were identified as a replacement for the benzimidazolone group, a wide range of further options for East-side iterations opened enabling fine-tuning of physicochemical properties. Next, we replaced the West-pyrimidine as this group renders the molecule vulnerable for CYP-mediated oxidation which was confirmed by Med-Id studies of <b>1</b>.</div><div class="NLM_p last">To synthesize a broad set of targets, we optimized the triazole-forming reaction from <b>E</b> to <b>G</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>b) from the existing method (TFA, DMA, 120 °C, 14 h, 10–21% yield). Here, we found that heating of <b>E</b> and <b>3a</b> in 1-butanol at 80–140 °C for 5–20 h, depending on the actual substrate, typically resulted in 60–90% yield. Under these conditions, a broader scope of South and West moieties was tolerated in the reaction. All compounds in the present study were prepared accordingly except the benzisoxazolone <b>18</b> and lactam <b>51</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). For compounds with the <i>cis</i>-cyclobutane (<b>75</b>) and bicyclo[1.1.1]pentane (<b>19</b>) moieties, the corresponding hydrazides <b>3b</b> and <b>3c</b> respectively were used (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>b).</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Biological Evaluation</h3><div class="NLM_p">All compounds were tested using a TNKS2 biochemical assay and a luciferase-based WNT/β<i>-</i>catenin signaling pathway reporter assay in human HEK293 cells.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> In the first round of the optimization campaign, we prepared single-point modifications changing any of the four regions in <b>1</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) while leaving the other regions constant. In the following stages of the optimization campaign, additional East, West, and South moieties were also utilized, combining the best structural elements of the first single-point modification round. For the optimization, <i>in vitro</i> ADME properties and solubility of selected compounds were measured. Mouse pharmacokinetics, after oral dosing, was tested for the selected and short-listed compounds <b>13</b>, <b>16</b>, and <b>27</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>c and indicated by # in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00208/20210315/images/medium/jm0c00208_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00208/20210315/images/large/jm0c00208_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (a) Selected key compounds in the optimization campaign and respective TNKS2 and HEK293 IC<sub>50</sub> values. Mean ± SD values for three independent experiments are shown. Moieties are in color when differing from <b>1</b>. (b) ADME data of key compounds. (c) Cellular efficacy and mouse po PK 5 mg/kg of the short-listed compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00208/20210315/images/large/jm0c00208_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00208&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Hybrids Derived from <b>19</b> and <b>20</b>, <b>22</b>, and three West Moieties<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00208/20210315/images/medium/jm0c00208_0008.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup><sup>a</sup></sup><p class="last"># indicates that these compounds were evaluated in a mouse pharmacokinetics analysis.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. 2D East (Green) and West Library (Red) with TNKS2 IC<sub>50</sub> (nM), HEK293 IC<sub>50</sub> (nM), and Solubility (μM) Values Depicted<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00208/20210315/images/medium/jm0c00208_0009.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup><sup>a</sup></sup><p class="last"># indicates that the compound was evaluated in a mouse pharmacokinetics analysis.</p></div></div><div></div></div><div class="NLM_p">Since <b>1</b> displayed low solubility and high Caco-2 efflux,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> we substituted the benzimidazolone NH group by forming the <i>N</i>-Me variant <b>17</b>;<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> however, this resulted in a 20-fold less efficacious compound (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>a). Likewise, the oxygen-containing analogue <b>18</b> displayed decreased efficacy when compared to <b>1</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>a). We then replaced the benzimidazolone moiety,<a onclick="showRef(event, 'ref10 ref20'); return false;" href="javascript:void(0);" class="ref ref10 ref20">(10,20)</a> as this can inflict high efflux and low solubility by a series of East-positioned amides. From these amides, <b>20</b> and <b>21</b> turned out to be the most potent resulting in picomolar cellular inhibitory IC<sub>50</sub> efficacies (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>a). Solubility and Caco-2 cell permeation were completely restored in <b>21</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>b). The amide having the <i>N</i>-Me group (<b>44</b>) was inactive, whereas activity was restored in the cyclic version (<b>51</b>) (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00208/suppl_file/jm0c00208_si_001.pdf" class="ext-link">Supplementary Table 1a</a>). Nonaromatic amides (<b>52</b>, <b>53</b>, and <b>54</b>) resulted in inactive compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00208/suppl_file/jm0c00208_si_001.pdf" class="ext-link">Supplementary Table 1a</a>).</div><div class="NLM_p">To interrogate the West-side of the pharmacophore, pyridine and pyrimidine analogues were prepared. These compounds inhibited the cellular WNT/β-catenin signaling pathway reporter assay to a similar extent as lead <b>1</b>, except the 2-pyrimidyl substituted compound (<b>56</b>). The ethoxypyridyl derivative <b>22</b> was consequently selected as a starting point for further hybrid synthesis (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>a and <a href="/doi/suppl/10.1021/acs.jmedchem.0c00208/suppl_file/jm0c00208_si_001.pdf" class="ext-link">Supplementary Table 1b</a>). Introduction of thiazoles to replace the six-membered heterocycle resulted in less efficacious compounds, with <b>59</b> displaying the most favorable properties in this cluster (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00208/suppl_file/jm0c00208_si_001.pdf" class="ext-link">Supplementary Table 1b</a>). Introduction of aliphatic rings, such as cyclopentane in <b>63</b> and cyclopropane in <b>64</b>, indicated that aromatic ring systems are required in this position for maintaining potency (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00208/suppl_file/jm0c00208_si_001.pdf" class="ext-link">Supplementary Table 1b</a>).</div><div class="NLM_p">Next, in a series of synthesized South-aryl products, the 2-trifluoromethyl (<b>66</b>) showed comparable activities to the previous lead <b>1</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00208/suppl_file/jm0c00208_si_001.pdf" class="ext-link">Supplementary Table 1b</a>). The thiophenyl moeity as a bioisosteric replacement for the aryl group was less tolerated, while cycloalkyl replacements resulted in activities in the micromolar range (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00208/suppl_file/jm0c00208_si_001.pdf" class="ext-link">Supplementary Table 1c</a>).</div><div class="NLM_p">Linker variations were addressed with the <i>cis</i>-cyclobutyl linker and bicyclo[1.1.1]pentane linker <b>75</b> and <b>19</b>, respectively (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00208/suppl_file/jm0c00208_si_001.pdf" class="ext-link">Supplementary Table 1d</a>). Compound <b>75</b> displayed decreased potency (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00208/suppl_file/jm0c00208_si_001.pdf" class="ext-link">Supplementary Table 1d</a>), while compound <b>19</b> suffered from low solubility (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>b). Despite the more rigid geometry of the bicyclo[1.1.1]pentane in comparison to <i>trans</i>-cyclobutyl of <b>1</b>, the cocrystal structure with TNKS2 showed a very similar binding mode at the NAD<sup>+</sup> binding cleft (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). <b>105</b> occupied the adenosine subpocket and formed the typical hydrogen bonds to the backbone amides of Tyr1060 and Asp1045 (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>a and <a href="/doi/suppl/10.1021/acs.jmedchem.0c00208/suppl_file/jm0c00208_si_001.pdf" class="ext-link">Supplementary Figure 1a</a>). A water molecule forms bridging interactions between the pyridine nitrogen and Gly1058 and Tyr1050, and the same applies to all the cocrystal structures described (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>a).</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00208/20210315/images/medium/jm0c00208_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00208/20210315/images/large/jm0c00208_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Cocrystal structures of TNKS2 with inhibitors. (a) Binding mode of <b>105</b> with TNKS2 catalytic domain (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6TKN">6TKN</a>). (b) Binding mode of <b>13</b> with TNKS2 catalytic domain (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6TG4">6TG4</a>). (c) Binding mode of <b>10</b> with TNKS2 catalytic domain (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6TKM">6TKM</a>). (d) Binding mode of <b>88</b> with TNKS2 catalytic domain (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6TKS">6TKS</a>). The dashed lines in black represent hydrogen bonds, and the red spheres represent water molecules. The σ<sub>A</sub> weighted 2<i>F</i><sub>o</sub> – <i>F</i><sub>c</sub> electron density maps around the ligands are contoured at (1.4–1.7)σ. Structures were solved with molecular replacement using the structure of TNKS2 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NOB">5NOB</a>) as a starting model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00208/20210315/images/large/jm0c00208_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00208&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Rotational isomerism (atropisomerism) is a known phenomenon for substituted triazoles and can potentially lead to complexity and challenges for the drug discovery and development processes as atropisomers might have differing biological activities toward a target, different off-target profiles, and different pharmacokinetic properties.<a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32,33)</a> Since <b>1</b> does not contain asymmetric centers, atropisomers are mirror images (enantiomers). Hence, on an achiral HPLC column, as well as in NMR, such atropisomers are indiscernible. In contrast, on a chiral SFC column, lead <b>1</b> showed two signals indicating rotational isomerism (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). When separated, these isomers did not interconvert at 20 °C for 72 h but showed a minor interconversion at 70 °C during 72 h (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Interestingly, both isomers, <b>1</b>-AT-1 and <b>1</b>-AT-2, differed in potency and efficacy with a factor of 30 to almost 60, respectively (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). To investigate whether atropisomerism was induced by the South 2-chlorophenyl substituent, we analyzed all synthesized compounds with chiral SFC. All compounds with a South 2-chlorophenyl group showed atropisomers, while compounds without this group, including the symmetric 2,6-dichlorophenyl <b>67</b>, did not (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00208/suppl_file/jm0c00208_si_001.pdf" class="ext-link">Supplementary Table 1c</a>). In addition, <b>66</b>, containing a bulky 2-trifluoromethyl group, also showed two signals on a chiral SFC column. No rotamers were observed for the 2-fluorophenyl South group at room temperature. Hence, this group was considered a viable substitution to avoid atropisomerism. As a consequence, in the following optimization campaign, the South 2-chlorophenyl moiety was replaced with the 2-fluorophenyl group of <b>23</b> resulting in acceptable efficacy compared to other substitutions (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>a and <a href="/doi/suppl/10.1021/acs.jmedchem.0c00208/suppl_file/jm0c00208_si_001.pdf" class="ext-link">Supplementary Table 1c</a>).</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00208/20210315/images/medium/jm0c00208_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00208/20210315/images/large/jm0c00208_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Atropisomerism of <b>1</b> (stereochemistry arbitrarily assigned) on chiral SFC and TNKS2 and HEK293 IC<sub>50</sub> values.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00208/20210315/images/large/jm0c00208_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00208&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The comparison of the binding modes of the 2-halogen-substituted compounds showed that the chlorine or fluorine atoms were pointing into the same direction in the TNKS2 active site (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.0c00208/suppl_file/jm0c00208_si_001.pdf" class="ext-link">Supplementary Figure 1b–e</a>). This is in agreement with the clear difference in the measured potencies of the atropisomers (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). The South moiety without a halogen was less potent, had similar orientation in the binding pocket, but caused a conformational change in the Tyr1050 covering the active site (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00208/suppl_file/jm0c00208_si_001.pdf" class="ext-link">Supplementary Figure 1d</a>).</div><div class="NLM_p">Next, all possible hybrid combinations were synthesized employing the East moieties of compounds <b>20</b> and <b>21</b>, a South 2-fluorophenyl group, and three different West moieties revisiting the 2-pyridyl-4-methylsulfonyl moiety as well (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> From these six molecules, compounds with the 1,5-naphthyridine moiety (<b>10</b>, <b>11</b>, and <b>12</b>) showed approximately 30-fold improved cellular inhibitory efficacy compared to their counterparts with the 2-pyridyl moiety (<b>13</b>, <b>14</b>, and <b>15</b>, respectively, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). The binding mode of compound <b>13</b> in cocrystal structures was similar, and the hydrogen bonds to the backbone amides seen in the <b>1</b> cocrystal structures were retained (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.0c00208/suppl_file/jm0c00208_si_001.pdf" class="ext-link">Supplementary Figure 1b</a>). The large East moieties 1,5- and 1,6-naphthyridine (e.g., see <b>87</b>, <b>88</b>, <b>106</b>, and <b>107</b><a href="/doi/suppl/10.1021/acs.jmedchem.0c00208/suppl_file/jm0c00208_si_001.pdf" class="ext-link">Supplementary Figure 4a</a>) appeared to form a more efficient π–π-stacking interaction with His1048 and a hydrophobic interaction with Phe1035, causing the side chain to gradually rotate according to the form of the East moiety (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>c,d, <a href="/doi/suppl/10.1021/acs.jmedchem.0c00208/suppl_file/jm0c00208_si_001.pdf" class="ext-link">Supplementary Figure 1c–e</a>, <a href="/doi/suppl/10.1021/acs.jmedchem.0c00208/suppl_file/jm0c00208_si_001.pdf" class="ext-link">Supplementary Table 2</a>). However, compounds with this naphthyridine moiety were less stable in microsomes relative to the corresponding East-pyridines, and consequently, <b>13</b> was short-listed for mouse pharmacokinetics studies. In addition, the quinoline-containing <b>16</b> displayed similar inhibition in the cellular WNT reporter assay compared to <b>12</b> and also possessed improved calculated physical–chemical properties (ChemAxon, cLogP = 3.0/3.7, tPSA = 128/141 for <b>16</b> and <b>12</b>, respectively) (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>a and <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). On the basis of these results, <b>16</b> was short-listed for mouse pharmacokinetics analysis. Further optimization focused on pyridine-type West-side variations and discarded the West 2-thiazole (<b>11</b>) because of adverse solubility and low efficacy (<b>14</b>) (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). In an East and West 2D library, fluorinated analogues of the 2-pyridyl and the 1,5-naphthyridine were introduced (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.0c00208/suppl_file/jm0c00208_si_001.pdf" class="ext-link">Supplementary Table 2</a>). From these compounds, <b>27</b> was short-listed for mouse pharmacokinetics analysis.</div><div class="NLM_p">Compared to the initial benchmark lead compound <b>1</b>, the peroral mouse pharmacokinetics data of the selected and short-listed compounds showed significantly improved profiles exhibiting lower clearance and volume of distribution and 15–35 times higher exposure (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>c). In due course of the study, <b>13</b> had been further characterized including selectivity toward other members of the PARP family, structural analysis of its binding mode, kinetic solubility, Caco-2 permeability and efflux, CYP3A4 inhibition, mouse plasma stability, mouse plasma protein binding, hERG inhibition, Ames test, and off-target safety panel, exhibiting overall favorable parameters (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>, <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, <a href="/doi/suppl/10.1021/acs.jmedchem.0c00208/suppl_file/jm0c00208_si_001.pdf" class="ext-link">Supplementary Table 3</a> and <a href="/doi/suppl/10.1021/acs.jmedchem.0c00208/suppl_file/jm0c00208_si_001.pdf" class="ext-link">Supplementary Figure 2</a>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Profiling of <b>1</b> and <b>13</b><a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="left">parameter</th><th class="colsep0 rowsep0" align="left"><b>1</b></th><th class="colsep0 rowsep0" align="left"><b>13</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MW (g/mol)</td><td class="colsep0 rowsep0" align="left">468.91</td><td class="colsep0 rowsep0" align="left">458.50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ALogP (LiveDesign 8.6)</td><td class="colsep0 rowsep0" align="left">4.7</td><td class="colsep0 rowsep0" align="left">3.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AlogD (LiveDesign 8.6)</td><td class="colsep0 rowsep0" align="left">5.3</td><td class="colsep0 rowsep0" align="left">4.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">tPSA (LiveDesign 8.6) (Å<sup>2</sup>)</td><td class="colsep0 rowsep0" align="left">118.1</td><td class="colsep0 rowsep0" align="left">94.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TNKS1 (IC<sub>50</sub>, nM)</td><td class="colsep0 rowsep0" align="left">29</td><td class="colsep0 rowsep0" align="left">127</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TNKS2 (IC<sub>50</sub>, nM)</td><td class="colsep0 rowsep0" align="left">6.3</td><td class="colsep0 rowsep0" align="left">14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PARPs/ARTDs (IC<sub>50</sub>, μM), ARTD1/2/3/4/7/8/10/12</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HEK293 cells (IC<sub>50</sub>, nM)</td><td class="colsep0 rowsep0" align="left">19</td><td class="colsep0 rowsep0" align="left">19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">kinetic solubility, PBS, pH = 7 (μM)</td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">95.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Caco-2 A–B: <i>P</i><sub>ap</sub><sub>p</sub> (10<sup>–6</sup> cm/s)</td><td class="colsep0 rowsep0" align="left">10.0</td><td class="colsep0 rowsep0" align="left">39.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Caco-2 efflux ratio</td><td class="colsep0 rowsep0" align="left">4.17</td><td class="colsep0 rowsep0" align="left">0.610</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">microsomal stability, human/mouse, Cl<sub>mt</sub> ((μL/min)/mg protein)</td><td class="colsep0 rowsep0" align="left">242/204</td><td class="colsep0 rowsep0" align="left"><15/37</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hepatocyte stability, human/mouse/dog/rat/cynomolgus, Cl<sub>int</sub> ((μL/min)/10<sup>6</sup> cells)</td><td class="colsep0 rowsep0" align="left">9.8/ND/ND/ND/ND</td><td class="colsep0 rowsep0" align="left"><0.1/28/<0.1/3.8/<0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CYP3A4 inhibition (IC<sub>50</sub>, μM)</td><td class="colsep0 rowsep0" align="left">1.26</td><td class="colsep0 rowsep0" align="left">>25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse plasma stability <i>t</i><sub>1/2</sub> (min)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">880</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse PPB (%)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">93.92</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hERG inhibition (IC<sub>50</sub>, μM)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">>25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Ames test</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">nongenotoxic</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Cerep safety panel, 44 targets (10 μM)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">clean (A2A, 53% inhib)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">bioavailability <i>F</i> (%)</td><td class="colsep0 rowsep0" align="left">47</td><td class="colsep0 rowsep0" align="left">107</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">po PK mouse <i>t</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">0.67</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">po PK mouse Cl ((L/h)/kg)</td><td class="colsep0 rowsep0" align="left">34.0</td><td class="colsep0 rowsep0" align="left">2.09</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">po PK mouse Vd (L/kg)</td><td class="colsep0 rowsep0" align="left">74.2</td><td class="colsep0 rowsep0" align="left">2.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">po PK mouse AUC<sub>0→<i>t</i></sub></td><td class="colsep0 rowsep0" align="left">145</td><td class="colsep0 rowsep0" align="left">2384</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup><sup>a</sup></sup><p class="last">ND = not determined.</p></div></div></div><div class="NLM_p">Tankyrase inhibition can context-dependently antagonize proliferation and viability in cancer cell lines <i>in vitro</i> and <i>in vivo</i>, including in the colorectal adenocarcinoma cell line COLO 320DM harboring WNT/β<i>-</i>catenin signaling-inducing <i>APC</i> mutations.<a onclick="showRef(event, 'ref5 ref22'); return false;" href="javascript:void(0);" class="ref ref5 ref22">(5,22)</a> Hence, cultured COLO 320DM cells were treated with various doses of <b>13</b> to evaluate the efficacy in reducing canonical WNT/β<i>-</i>catenin signaling and the potential as an antiproliferative agent. As expected for a potent tankyrase inhibitor, treatment with <b>13</b> reduced TNKS1/2 protein levels, stabilized AXIN1 and AXIN2 proteins, and reduced the level of transcriptionally active β<i>-</i>catenin (nonphoshorylated) in both the cytoplasmic and nuclear fraction (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>a and <a href="/doi/suppl/10.1021/acs.jmedchem.0c00208/suppl_file/jm0c00208_si_001.pdf" class="ext-link">Supplementary Figure 3a,b</a>). Administration of <b>13</b> also decreased transcription of the WNT/β<i>-</i>catenin signaling target genes <i>AXIN2</i>, <i>DKK1</i>, <i>NKD1</i>, and <i>APCDD1</i> (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>b). Moreover, <b>13</b> exposure decreased proliferation and viability in COLO 320DM cells (GI<sub>50</sub> = 650 nM and GI<sub>25</sub> = 94 nM), while control <i>APC</i><sup>wild-type</sup> RKO colorectal cancer cells were only modestly affected by the treatment at a 10 μM compound concentration (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>c). In conclusion, these results authenticate that <b>13</b> can both potently and specifically inhibit WNT/β<i>-</i>catenin signaling activity and act as an antiproliferative agent in COLO 320DM cells.</div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00208/20210315/images/medium/jm0c00208_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00208/20210315/images/large/jm0c00208_0005.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. <b>13</b> can inhibit WNT/β<i>-</i>catenin signaling activity and act as an antiproliferative agent in COLO 320DM cells. (a) Representative immunoblots of cytoplasmic TNKS1/2, AXIN1, AXIN2 and cytoplasmic and nuclear transcriptionally active β<i>-</i>catenin (non-phospho) and β-catenin. Actin or lamin B1 document equals protein loading, and ∗ indicates that the same actin immunoblot is used as loading control for both AXIN2 and β<i>-</i>catenin. For (a) and (b), control = 0.01% DMSO. (b) Real-time RT-qPCR analyses of WNT/β<i>-</i>catenin signaling target genes (<i>AXIN2</i>, <i>DKK1</i>, <i>NKD1</i>, and <i>APCDD1</i>). For (b) and (c), ANOVA tests (Holm–Sidak method, versus control) are indicated by ∗∗∗ (<i>P</i> < 0.001), and ANOVA on ranks tests (Tukeys test versus control) are indicated by † (<i>P</i> < 0.05). Mean values ± standard deviations for combined data from a minimum of three independent experiments with three replicates each are shown. (c) MTS colorimetric cell growth assay for various doses of 13 in APC<sup>mutated</sup> COLO 320DM (black) and APC<sup>wild-type</sup> RKO (gray) cells. Control = 0. 1% DMSO. Dotted lines depict 50% (GI<sub>50</sub>) and 25% (GI<sub>25</sub>) growth inhibition levels. Mean values ± standard deviations for one representative experiment out of three independent experiments are shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00208/20210315/images/large/jm0c00208_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00208&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25333" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25333" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, through a systematic building-block-based and crystallography-guided structure–activity-relationship analysis, we identified novel 1,2,4-triazole-based optimized lead tankyrase inhibitors with low nanomolar and picomolar IC<sub>50</sub> activities in a WNT/β<i>-</i>catenin signaling cellular reporter assay. The adverse chemical properties of the preceding lead compound <b>1</b>,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> displaying atropisomerism and solubility liabilities, were excluded in the here identified advanced lead compound <b>13</b>. Compound <b>13</b> shows high selectivity toward TNKS1/2, an overall favorable ADME, including highly improved Caco-2 permeability and microsomal stability, a clean off-target safety profile, a >15-fold increased exposure in a mouse pharmacokinetics analysis, and a robust inhibition of WNT/β<i>-</i>catenin signaling and proliferation in the colon cancer cell line COLO 320DM. Our work provides a considerably optimized compound for targeting TNKS1/2 and WNT/β<i>-</i>catenin signaling in cancer and other disease models.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38137" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38137" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> General Methods</h3><div class="NLM_p last">All starting materials and dry solvents were commercially obtained. The synthesis of hydrazide <b>2</b> was scaled up employing a similar procedure reported in our earlier publication.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Reactions were performed under an inert atmosphere of nitrogen when necessary. Microwave reactions were carried out in sealed vials. Column chromatography was carried out on silica gel cartridges (40 μm irregular), and TLC analysis was performed on silica gel 60 F<sub>254</sub> plates.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> NMR</h3><div class="NLM_p last">NMR spectra were recorded in chloroform-<i>d</i>, unless otherwise stated, on a 400 MHz spectrometer with tetramethylsilane as internal standards. Coupling constants are given in Hz. Peaks are reported as singlet (s), doublet (d), triplet (t), quartet (q), quintet (p), sextet (h), septet (hept), multiplet (m), or a combination thereof. br stands for broad.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> LC/MS</h3><div class="NLM_p last">LC/MS chromatograms mass spectra were recorded using electrospray ionization in positive or negative ionization mode on Agilent 1260 Bin: pump, G1312B, degasser; autosampler; ColCom; DAD G1315C; MSD G6130B ESI; eluent A, acetonitrile; eluent B, 10 mM ammonium bicarbonate in water (base mode) or 0.1% formic acid in water (acid mode).</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> HRMS</h3><div class="NLM_p last">HRMS spectra were recorded with a LC-MS Q Exactive Focus spectrometer calibrated with the Pierce calibration solution both in positive and negative modes.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> GC/MS</h3><div class="NLM_p last">Agilent 6890N, injection S/SL; injector 7683. MS: 5973 MS, EI-positive; carrier gas He.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Analytical SFC</h3><div class="NLM_p last">Waters UPC2, Bin pump ACQ-ccBSM; autosampler, column manager, PDA ACQ-PDA; QDA and isocratic pump ACQ-ISM; eluent A, CO<sub>2</sub>; eluent B, MeOH + 20 mM ammonia.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Preparative SFC</h3><div class="NLM_p last">Waters Prep 100 SFC UV/MS directed system; Waters 2998 photodiode array (PDA) detector; Waters Acquity QDa MS detector; Waters 2767 sample manager. Columns: Phenomenex Lux Amylose-1 (250 mm × 21 mm, 5 μm), Phenomenex Lux Cellulose-1 (250 mm × 21.2 mm, 5 μm), Phenomenex Lux Cellulose-2 (250 mm × 21.2 mm, 5 μm), Diacel Chiralpak IC for SFC (250 mm × 20 mm, 5 μm); column temp 35 °C; flow 70 mL/min; ABPR 120 bar; eluent A, CO<sub>2</sub>; eluent B, 20 mM ammonia in methanol. Linear gradient: <i>t</i> = 0 min 10% B, <i>t</i> = 5 min 50% B; <i>t</i> = 7.5 min 50% B. Detection: PDA (210–400 nm). Fraction collection is based on PDA TIC.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Analytical SFC</h3><div class="NLM_p last">Waters UPC2, Bin pump ACQ-ccBSM; autosampler, column manager; PDA ACQ-PDA; QDA and isocratic pump ACQ-ISM. Phenomenex Amylose-1 (100 mm × 4.6 mm, 5 μm); column temp 35 °C; flow 2.5 mL/min; BPR 170 bar; eluent A, CO<sub>2</sub>; eluent B, MeOH + 20 mM ammonia. Linear gradient: <i>t</i> = 0 min 5% B, <i>t</i> = 5 min 50% B; <i>t</i> = 6 min 50% B. Detection: PDA (210–320 nm).</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> MPLC</h3><div class="NLM_p last">Preparative base XSelect. Instrument type: Reveleris prep MPLC; column, Waters XSelect CSH C18 (145 mm × 25 mm, 10 μm); flow 40 mL/min; column temp, room temperature; eluent A, 10 mM ammonium bicarbonate in water (pH = 9.0); eluent B, 99% acetonitrile + 1% 10 mM ammonium bicarbonate in water. Gradient: <i>t</i> = 0 min 5% B, <i>t</i> = 1 min 5% B, <i>t</i> = 2 min 30% B, <i>t</i> = 17 min 70% B, <i>t</i> = 18 min 100% B, <i>t</i> = 23 min 100% B. Detection UV: 220, 254, 340 nm.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> MPLC</h3><div class="NLM_p">Preparative acid Luna. Instrument type: Reveleris prep MPLC; column, Phenomenex Luna C18(3) (150 mm × 25 mm, 10 μm); flow 40 mL/min; column temp, room temperature; eluent A, 0.1% (v/v) formic acid in water; eluent B, 0.1% (v/v) formic acid in acetonitrile. Gradient: <i>t</i> = 0 min 5% B, <i>t</i> = 1 min 5% B, <i>t</i> = 2 min 30% B, <i>t</i> = 17 min 70% B, <i>t</i> = 18 min 100% B, <i>t</i> = 23 min 100% B. Detection UV: 220, 254, 340 nm, ELSD.</div><div class="NLM_p last">All test compounds were found to be >95% pure by LCMS and H NMR analysis. Intermediates in the synthesis were >95% pure unless stated otherwise.</div></div><div id="sec4_10_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 3-(<i>trans</i>-3-(5-(5-Ethoxypyridin-2-yl)-4-(2-fluorophenyl)-4<i>H</i>-1,2,4-triazol-3-yl)cyclobutyl)-1,5-naphthyridine-4-carboxamide (<b>10</b>)</h3><div class="NLM_p last">The title compound was prepared according to general procedure F as a white solid (21.4 mg, 38% yield). LC/MS (ESI) <i>m</i>/<i>z</i> for C<sub>28</sub>H<sub>24</sub>FN<sub>7</sub>O<sub>2</sub> 509 (calcd) 510 ([M + H]<sup>+</sup>, found). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 11.31 (d, <i>J</i> = 5.9 Hz, 1H), 9.14 (d, <i>J</i> = 4.4 Hz, 1H), 8.98 (dd, <i>J</i> = 4.2, 1.8 Hz, 1H), 8.58–8.52 (m, 2H), 8.17 (d, <i>J</i> = 8.8 Hz, 1H), 7.88 (d, <i>J</i> = 2.9 Hz, 1H), 7.74 (dd, <i>J</i> = 8.6, 4.2 Hz, 1H), 7.48–7.40 (m, 1H), 7.26–7.14 (m, 4H), 4.84 (h, <i>J</i> = 6.9 Hz, 1H), 4.04 (q, <i>J</i> = 7.0 Hz, 2H), 3.53 (tt, <i>J</i> = 10.3, 5.6 Hz, 1H), 3.14–3.02 (m, 2H), 2.62–2.48 (m, 2H), 1.40 (t, <i>J</i> = 7.0 Hz, 3H).</div></div><div id="sec4_10_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 3-(<i>trans</i>-3-(4-(2-Fluorophenyl)-5-(thiazol-2-yl)-4<i>H</i>-1,2,4-triazol-3-yl)cyclobutyl)-1,5-naphthyridine-4-carboxamide (<b>11</b>)</h3><div class="NLM_p last">The title compound was prepared according to general procedure F as a white solid (6.6 mg, 23% yield). LC/MS (ESI) <i>m</i>/<i>z</i> for C<sub>24</sub>H<sub>18</sub>FN<sub>7</sub>OS 471 (calcd) 472 ([M + H]<sup>+</sup>, found). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 11.33 (d, <i>J</i> = 6.0 Hz, 1H), 9.15 (d, <i>J</i> = 4.5 Hz, 1H), 8.98 (dd, <i>J</i> = 4.2, 1.8 Hz, 1H), 8.59–8.52 (m, 2H), 7.75 (dd, <i>J</i> = 8.5, 4.2 Hz, 1H), 7.65 (d, <i>J</i> = 3.2 Hz, 1H), 7.57–7.47 (m, 1H), 7.37 (d, <i>J</i> = 3.2 Hz, 1H), 7.34–7.22 (m, 3H), 4.92–4.80 (m, 1H), 3.60–3.49 (m, 1H), 3.15–3.02 (m, 2H), 2.68–2.51 (m, 2H).</div></div><div id="sec4_10_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 3-(<i>trans</i>-3-(4-(2-Fluorophenyl)-5-(5-(methylsulfonyl)pyridin-2-yl)-4<i>H</i>-1,2,4-triazol-3-yl)cyclobutyl)-1,5-naphthyridine-4-carboxamide (<b>12</b>)</h3><div class="NLM_p last">The title compound was prepared according to general procedure F as a white solid (14.8 mg, 53% yield). LC/MS (ESI) <i>m</i>/<i>z</i> for C<sub>27</sub>H<sub>22</sub>FN<sub>7</sub>O<sub>3</sub>S 543 (calcd) 544 ([M + H]<sup>+</sup> found). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 11.31 (br d, <i>J</i> = 6.1 Hz, 1H), 9.15 (d, <i>J</i> = 4.5 Hz, 1H), 8.97 (dd, <i>J</i> = 4.2, 1.8 Hz, 1H), 8.73 (dd, <i>J</i> = 2.5, 0.8 Hz, 1H), 8.57 (pseudo d, <i>J</i> = 1.6 Hz, 1H), 8.55 (pseudo d, <i>J</i> = 4.2 Hz, 2H), 8.29 (dd, <i>J</i> = 8.3, 2.3 Hz, 1H), 7.74 (dd, <i>J</i> = 8.5, 4.2 Hz, 1H), 7.55–7.46 (m, 1H), 7.30–7.19 (m, 3H), 4.89 (h, <i>J</i> = 7.1 Hz, 1H), 3.55 (tt, <i>J</i> = 10.0, 5.5 Hz, 1H), 3.17–3.02 (m, 2H), 3.08 (s, 3H), 2.69–2.52 (m, 2H).</div></div><div id="sec4_10_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 3-(<i>trans</i>-3-(5-(5-Ethoxypyridin-2-yl)-4-(2-fluorophenyl)-4<i>H</i>-1,2,4-triazol-3-yl)cyclobutyl)picolinamide (<b>13</b>)</h3><div class="NLM_p last">The title compound was prepared according to general procedure F as a white solid (16.8 mg, 46% yield). LC/MS (ESI) <i>m</i>/<i>z</i> for C<sub>25</sub>H<sub>23</sub>FN<sub>6</sub>O<sub>2</sub> = 458 (calculated), 459 ([M + H]<sup>+</sup>, found). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 8.53 (dt, <i>J</i> = 4.7, 1.3 Hz, 1H), 8.21 (d, <i>J</i> = 7.0 Hz, 1H), 8.19–8.12 (m, 2H), 7.88 (d, <i>J</i> = 2.8 Hz, 1H), 7.83 (td, <i>J</i> = 7.7, 1.7 Hz, 1H), 7.48–7.38 (m, 2H), 7.24–7.15 (m, 4H), 4.76 (h, <i>J</i> = 7.0 Hz, 1H), 4.04 (q, <i>J</i> = 6.9 Hz, 2H), 3.47 (tt, <i>J</i> = 10.0, 5.1 Hz, 1H), 3.09–2.97 (m, 2H), 2.52–2.36 (m, 2H), 1.40 (t, <i>J</i> = 7.0 Hz, 3H). HRMS 459.19393 ([M + H]<sup>+</sup>, calculated), 459.19353 ([M + H]<sup>+</sup>, found), Δ = −0.87 ppm.</div></div><div id="sec4_10_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 3-(<i>trans</i>-3-(4-(2-Fluorophenyl)-5-(thiazol-2-yl)-4<i>H</i>-1,2,4-triazol-3-yl)cyclobutyl)picolinamide (<b>14</b>)</h3><div class="NLM_p last">The title compound was prepared according to general procedure F as a white solid (21.3 mg, 84% yield). LC/MS (ESI) <i>m</i>/<i>z</i> for C<sub>21</sub>H<sub>17</sub>FN<sub>6</sub>OS 420 (calcd) 421 ([M + H]<sup>+</sup>, found). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 8.53 (dq, <i>J</i> = 4.5, 0.9 Hz, 1H), 8.23 (br d, <i>J</i> = 7.0 Hz, 1H), 8.17 (dt, <i>J</i> = 7.8, 1.1 Hz, 1H), 7.84 (td, <i>J</i> = 7.7, 1.7 Hz, 1H), 7.64 (d, <i>J</i> = 3.2 Hz, 1H), 7.57–7.49 (m, 1H), 7.43 (ddd, <i>J</i> = 7.8, 4.7, 1.3 Hz, 1H), 7.37 (d, <i>J</i> = 3.2 Hz, 1H), 7.33–7.27 (m, 2H), 7.26–7.21 (m, 1H), 4.78 (h, <i>J</i> = 7.0 Hz, 1H), 3.54–3.43 (m, 1H), 3.11–2.96 (m, 2H), 2.56–2.39 (m, 2H). HRMS 421.12413 ([M + H]<sup>+</sup>, calculated), 421.12330 ([M + H]<sup>+</sup>, found), Δ = −0.84 ppm.</div></div><div id="sec4_10_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 3-(<i>trans</i>-3-(4-(2-Fluorophenyl)-5-(5-(methylsulfonyl)pyridin-2-yl)-4<i>H</i>-1,2,4-triazol-3-yl)cyclobutyl)picolinamide (<b>15</b>)</h3><div class="NLM_p last">The title compound was prepared according to general procedure F as a white solid (6.1 mg, 40% yield). LC/MS (ESI) <i>m</i>/<i>z</i> for C<sub>24</sub>H<sub>21</sub>FN<sub>6</sub>O<sub>3</sub>S 492 (calcd) 493 ([M + H]<sup>+</sup> found). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 8.72 (d, <i>J</i> = 2.3 Hz, 1H), 8.58–8.51 (m, 2H), 8.28 (dd, <i>J</i> = 8.4, 2.3 Hz, 1H), 8.23 (br d, <i>J</i> = 7.0 Hz, 1H), 8.17 (dt, <i>J</i> = 7.7, 1.1 Hz, 1H), 7.84 (td, <i>J</i> = 7.7, 1.7 Hz, 1H), 7.55–7.47 (m, 1H), 7.43 (ddd, <i>J</i> = 7.6, 4.8, 1.2 Hz, 1H), 7.29–7.17 (m, 3H), 4.80 (h, <i>J</i> = 7.1 Hz, 1H), 3.53–3.44 (m, 1H), 3.07 (s, 3H), 3.14–2.97 (m, 2H), 2.57–2.40 (m, 2H).</div></div><div id="sec4_10_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 3-(<i>trans</i>-3-(4-(2-Fluorophenyl)-5-(5-(methylsulfonyl)pyridin-2-yl)-4<i>H</i>-1,2,4-triazol-3-yl)cyclobutyl)quinoline-8-carboxamide (<b>16</b>)</h3><div class="NLM_p last">The title compound was prepared according to general procedure F as a white solid (24.9 mg, 91% yield). LC/MS (ESI) <i>m</i>/<i>z</i> for C<sub>28</sub>H<sub>23</sub>FN<sub>6</sub>O<sub>3</sub>S = 542 (calculated), 543 ([M + H]<sup>+</sup> found). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 11.56 (d, <i>J</i> = 5.8 Hz, 1H), 8.91 (dd, <i>J</i> = 4.3, 1.8 Hz, 1H), 8.83 (dd, <i>J</i> = 7.4, 1.6 Hz, 1H), 8.73 (d, <i>J</i> = 2.3 Hz, 1H), 8.56 (d, <i>J</i> = 8.4 Hz, 1H), 8.28 (dt, <i>J</i> = 8.4, 2.5 Hz, 2H), 7.96 (dd, <i>J</i> = 8.1, 1.6 Hz, 1H), 7.67 (t, <i>J</i> = 7.7 Hz, 1H), 7.49 (dt, <i>J</i> = 8.3, 5.0 Hz, 2H), 7.26–7.18 (m, 3H), 4.85 (apparent dq, <i>J</i> = 13.4, 6.8 Hz, 1H), 3.57 (apparent tt, <i>J</i> = 10.1, 5.8 Hz, 1H), 3.16–3.01 (m, 2H), 3.08 (s, 3H), 2.67–2.50 (m, 2H). HRMS 543.16091 ([M + H]<sup>+</sup>, calculated), 543.16007 ([M + H]<sup>+</sup>, found), Δ = −0.84 ppm.</div></div><div id="sec4_10_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 3-(<i>trans</i>-3-(4-(2-Chlorophenyl)-5-(pyrimidin-4-yl)-4<i>H</i>-1,2,4-triazol-3-yl)cyclobutyl)-2-oxo-2,3-dihydrobenzo[<i>d</i>]oxazole-6-carbonitrile (<b>18</b>)</h3><div class="NLM_p last">Crude hydroxybenzonitrile (<b>8</b>) (10 mg, 0.014 mmol, ∼60% pure) was dissolved in DCM (dried, 3.0 mL) under a nitrogen atmosphere. Acetonitrile (anhydrous, 1.0 mL) was also added followed by CDI (11 mg, 0.070 mmol), and the mixture was stirred for 60 h at ambient temperature. The solvent was evaporated, and the residue was purified by preparative SFC. After freeze-drying the purified fractions from acetonitrile/water, 2.8 mg (42% yield) of a white powder of the target compound (<b>18</b>) was obtained. LC/MS (ESI) <i>m</i>/<i>z</i> for C<sub>24</sub>H<sub>16</sub>ClN<sub>7</sub>O<sub>2</sub> = 469/471 (calculated), 470/472 ([M + H]<sup>+</sup>, found). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 8.86–8.82 (m, 2H), 8.28 (dd, <i>J</i> = 5.3, 1.2 Hz, 1H), 7.60–7.50 (m, 3H), 7.51–7.42 (m, 2H), 7.30 (dd, <i>J</i> = 7.8, 1.4 Hz, 1H), 7.18 (d, <i>J</i> = 8.2 Hz, 1H), 5.20 (p, <i>J</i> = 8.3 Hz, 1H), 3.44–3.34 (m, 2H), 3.34–3.25 (m, 1H), 2.98 (td, <i>J</i> = 8.5, 4.1 Hz, 1H), 2.93–2.83 (m, 1H).</div></div><div id="sec4_10_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 1-(3-(4-(2-Chlorophenyl)-5-(pyrimidin-4-yl)-4<i>H</i>-1,2,4-triazol-3-yl)bicyclo[1.1.1]pentan-1-yl)-2-oxo-2,3-dihydro-1<i>H</i>-benzo[<i>d</i>]imidazole-5-carbonitrile (<b>19</b>)</h3><div class="NLM_p last">Under a nitrogen atmosphere an impure batch of 3-amino-4-((3-(4-(2-chlorophenyl)-5-(pyrimidin-4-yl)-4<i>H</i>-1,2,4-triazol-3-yl)bicyclo[1.1.1]pentan-1-yl)amino)benzonitrile <b>19b</b> (36 mg, 0.060 mmol, ∼75% pure; see <a href="/doi/suppl/10.1021/acs.jmedchem.0c00208/suppl_file/jm0c00208_si_002.pdf" class="ext-link">Supporting Information</a>) was dissolved in dry DCM (6.0 mL), and it was treated at ambient temperature with several portions of CDI (in total 9 equiv) over a period of 24 h until the complete conversion was reached. The mixture was evaporated to dryness and the residue was first flashed on a 12 g silica gel cartridge eluted with a gradient of methanol (0% via 3% to 10%) in DCM. Then it was submitted to purification by preparative SFC isolating 19.0 mg (65% yield) of a white powder. LC/MS (ESI) <i>m</i>/<i>z</i> for C<sub>25</sub>H<sub>17</sub>ClN<sub>8</sub>O = 480/482 (calculated), 481/483 ([M + H]<sup>+</sup>, found). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.36 (s, 1H), 8.95 (d, <i>J</i> = 5.3 Hz, 1H), 8.90 (d, <i>J</i> = 1.2 Hz, 1H), 8.23 (dd, <i>J</i> = 5.3, 1.3 Hz, 1H), 7.79 (dd, <i>J</i> = 7.8, 1.5 Hz, 1H), 7.76 (dd, <i>J</i> = 8.0, 1.2 Hz, 1H), 7.66 (td, <i>J</i> = 7.8, 1.6 Hz, 1H), 7.58 (td, <i>J</i> = 7.6, 1.3 Hz, 1H), 7.44 (dd, <i>J</i> = 8.3, 1.4 Hz, 1H), 7.40–7.30 (m, 2H), 2.61–2.52 (m-distorted q, 6H). HRMS 481.12866 ([M + H]<sup>+</sup>, calculated), 481.12796 ([M + H]<sup>+</sup>, found), Δ = −1.46 ppm.</div></div><div id="sec4_10_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 3-(<i>trans</i>-3-(4-(2-Chlorophenyl)-5-(pyrimidin-4-yl)-4<i>H</i>-1,2,4-triazol-3-yl)cyclobutyl)picolinamide (<b>20</b>)</h3><div class="NLM_p last">The title compound was prepared according to general procedure F and obtained as a white solid (41.1 mg, 94% yield). LC/MS (ESI) <i>m</i>/<i>z</i> for C<sub>22</sub>H<sub>18</sub>ClN<sub>7</sub>O = 431/433 (calculated), 432/434 ([M + H]<sup>+</sup>, found). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 8.82 (s, 1H), 8.81 (d, <i>J</i> = 3.3 Hz, 1H), 8.53 (qd, <i>J</i> = 4.8, 0.6 Hz, 1H), 8.28 (dd, <i>J</i> = 5.3, 1.3 Hz, 1H), 8.23 (d, <i>J</i> = 6.6 Hz, 1H), 8.17 (d, <i>J</i> = 7.8 Hz, 1H), 7.84 (td, <i>J</i> = 7.7, 1.7 Hz, 1H), 7.54 (dd, <i>J</i> = 8.0, 1.5 Hz, 1H), 7.49 (td, <i>J</i> = 7.7, 1.6 Hz, 1H), 7.46–7.38 (m, 2H), 7.30 (dd, <i>J</i> = 7.8, 1.5 Hz, 1H), 4.86–4.72 (m, 1H), 3.49–3.36 (m, 1H), 3.11–3.00 (m, 2H), 2.53–2.38 (m, 2H). HRMS 432.13341 ([M + H]<sup>+</sup>, calculated), 432.13272 ([M + H]<sup>+</sup>, found), Δ = −1.61 ppm.</div></div><div id="sec4_10_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 3-(<i>trans</i>-3-(4-(2-Chlorophenyl)-5-(pyrimidin-4-yl)-4<i>H</i>-1,2,4-triazol-3-yl)cyclobutyl)-1,5-naphthyridine-4-carboxamide (<b>21</b>)</h3><div class="NLM_p last">The title compound was prepared according to general procedure F and obtained as a white solid (12.7 mg, 26% yield). LC/MS (ESI) <i>m</i>/<i>z</i> for C<sub>25</sub>H<sub>19</sub>ClN<sub>8</sub>O = 482/484 (calculated), 483/485 ([M + H]<sup>+</sup>, found). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 11.32 (d, <i>J</i> = 5.8 Hz, 1H), 9.15 (d, <i>J</i> = 4.4 Hz, 1H), 8.98 (dd, <i>J</i> = 4.2, 1.7 Hz, 1H), 8.85–8.79 (m, 2H), 8.60–8.52 (m, 2H), 8.29 (dd, <i>J</i> = 5.3, 1.3 Hz, 1H), 7.75 (dd, <i>J</i> = 8.5, 4.2 Hz, 1H), 7.54 (dd, <i>J</i> = 7.9, 1.5 Hz, 1H), 7.48 (td, <i>J</i> = 7.7, 1.6 Hz, 1H), 7.42 (td, <i>J</i> = 7.6, 1.6 Hz, 1H), 7.32 (dd, <i>J</i> = 7.8, 1.5 Hz, 1H), 4.88 (h, <i>J</i> = 7.2 Hz, 1H), 3.49 (tt, <i>J</i> = 9.7, 5.4 Hz, 1H), 3.17–3.04 (m, 2H), 2.65–2.50 (m, 2H). HRMS 483.14431 ([M + H]<sup>+</sup>, calculated), 483.14350 ([M + H]<sup>+</sup>, found), Δ = −0.81 ppm.</div></div><div id="sec4_10_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 3-(<i>trans</i>-3-(4-(2-Chlorophenyl)-5-(5-ethoxypyridin-2-yl)-4<i>H</i>-1,2,4-triazol-3-yl)cyclobutyl)-2-oxo-2,3-dihydro-1<i>H</i>-benzo[<i>d</i>]imidazole-5-carbonitrile (<b>22</b>)</h3><div class="NLM_p last">The title compound was prepared according to general procedure D from (1<i>r</i>,3<i>r</i>)-3-(5-cyano-2-oxo-2,3-dihydro-1<i>H</i>-benzo[<i>d</i>]imidazol-1-yl)cyclobutane-1-carbohydrazide <b>2</b><a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> (60.2 mg, 0.222 mmol) and methyl <i>N-</i>(2-chlorophenyl)-5-ethoxypyridine-2-carbimidothioate <b>E2</b> (68 mg, 0.222 mmol) affording 49.9 mg (42% yield) of a white solid. LC/MS (ESI) <i>m</i>/<i>z</i> for C<sub>27</sub>H<sub>22</sub>ClN<sub>7</sub>O<sub>2</sub> = 511 (calculated), 512 ([M + H]<sup>+</sup>, found). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 8.69 (s, 1H), 8.17 (d, <i>J</i> = 8.8 Hz, 1H), 7.87 (d, <i>J</i> = 2.8 Hz, 1H), 7.51 (distorted dd, <i>J</i> = 7.8, 1.8 Hz, 1H), 7.46 (td, <i>J</i> = 7.6, 1.8 Hz, 1H), 7.44–7.38 (m, 2H), 7.31 (distorted dd, <i>J</i> = 7.7, 1.7 Hz, 2H), 7.25–7.18 (m, 2H), 5.28 (t, <i>J</i> = 8.4 Hz, 1H), 4.04 (q, <i>J</i> = 7.0 Hz, 2H), 3.45–3.29 (m, 3H), 3.00–2.84 (m, 2H), 1.40 (t, <i>J</i> = 7.0 Hz, 3H). HRMS 512.15963 ([M + H]<sup>+</sup>, calculated), 512.15900 ([M + H]<sup>+</sup>, found), Δ = −1.23 ppm.</div></div><div id="sec4_10_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 3-(<i>trans</i>-3-(4-(2-Fluorophenyl)-5-(pyrimidin-4-yl)-4<i>H</i>-1,2,4-triazol-3-yl)cyclobutyl)-2-oxo-2,3-dihydro-1<i>H</i>-benzo[<i>d</i>]imidazole-5-carbonitrile (<b>23</b>)</h3><div class="NLM_p last">The title compound was prepared according to general procedure D from (1<i>r</i>,3<i>r</i>)-3-(5-cyano-2-oxo-2,3-dihydro-1<i>H</i>-benzo[<i>d</i>]imidazol-1-yl)cyclobutane-1-carbohydrazide <b>2</b><a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> (43.9 mg, 0.162 mmol) and methyl <i>N-</i>(2-fluorophenyl)pyrimidine-4-carbimidothioate <b>E3</b> (40 mg, 0.162 mmol) as a white powder (14 mg, 19% yield). LC/MS (ESI) <i>m</i>/<i>z</i> for C<sub>24</sub>H<sub>17</sub>FN<sub>8</sub>O = 452 (calculated), 453 ([M + H]<sup>+</sup>, found). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 8.87 (d, <i>J</i> = 1.4 Hz, 1H), 8.85 (d, <i>J</i> = 5.2 Hz, 1H), 8.71 (br s, 1H), 8.29 (dd, <i>J</i> = 5.3, 1.4 Hz, 1H), 7.61–7.53 (m, 1H), 7.43 (dd, <i>J</i> = 8.3, 1.5 Hz, 1H), 7.35–7.29 (m, 2H), 7.26–7.22 (m, 2H), 7.19 (d, <i>J</i> = 8.3 Hz, 1H), 5.27 (p, <i>J</i> = 8.7 Hz, 1H), 3.54–3.44 (m, 2H), 3.39 (apparent q, <i>J</i> = 10.3 Hz, 1H), 3.05–2.97 (m, 1H), 2.88–2.78 (m, 1H). HRMS 453.15821 ([M + H]<sup>+</sup>, calculated), 453.15769 ([M + H]<sup>+</sup>, found), Δ = −1.16 ppm.</div></div><div id="sec4_10_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 3-(<i>trans</i>-3-(4-(2-Fluorophenyl)-5-(pyridin-2-yl)-4<i>H</i>-1,2,4-triazol-3-yl)cyclobutyl)-7-fluoro-1,5-naphthyridine-4-carboxamide (<b>27</b>)</h3><div class="NLM_p last">The title compound was prepared according to general procedure F as a white solid (17.2 mg, 70% yield). LC/MS (ESI) <i>m</i>/<i>z</i> for C<sub>26</sub>H<sub>19</sub>F<sub>2</sub>N<sub>7</sub>O = 483 (calculated), 484 ([M + H]<sup>+</sup>, found). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 10.83 (d, <i>J</i> = 6.0 Hz, 1H), 9.15 (d, <i>J</i> = 4.5 Hz, 1H), 8.91 (d, <i>J</i> = 2.8 Hz, 1H), 8.52 (d, <i>J</i> = 4.4 Hz, 1H), 8.26 (dt, <i>J</i> = 7.9, 1.0 Hz, 1H), 8.24–8.16 (m, 2H), 7.77 (td, <i>J</i> = 7.8, 1.8 Hz, 1H), 7.50–7.42 (m, 1H), 7.25–7.15 (m, 4H), 4.87 (ht, <i>J</i> = 6.8, 1.6 Hz, 1H), 3.53 (tt, <i>J</i> = 9.3, 5.6 Hz, 1H), 3.15–3.02 (sym. m, 2H), 2.63–2.47 (sym. m, 2H). HRMS 484.16919 ([M + H]<sup>+</sup>, calculated), 484.16833 ([M + H]<sup>+</sup>, found), Δ = −1.78 ppm.</div></div><div id="sec4_10_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Preparation of 3-(<i>trans</i>-3-(4-(2-Chlorophenyl)-5-(pyrimidin-4-yl)-4<i>H</i>-1,2,4-triazol-3-yl)cyclobutyl)isoindolin-1-one (<b>51</b>)</h3><div class="NLM_p last">2-Formylbenzoic acid (<b>9</b>) (33 mg, 0.22 mmol) was suspended in DCM (dry, 1.0 mL) under a nitrogen atmosphere, and a solution of <i>trans</i>-3-(4-(2-chlorophenyl)-5-(pyrimidin-4-yl)-4<i>H</i>-1,2,4-triazol-3-yl)cyclobutan-1-amine (<b>Ga</b>) (0.20 mmol) in acetonitrile (anhydrous, 1.0 mL) and acetic acid (13 μL, 0.22 mmol) were added. The resulting solution was stirred for 17 h at ambient temperature. Then, two portions of sodium triacetoxyborohydride (each of 85 mg, 0.40 mmol) were added and the mixture was stirred for 3 h at ambient temperature. Extra methanol was added (extra dry, 1.0 mL) for better dissolution. The mixture was then heated at 50 °C overnight for 40 h while two extra portions of sodium triacetoxyborohydride were added (each of 85 mg, 0.40 mmol). The mixture was evaporated to dryness, and the residue was quenched with water and a few mL of 1 N aqueous HCl. DCM was added, the aqueous phase was basified with aqueous sodium bicarbonate, and the crude product was extracted with DCM (three times). The extracts were dried over sodium sulfate, filtered, and evaporated to dryness. The crude material was purified on a 12 g silica gel cartridge eluted with a gradient of methanol (0% to 5%) in DCM. The product fraction was lyophilized from acetonitrile/water providing a white powder (34.1 mg, 38% yield) of the target compound. LC/MS (ESI) <i>m</i>/<i>z</i> for C<sub>24</sub>H<sub>19</sub>ClN<sub>6</sub>O = 442/444 (calculated) 443/445 ([M + H]<sup>+</sup>, found). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 8.86–8.78 (m, 2H), 8.29 (dd, <i>J</i> = 5.3, 1.2 Hz, 1H), 7.81 (d, <i>J</i> = 7.4 Hz, 1H), 7.58–7.47 (m, 3H), 7.47–7.39 (m, 3H), 5.09 (p, <i>J</i> = 8.2 Hz, 1H), 4.44 (s, 2H), 3.42–3.31 (m, 1H), 2.98–2.80 (m, 4H).</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> Separation of Atropisomers of <b>1</b> and Investigation of Their Interconversion</h3><div class="NLM_p last">An amount of 40 mg of racemic <b>1</b><a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> (40 mg, 0.085 mmol) was separated into pure atropisomers by preparative chiral SFC (see <a href="/doi/suppl/10.1021/acs.jmedchem.0c00208/suppl_file/jm0c00208_si_002.pdf" class="ext-link">Supporting Information</a>) providing, respectively, 16.1 and 11.8 mg of off-white solids. Two sets of two samples dissolved in an acetonitrile/methanol mixture were prepared for each atropisomers. One set was heated in a reaction block at 70 °C, while the other was kept at ambient temperature. Samples were analyzed after 24, 48, and 72 h to check for the interconversion of atropisomers. After 24 h no interconversion was observed at ambient temperature, while at 70 °C 2.5% of the opposite isomers were detected in both samples. After 48 h of heating about 5–6% interconversion was observed at 70 °C. After 72 h, the isomers showed no interconversion at ambient temperature, whereas at 70 °C about 8–9% of the other atropisomer was observed by chiral SFC.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> Biochemical Assays</h3><div class="NLM_p last">Human tankyrase active constructs for TNKS1 (residues 1030–1317) and TNKS2 (residues 873–1162) and other ARTD/PARP enzymes used in the assays were expressed and purified as previously described.<a onclick="showRef(event, 'ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref34 ref35">(34,35)</a> The enzymatic assay is based on the measurement of unreacted NAD<sup>+</sup>, which is chemically converted into a fluorescent compound.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> The fluorescence intensity was measured with excitation/emission wavelengths of 372 and 444 nm, respectively, using Tecan Infinity M1000 Pro. The compounds were prepared in half log dilution series and the reactions were done in quadruplicates with protein and compound controls to exclude the effect of compound autofluorescence. All reactions were done at ambient temperature. 20 nM TNKS1 or 5 nM TNKS2 was incubated for 20 h in assay buffer (50 mM BTP, pH 7.0, 0.5 mM TCEP, 0.01% Triton-X100) with compound and 10 μM or 500 nM NAD<sup>+</sup>, respectively. 5 nM ARTD1/PARP1 or 20 nM ARTD2/PARP2 was incubated for 30 min with compound and 500 nM NAD<sup>+</sup> in assay buffer (50 mM Tris, pH 8.0, 5 mM MgCl<sub>2</sub>, 10 μg/mL activated DNA) supplemented with 0.2 or 0.1 mg/mL BSA, respectively. For ARTD3/PARP3, 20 nM enzyme was incubated for 4 h with compound and 500 nM NAD<sup>+</sup> in assay buffer (50 mM PIPES, pH 7.0, 5 mM MgCl<sub>2</sub>, 20 μg/mL activated DNA, 0.2 mg/mL BSA). The assay conditions for the other ARTD enzymes were used as previously described.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> WNT/β-Catenin in Signaling Reporter Assay</h3><div class="NLM_p last">The luciferase-based WNT/β<i>-</i>catenin signaling pathway reporter assay in human HEK293 cells, as well as IC<sub>50</sub> and GI<sub>50</sub>/GI<sub>25</sub> calculations, was performed as previously described.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> In vitro ADME assays</h3><div class="NLM_p last">Kinetic solubility assay was performed following standard protocols of Mercachem. The following assays were performed according to the standard protocols of Cyprotex: Caco-2 permeability, dog microsomal stability, hepatocyte stability (human, mouse, dog, rat, and cynomolgus), CYP3A4 inhibition, mouse plasma stability, mouse plasma protein binding, and Ames test.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> Microsomal Stability Assay</h3><div class="NLM_p last">Test compounds in DMSO (10 mM) were further diluted to 100 μM in acetonitrile. Human or mouse liver microsomes (BioIVT) from selected species are incubated in duplicate with the test compound at a final concentration of 1 μM in 0.1 M potassium phosphate buffer (pH 7.4) containing 3.3 mM MgCl<sub>2</sub>, 0.5 mg/mL microsomal protein, in the presence or absence of NADPH (1 mM). Incubations were performed at 37 °C in a total volume of 500 μL. Control incubations with reference substances were included for each experiment. At <i>t</i> = 0, 5, 15, 30, 45 min, an amount of 50 μL of the incubation mixture was transferred to a quench plate containing acetonitrile and internal standard (200 nM labetalol) cooled at 4 °C. After the last time point, the quench plates are mixed thoroughly and centrifuged for 15 min at 3700 rpm and 10 °C (Eppendorf 5804R). The supernatant was transferred to a 96-well plate and analyzed by LCMS (Vanquish Horizon UHPLC equipped with a diode array detector coupled to a Q Exactive focus hybrid quadrupole-Orbitrap mass spectrometer). The metabolic stability is evaluated by plotting the natural logarithm of the percentage test compound remaining versus time and performing linear regression.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> Safety Panel and hERG Inhibition</h3><div class="NLM_p last">Inhibition of 44 selected targets (<i>n</i> = 2) including hERG (SafetyScreen 44) using 10 μM <b>13</b> was performed by Eurofins (Cerep-Panlabs).</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> Mouse Pharmacokinetical Analysis</h3><div class="NLM_p last">The pharmacokinetical analyses in mice were performed according to the standard protocols of Medicilon and, as previously described,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> using 3 animals per treatment group using 5% DMSO, 50% PEG400 (both Sigma-Aldrich) and 45% saline as vehicle.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> Crystallography</h3><div class="NLM_p last">Compounds <b>105</b>, <b>13</b>, <b>10</b>, <b>106</b>, <b>107</b>, <b>87</b>, <b>88</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00208/suppl_file/jm0c00208_si_001.pdf" class="ext-link">Supplementary Table 4</a>) were cocrystallized with the catalytic domain of human TNKS2 (residues 952–1161) in the presence of chymotrypsin (1:100) based on crystallization efforts previously described.<a onclick="showRef(event, 'ref11 ref20'); return false;" href="javascript:void(0);" class="ref ref11 ref20">(11,20)</a> Protein (0.2 mM, 5.6 mg/mL) was mixed with 0.4 mM compound from a 10 mM DMSO stock solution. The crystallization was set up at 22 °C using sitting-drop vapor diffusion method by mixing 200 nL of protein with 100 nL of precipitant solution (0.1 M Bicine, pH 8.5–9.0, 7.5–25% PEG6000). Rod-shaped crystals appeared within 24 h and were cryoprotected using the precipitant solution containing 25% PEG6000 and 20% glycerol. Data were collected at ESRF Grenoble on beamlines ID30B, ID23-1, and ID30A-1 or at Diamond Light Source on beamline I04. Diffraction data were processed using the XDS package.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> All structures were solved using molecular replacement with PHASER<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> using the structure of TNKS2 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NOB">5NOB</a>) as a starting model. Coot<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> and Refmac5<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> were used for model building and refinement, respectively. The images of the structures were prepared using PyMOL (The PyMOL Molecular Graphics System, version 1.8.4.0, Schrödinger, LLC.).</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> Western Blot Analysis</h3><div class="NLM_p last">Western blot analysis of nuclear and cytoplasmic lysates from compound-treated COLO 320DM cells was performed as previously described<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> using the following primary antibodies: tankyrase-1/2 (TNKS1/2, E-10, sc-365897, Santa Cruz Biotechnology), AXIN1 (C7B12, 3323, Cell Signaling Technology), AXIN2 (76G6, 2151, Cell Signaling Technology), non-phospho (active) β-catenin (D13A1, 8814, Cell Signaling Technology), β-catenin (610153,1:500, BD Biosciences). Actin (A2066, Sigma-Aldrich) and lamin B1 (ab16048, Abcam) were used as loading controls. Primary antibodies were visualized with HRP-conjugated secondary antibodies (mouse anti-rabbit IgG, sc-2357, Santa Cruz Biotechnology or donkey anti-rabbit IgG, 711-035-152, Jackson ImmunoResearch) using ChemiDoc Touch Imaging System (Bio-Rad).</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> RNA Isolation and Real-Time qRT-PCR</h3><div class="NLM_p last">RNA isolation and real-time qRT-PCR were performed as previously described<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> using the following probes (all from Applied Biosystems): AXIN2 (Hs00610344_m1), DKK1 (Hs00183740_m1), NKD1 (Hs01548773_m1), APCDD1 (Hs00537787_m1), and GAPDH (Hs02758991_g1).</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> Proliferation Assay</h3><div class="NLM_p last">1000 COLO 320DM cells per well were seeded in 96-well plates. The day after, cell culture medium was changed to contain various doses of <b>13</b> (<i>n</i> = 4) or vehicle (DMSO, Sigma-Aldrich) and the plates were incubated at 37 °C for 5 days. The cells were incubated for 1 h at 37 °C with CellTiter 96 AQueous nonradioactive cell proliferation assay (MTS, Promega) according to the supplier’s recommendations. Abs<sub>490</sub> was measured (Wallac 1420 Victor2 microplate reader, PerkinElmer) and compared to Abs<sub>490</sub> (<i>t</i><sub>0</sub>) using the following formula to determine single well values relative to the DMSO vehicle control: (sample <i>A</i><sub>490</sub> – average <i>A</i><sub>490</sub><i>t</i><sub>0</sub>) × 100/(average <i>A</i><sub>490</sub> [for 0.01% DMSO controls] – average <i>A</i><sub>490</sub><i>t</i><sub>0</sub>).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i49"><a href="/doi/suppl/10.1021/acs.jmedchem.0c00208" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77844" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77844" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c00208?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00208</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">General and specific synthetic procedures and spectra (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00208/suppl_file/jm0c00208_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Additional figures and tables for inhibition data and crystallography (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00208/suppl_file/jm0c00208_si_002.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00208/suppl_file/jm0c00208_si_003.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00208/suppl_file/jm0c00208_si_001.pdf">jm0c00208_si_001.pdf (2.1 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00208/suppl_file/jm0c00208_si_002.pdf">jm0c00208_si_002.pdf (6.9 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00208/suppl_file/jm0c00208_si_003.csv">jm0c00208_si_003.csv (2.73 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Atomic coordinates and structure factors have been deposited to Protein Data Bank with accession codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6TG4">6TG4</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6TKM">6TKM</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6TKN">6TKN</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6TKP">6TKP</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6TKQ">6TKQ</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6TKR">6TKR</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6TKS">6TKS</a>.</p><div class="testing" data-doi="10.1021/acs.jmedchem.0c00208" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55718" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55718" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jo Waaler</span> - <span class="hlFld-Affiliation affiliation">Hybrid
Technology Hub—Centre of Excellence, Institute of Basic Medical
Sciences, University of Oslo, P.O. Box 1110 Blindern, 0317 Oslo, Norway</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Immunology and Transfusion Medicine, Oslo University Hospital, P.O. Box 4950
Nydalen, 0424 Oslo, Norway</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8501-6225" title="Orcid link">http://orcid.org/0000-0002-8501-6225</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#adc7c283daccccc1c8dfeddfdf80dfc8dec8ccdfcec583c3c2"><span class="__cf_email__" data-cfemail="a5cfca8bd2c4c4c9c0d7e5d7d788d7c0d6c0c4d7c6cd8bcbca">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ruben G. G. Leenders</span> - <span class="hlFld-Affiliation affiliation">Mercachem
BV, Kerkenbos 1013, 6546 BB Nijmegen, The Netherlands</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sven T. Sowa</span> - <span class="hlFld-Affiliation affiliation">Faculty
of Biochemistry and Molecular Medicine, Biocenter Oulu, University of Oulu, P.O. Box 5400, 90014 Oulu, Finland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shoshy Alam Brinch</span> - <span class="hlFld-Affiliation affiliation">Hybrid
Technology Hub—Centre of Excellence, Institute of Basic Medical
Sciences, University of Oslo, P.O. Box 1110 Blindern, 0317 Oslo, Norway</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Immunology and Transfusion Medicine, Oslo University Hospital, P.O. Box 4950
Nydalen, 0424 Oslo, Norway</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Max Lycke</span> - <span class="hlFld-Affiliation affiliation">Hybrid
Technology Hub—Centre of Excellence, Institute of Basic Medical
Sciences, University of Oslo, P.O. Box 1110 Blindern, 0317 Oslo, Norway</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Immunology and Transfusion Medicine, Oslo University Hospital, P.O. Box 4950
Nydalen, 0424 Oslo, Norway</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Piotr Nieczypor</span> - <span class="hlFld-Affiliation affiliation">Mercachem
BV, Kerkenbos 1013, 6546 BB Nijmegen, The Netherlands</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sjoerd Aertssen</span> - <span class="hlFld-Affiliation affiliation">Mercachem
BV, Kerkenbos 1013, 6546 BB Nijmegen, The Netherlands</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sudarshan Murthy</span> - <span class="hlFld-Affiliation affiliation">Faculty
of Biochemistry and Molecular Medicine, Biocenter Oulu, University of Oulu, P.O. Box 5400, 90014 Oulu, Finland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Albert Galera-Prat</span> - <span class="hlFld-Affiliation affiliation">Faculty
of Biochemistry and Molecular Medicine, Biocenter Oulu, University of Oulu, P.O. Box 5400, 90014 Oulu, Finland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eddy Damen</span> - <span class="hlFld-Affiliation affiliation">Mercachem
BV, Kerkenbos 1013, 6546 BB Nijmegen, The Netherlands</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anita Wegert</span> - <span class="hlFld-Affiliation affiliation">Mercachem
BV, Kerkenbos 1013, 6546 BB Nijmegen, The Netherlands</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marc Nazaré</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry, Leibniz-Forschungsinstitut für
Molekulare Pharmakologie (FMP), Campus Berlin Buch, Robert-Roessle-Straße 10, 13125 Berlin, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lari Lehtiö</span> - <span class="hlFld-Affiliation affiliation">Faculty
of Biochemistry and Molecular Medicine, Biocenter Oulu, University of Oulu, P.O. Box 5400, 90014 Oulu, Finland</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7250-832X" title="Orcid link">http://orcid.org/0000-0001-7250-832X</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stefan Krauss</span> - <span class="hlFld-Affiliation affiliation">Hybrid
Technology Hub—Centre of Excellence, Institute of Basic Medical
Sciences, University of Oslo, P.O. Box 1110 Blindern, 0317 Oslo, Norway</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Immunology and Transfusion Medicine, Oslo University Hospital, P.O. Box 4950
Nydalen, 0424 Oslo, Norway</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>J.W., R.G.G.L., and S.T.S. contributed equally. The manuscript was written through contributions of all authors, and all authors have given approval to the final version of the manuscript.</p></li><li><span class="author-information-subsection-header">Funding</span><p>J.W. and S.K. were supported by the Research Council of Norway (Grants 262613, 267639, and 296226), by South-Eastern Norway Regional Health Authority (Grants 16/00528-9, 15/00779-2, 2015012, and 2019090), and by the Norwegian Cancer Society (Grant 5803958). L.L., S.T.S., A.G.-P., and S.M. were supported by the Jane and Aatos Erkko Foundation, Sigrid Jusélius Foundation, and Academy of Finland (Grants 287063, 294085, and 319299).</p></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): J.W., M.N., L.L., A.W., R.G.G.L., and S.K. hold patents related to tankyrase inhibitor therapy, and these authors declare no additional interests. The remaining authors declare no competing interests.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e3175-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i52">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61748" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61748" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Heli Alanen and Dr. Yves Nkizinkiko are acknowledged for their contributions in performing some of the biochemical assays. Ilonka Meerts and Eef van den Elzen, both of Mercachem BV, are acknowledged for their contributions with the human and mouse microsomal stability assay. Protein crystallography experiments were performed at the Diamond Light Source (Didcot, U.K.) on beamline I04, and at European Synchrotron Radiation Facility (ESRF, Grenoble, France) on beamlines ID30B, ID23-1, and ID30A-1. We are grateful to local contacts for providing assistance in using the beamlines. The use of the facilities and expertise of the Biocenter Oulu Protein Crystallography Core Facility, a member of Biocenter Finland and Instruct-FI, is gratefully acknowledged.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">ADME</td><td class="NLM_def"><p class="first last">absorption, distribution, metabolism, and excretion</p></td></tr><tr><td class="NLM_term">ADP</td><td class="NLM_def"><p class="first last">adenosine 5′-diphosphate</p></td></tr><tr><td class="NLM_term">AKT</td><td class="NLM_def"><p class="first last">serine/threonine kinase</p></td></tr><tr><td class="NLM_term">AMOT</td><td class="NLM_def"><p class="first last">angiomotin</p></td></tr><tr><td class="NLM_term">AMP</td><td class="NLM_def"><p class="first last">adenosine monophosphate</p></td></tr><tr><td class="NLM_term">AMPK</td><td class="NLM_def"><p class="first last">AMP-activated protein kinase</p></td></tr><tr><td class="NLM_term">APC</td><td class="NLM_def"><p class="first last">adenomatous polyposis coli</p></td></tr><tr><td class="NLM_term">APCDD1</td><td class="NLM_def"><p class="first last">APC down-regulated 1</p></td></tr><tr><td class="NLM_term">ARTD</td><td class="NLM_def"><p class="first last">diphtheria toxin-like ADP-ribosyltransferase</p></td></tr><tr><td class="NLM_term">AT</td><td class="NLM_def"><p class="first last">atropisomer</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the curve</p></td></tr><tr><td class="NLM_term">AXIN</td><td class="NLM_def"><p class="first last">axis inhibition protein</p></td></tr><tr><td class="NLM_term">Boc</td><td class="NLM_def"><p class="first last"><i>tert</i>-butyloxycarbonyl</p></td></tr><tr><td class="NLM_term">CDI</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>′-carbonyldiimidazole</p></td></tr><tr><td class="NLM_term">Cl</td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last">diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DKK1</td><td class="NLM_def"><p class="first last">dickkopf WNT signaling pathway inhibitor 1</p></td></tr><tr><td class="NLM_term">DMA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylacetamide</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">EGFR</td><td class="NLM_def"><p class="first last">epidermal growth factor receptor</p></td></tr><tr><td class="NLM_term">equiv</td><td class="NLM_def"><p class="first last">equivalents</p></td></tr><tr><td class="NLM_term">GSK3β</td><td class="NLM_def"><p class="first last">glycogen synthase kinase 3β</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last">hexafluorophosphate azabenzotriazole tetramethyluronium</p></td></tr><tr><td class="NLM_term">HEK293</td><td class="NLM_def"><p class="first last">human embryonic kidney 293</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human ether-à-go-go-related gene</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high pressure liquid chromatography</p></td></tr><tr><td class="NLM_term">LATS1/2</td><td class="NLM_def"><p class="first last">large tumor suppressor kinase 1 and 2</p></td></tr><tr><td class="NLM_term">LC/MS</td><td class="NLM_def"><p class="first last">liquid chromatography/mass spectroscopy</p></td></tr><tr><td class="NLM_term">MPLC</td><td class="NLM_def"><p class="first last">medium pressure liquid chromatography</p></td></tr><tr><td class="NLM_term">MRT</td><td class="NLM_def"><p class="first last">mean residence time</p></td></tr><tr><td class="NLM_term">MTS</td><td class="NLM_def"><p class="first last">3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2<i>H</i>-tetrazolium</p></td></tr><tr><td class="NLM_term">NKD1</td><td class="NLM_def"><p class="first last">NKD inhibitor of WNT signaling pathway 1</p></td></tr><tr><td class="NLM_term">NAD</td><td class="NLM_def"><p class="first last">nicotinamide adenine dinucleotide</p></td></tr><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">nuclear magnetic resonance</p></td></tr><tr><td class="NLM_term">PARP</td><td class="NLM_def"><p class="first last">poly-ADP-ribose polymerase</p></td></tr><tr><td class="NLM_term">PARsylate</td><td class="NLM_def"><p class="first last">poly(ADP-ribose)sylate</p></td></tr><tr><td class="NLM_term">PDA</td><td class="NLM_def"><p class="first last">photodiode array</p></td></tr><tr><td class="NLM_term">PI3K</td><td class="NLM_def"><p class="first last">phosphoinositide-3-kinase</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr><tr><td class="NLM_term">po</td><td class="NLM_def"><p class="first last">per oral</p></td></tr><tr><td class="NLM_term">PPB</td><td class="NLM_def"><p class="first last">plasma protein binding</p></td></tr><tr><td class="NLM_term">RT-qPCR</td><td class="NLM_def"><p class="first last">reverse transcription quantitative polymerase chain reaction</p></td></tr><tr><td class="NLM_term">RNF146</td><td class="NLM_def"><p class="first last">ring finger protein 146</p></td></tr><tr><td class="NLM_term">SD</td><td class="NLM_def"><p class="first last">standard deviation</p></td></tr><tr><td class="NLM_term">SFC</td><td class="NLM_def"><p class="first last">supercritical fluid chromatography</p></td></tr><tr><td class="NLM_term"><i>t</i><sub>1/2</sub></td><td class="NLM_def"><p class="first last">half-life</p></td></tr><tr><td class="NLM_term">TAZ</td><td class="NLM_def"><p class="first last">tafazzin</p></td></tr><tr><td class="NLM_term">TEAD</td><td class="NLM_def"><p class="first last">TEA domain transcription factor</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">TLC</td><td class="NLM_def"><p class="first last">thin layer chromatography</p></td></tr><tr><td class="NLM_term">TNKS</td><td class="NLM_def"><p class="first last">telomeric repeat factor (TRF1)-interacting ankyrin-related ADP-ribose polymerases, tankyrase</p></td></tr><tr><td class="NLM_term">TNKS1/2</td><td class="NLM_def"><p class="first last">tankyrase 1 and tankyrase 2</p></td></tr><tr><td class="NLM_term">tPSA</td><td class="NLM_def"><p class="first last">total polar surface area</p></td></tr><tr><td class="NLM_term">Vd</td><td class="NLM_def"><p class="first last">volume of distribution</p></td></tr><tr><td class="NLM_term">WNT</td><td class="NLM_def"><p class="first last">wingless-type mammary tumor virus integration site</p></td></tr><tr><td class="NLM_term">YAP</td><td class="NLM_def"><p class="first last">yes associated protein 1</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i54">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65786" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65786" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 41 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haikarainen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauss, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehtio, L.</span></span> <span> </span><span class="NLM_article-title">Tankyrases: structure, function and therapeutic implications in cancer</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">6472</span>– <span class="NLM_lpage">6488</span>, <span class="refDoi"> DOI: 10.2174/1381612820666140630101525</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.2174%2F1381612820666140630101525" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=24975604" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVGgtLfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=6472-6488&author=T.+Haikarainenauthor=S.+Kraussauthor=L.+Lehtio&title=Tankyrases%3A+structure%2C+function+and+therapeutic+implications+in+cancer&doi=10.2174%2F1381612820666140630101525"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Tankyrases: Structure, Function and Therapeutic Implications in Cancer</span></div><div class="casAuthors">Haikarainen, Teemu; Krauss, Stefan; Lehtio, Lari</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">6472-6488</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Several cellular signaling pathways are regulated by ADP-ribosylation, a posttranslational modification catalyzed by members of the ARTD superfamily.  Tankyrases are distinguishable from the rest of this family by their unique domain organization, notably the sterile alpha motif responsible for oligomerization and ankyrin repeats mediating protein-protein interactions.  Tankyrases are involved in various cellular functions, such as telomere homeostasis, Wnt/β -catenin signaling, glucose metab., and cell cycle progression.  In these processes, Tankyrases regulate the interactions and stability of target proteins by poly (ADP-ribosyl)ation.  Modified proteins are subsequently recognized by the E3 ubiquitin ligase RNF146, poly-ubiquitinated and predominantly guided to 26S proteasomal degrdn.  Several small mol. inhibitors have been described for Tankyrases; they compete with the co-substrate NAD+ for binding to the ARTD catalytic domain.  The recent, highly potent and selective inhibitors possess several properties of lead compds. and can be used for proof-of-concept studies in cancer and other Tankyrase linked diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotYUovVf-x6LVg90H21EOLACvtfcHk0lh5LYXOVc_MCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVGgtLfN&md5=ced27d2889d245696043a8cfa891166c</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.2174%2F1381612820666140630101525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612820666140630101525%26sid%3Dliteratum%253Aachs%26aulast%3DHaikarainen%26aufirst%3DT.%26aulast%3DKrauss%26aufirst%3DS.%26aulast%3DLehtio%26aufirst%3DL.%26atitle%3DTankyrases%253A%2520structure%252C%2520function%2520and%2520therapeutic%2520implications%2520in%2520cancer%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2014%26volume%3D20%26spage%3D6472%26epage%3D6488%26doi%3D10.2174%2F1381612820666140630101525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishina, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stegmeier, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michaud, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charlat, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiellette, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiessner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hild, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mickanin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myer, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fazal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomlinson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serluca, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shultz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schirle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlegl, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghidelli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fawell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirschner, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lengauer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finan, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tallarico, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouwmeester, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cong, F.</span></span> <span> </span><span class="NLM_article-title">Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>461</i></span>,  <span class="NLM_fpage">614</span>– <span class="NLM_lpage">620</span>, <span class="refDoi"> DOI: 10.1038/nature08356</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.1038%2Fnature08356" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=19759537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFentbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=461&publication_year=2009&pages=614-620&author=S.+M.+Huangauthor=Y.+M.+Mishinaauthor=S.+Liuauthor=A.+Cheungauthor=F.+Stegmeierauthor=G.+A.+Michaudauthor=O.+Charlatauthor=E.+Wielletteauthor=Y.+Zhangauthor=S.+Wiessnerauthor=M.+Hildauthor=X.+Shiauthor=C.+J.+Wilsonauthor=C.+Mickaninauthor=V.+Myerauthor=A.+Fazalauthor=R.+Tomlinsonauthor=F.+Serlucaauthor=W.+Shaoauthor=H.+Chengauthor=M.+Shultzauthor=C.+Rauauthor=M.+Schirleauthor=J.+Schleglauthor=S.+Ghidelliauthor=S.+Fawellauthor=C.+Luauthor=D.+Curtisauthor=M.+W.+Kirschnerauthor=C.+Lengauerauthor=P.+M.+Finanauthor=J.+A.+Tallaricoauthor=T.+Bouwmeesterauthor=J.+A.+Porterauthor=A.+Bauerauthor=F.+Cong&title=Tankyrase+inhibition+stabilizes+axin+and+antagonizes+Wnt+signalling&doi=10.1038%2Fnature08356"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling</span></div><div class="casAuthors">Huang, Shih-Min A.; Mishina, Yuji M.; Liu, Shanming; Cheung, Atwood; Stegmeier, Frank; Michaud, Gregory A.; Charlat, Olga; Wiellette, Elizabeth; Zhang, Yue; Wiessner, Stephanie; Hild, Marc; Shi, Xiaoying; Wilson, Christopher J.; Mickanin, Craig; Myer, Vic; Fazal, Aleem; Tomlinson, Ronald; Serluca, Fabrizio; Shao, Wenlin; Cheng, Hong; Shultz, Michael; Rau, Christina; Schirle, Markus; Schlegl, Judith; Ghidelli, Sonja; Fawell, Stephen; Lu, Chris; Curtis, Daniel; Kirschner, Marc W.; Lengauer, Christoph; Finan, Peter M.; Tallarico, John A.; Bouwmeester, Tewis; Porter, Jeffery A.; Bauer, Andreas; Cong, Feng</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">461</span>
        (<span class="NLM_cas:issue">7264</span>),
    <span class="NLM_cas:pages">614-620</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The stability of the Wnt pathway transcription factor β-catenin is tightly regulated by the multi-subunit destruction complex.  Deregulated Wnt pathway activity has been implicated in many cancers, making this pathway an attractive target for anticancer therapies.  However, the development of targeted Wnt pathway inhibitors has been hampered by the limited no. of pathway components that are amenable to small mol. inhibition.  Here, we used a chem. genetic screen to identify a small mol., XAV939, which selectively inhibits β-catenin-mediated transcription.  XAV939 stimulates β-catenin degrdn. by stabilizing axin, the concn.-limiting component of the destruction complex.  Using a quant. chem. proteomic approach, we discovered that XAV939 stabilizes axin by inhibiting the poly-ADP-ribosylating enzymes tankyrase 1 and tankyrase 2.  Both tankyrase isoforms interact with a highly conserved domain of axin and stimulate its degrdn. through the ubiquitin-proteasome pathway.  Thus, our study provides new mechanistic insights into the regulation of axin protein homeostasis and presents new avenues for targeted Wnt pathway therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom3c1M4OoOarVg90H21EOLACvtfcHk0lh5LYXOVc_MCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFentbzP&md5=6a76dfa7ed2a57b29e0c1ee367bd652c</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnature08356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08356%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DS.%2BM.%26aulast%3DMishina%26aufirst%3DY.%2BM.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DCheung%26aufirst%3DA.%26aulast%3DStegmeier%26aufirst%3DF.%26aulast%3DMichaud%26aufirst%3DG.%2BA.%26aulast%3DCharlat%26aufirst%3DO.%26aulast%3DWiellette%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWiessner%26aufirst%3DS.%26aulast%3DHild%26aufirst%3DM.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DWilson%26aufirst%3DC.%2BJ.%26aulast%3DMickanin%26aufirst%3DC.%26aulast%3DMyer%26aufirst%3DV.%26aulast%3DFazal%26aufirst%3DA.%26aulast%3DTomlinson%26aufirst%3DR.%26aulast%3DSerluca%26aufirst%3DF.%26aulast%3DShao%26aufirst%3DW.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DShultz%26aufirst%3DM.%26aulast%3DRau%26aufirst%3DC.%26aulast%3DSchirle%26aufirst%3DM.%26aulast%3DSchlegl%26aufirst%3DJ.%26aulast%3DGhidelli%26aufirst%3DS.%26aulast%3DFawell%26aufirst%3DS.%26aulast%3DLu%26aufirst%3DC.%26aulast%3DCurtis%26aufirst%3DD.%26aulast%3DKirschner%26aufirst%3DM.%2BW.%26aulast%3DLengauer%26aufirst%3DC.%26aulast%3DFinan%26aufirst%3DP.%2BM.%26aulast%3DTallarico%26aufirst%3DJ.%2BA.%26aulast%3DBouwmeester%26aufirst%3DT.%26aulast%3DPorter%26aufirst%3DJ.%2BA.%26aulast%3DBauer%26aufirst%3DA.%26aulast%3DCong%26aufirst%3DF.%26atitle%3DTankyrase%2520inhibition%2520stabilizes%2520axin%2520and%2520antagonizes%2520Wnt%2520signalling%26jtitle%3DNature%26date%3D2009%26volume%3D461%26spage%3D614%26epage%3D620%26doi%3D10.1038%2Fnature08356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span> <span> </span><span class="NLM_article-title">Tankyrase inhibitors target YAP by stabilizing angiomotin family proteins</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">524</span>– <span class="NLM_lpage">532</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2015.09.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.1016%2Fj.celrep.2015.09.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=26456820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1CqtLjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2015&pages=524-532&author=W.+Wangauthor=N.+Liauthor=X.+Liauthor=M.+K.+Tranauthor=X.+Hanauthor=J.+Chen&title=Tankyrase+inhibitors+target+YAP+by+stabilizing+angiomotin+family+proteins&doi=10.1016%2Fj.celrep.2015.09.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Tankyrase Inhibitors Target YAP by Stabilizing Angiomotin Family Proteins</span></div><div class="casAuthors">Wang, Wenqi; Li, Nan; Li, Xu; Tran, My Kim; Han, Xin; Chen, Junjie</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">524-532</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">As the key effector in the Hippo pathway, YAP was identified as an oncoprotein whose expression is elevated in various human cancers.  However, the development of potentially therapeutic compds. targeting YAP has been slow and limited.  Here, we find that tankyrase inhibitors suppress YAP activity.  This effect is mediated by angiomotin (AMOT) family proteins.  Tankyrases assoc. with AMOT family proteins and promote their degrdn. through E3 ligase RNF146.  By antagonizing tankyrase activity, tankyrase inhibitors stabilize AMOT family proteins, thereby suppressing YAP oncogenic functions.  Together, our studies not only demonstrate the tankyrase-RNF146-AMOT axis as an upstream pathway regulating YAP but also reveal a therapeutic opportunity in targeting YAP for cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5bR3ZFLB_P7Vg90H21EOLACvtfcHk0lhepGw8wBx3_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1CqtLjK&md5=7bb440ebc97018d11035ebd295eb3e5e</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2015.09.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2015.09.014%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DTran%26aufirst%3DM.%2BK.%26aulast%3DHan%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DJ.%26atitle%3DTankyrase%2520inhibitors%2520target%2520YAP%2520by%2520stabilizing%2520angiomotin%2520family%2520proteins%26jtitle%3DCell%2520Rep.%26date%3D2015%26volume%3D13%26spage%3D524%26epage%3D532%26doi%3D10.1016%2Fj.celrep.2015.09.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhardwaj, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueberheide, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S.</span></span> <span> </span><span class="NLM_article-title">Whole proteome analysis of human tankyrase knockout cells reveals targets of tankyrase-mediated degradation</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">2214</span>, <span class="refDoi"> DOI: 10.1038/s41467-017-02363-w</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.1038%2Fs41467-017-02363-w" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=29263426" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A280%3ADC%252BC1MzjslWhtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=2214&author=A.+Bhardwajauthor=Y.+Yangauthor=B.+Ueberheideauthor=S.+Smith&title=Whole+proteome+analysis+of+human+tankyrase+knockout+cells+reveals+targets+of+tankyrase-mediated+degradation&doi=10.1038%2Fs41467-017-02363-w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Whole proteome analysis of human tankyrase knockout cells reveals targets of tankyrase-mediated degradation</span></div><div class="casAuthors">Bhardwaj Amit; Smith Susan; Yang Yanling; Ueberheide Beatrix</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2214</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Tankyrase 1 and 2 are poly(ADP-ribose) polymerases that function in pathways critical to cancer cell growth.  Tankyrase-mediated PARylation marks protein targets for proteasomal degradation.  Here, we generate human knockout cell lines to examine cell function and interrogate the proteome.  We show that either tankyrase 1 or 2 is sufficient to maintain telomere length, but both are required to resolve telomere cohesion and maintain mitotic spindle integrity.  Quantitative analysis of the proteome of tankyrase double knockout cells using isobaric tandem mass tags reveals targets of degradation, including antagonists of the Wnt/β-catenin signaling pathway (NKD1, NKD2, and HectD1) and three (Notch 1, 2, and 3) of the four Notch receptors.  We show that tankyrases are required for Notch2 to exit the plasma membrane and enter the nucleus to activate transcription.  Considering that Notch signaling is commonly activated in cancer, tankyrase inhibitors may have therapeutic potential in targeting this pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcREMjSSm_naSOQ4Pl9hzjQhfW6udTcc2ebbKHs9EG9mmLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MzjslWhtg%253D%253D&md5=923f6857cba7fd386c7ebc3e6857fae5</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fs41467-017-02363-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-017-02363-w%26sid%3Dliteratum%253Aachs%26aulast%3DBhardwaj%26aufirst%3DA.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DUeberheide%26aufirst%3DB.%26aulast%3DSmith%26aufirst%3DS.%26atitle%3DWhole%2520proteome%2520analysis%2520of%2520human%2520tankyrase%2520knockout%2520cells%2520reveals%2520targets%2520of%2520tankyrase-mediated%2520degradation%26jtitle%3DNat.%2520Commun.%26date%3D2017%26volume%3D8%26spage%3D2214%26doi%3D10.1038%2Fs41467-017-02363-w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M. K.</span></span> <span> </span><span class="NLM_article-title">Novel insight into the function of tankyrase</span>. <i>Oncol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">6895</span>– <span class="NLM_lpage">6902</span>, <span class="refDoi"> DOI: 10.3892/ol.2018.9551</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.3892%2Fol.2018.9551" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=30546421" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvVGhs7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2018&pages=6895-6902&author=M.+K.+Kim&title=Novel+insight+into+the+function+of+tankyrase&doi=10.3892%2Fol.2018.9551"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Novel insight into the function of tankyrase (review)</span></div><div class="casAuthors">Kim, Mi Kyung</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">6895-6902</span>CODEN:
                <span class="NLM_cas:coden">OLNEB5</span>;
        ISSN:<span class="NLM_cas:issn">1792-1082</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Tankyrases are multifunctional poly(ADP-ribose) polymerases that regulate a variety of cellular processes, including Wnt signaling, telomere maintenance and mitosis regulation.  Tankyrases interact with target proteins and regulate their interactions and stability through poly(ADP-ribosyl) ation.  In addn. to their roles in telomere maintenance and regulation of mitosis, tankyrase proteins regulate tumor suppressors, including AXIN, phosphatase and tensin homolog and angiomotin.  Therefore, tankyrases may be effective targets for cancer treatment.  Tankyrase inhibitors could affect a variety of carcinogenic pathways that promote uncontrolled proliferation, including Wnt, AKT, yes-assocd. protein, telomere maintenance and mitosis regulation.  Recently, novel aspects of the function and mechanism of tankyrases have been reported, and a no. of tankyrase inhibitors have been identified.  A combination of conventional chemotherapy agents with tankyrase inhibitors may have synergistic anticancer effects.  Therefore, it is expected that more advanced and improved tankyrase inhibitors will be developed, enabling novel therapeutic strategies against cancer and other tankyrase-assocd. diseases.  The present review discusses tankyrase function and the role of tankyrase inhibitors in the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoh_4RkO1ZDG7Vg90H21EOLACvtfcHk0liZu0e6RBkN6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvVGhs7jN&md5=a9e97dd985c969af20c63b5c7c3f4458</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.3892%2Fol.2018.9551&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fol.2018.9551%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DM.%2BK.%26atitle%3DNovel%2520insight%2520into%2520the%2520function%2520of%2520tankyrase%26jtitle%3DOncol.%2520Lett.%26date%3D2018%26volume%3D16%26spage%3D6895%26epage%3D6902%26doi%3D10.3892%2Fol.2018.9551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fong, L. W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S. H.</span></span> <span> </span><span class="NLM_article-title">Tankyrase disrupts metabolic homeostasis and promotes tumorigenesis by inhibiting LKB1-AMPK signalling</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">4363</span>, <span class="refDoi"> DOI: 10.1038/s41467-019-12377-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.1038%2Fs41467-019-12377-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=31554794" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A280%3ADC%252BB3MnitFaisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=4363&author=N.+Liauthor=Y.+Wangauthor=S.+Neriauthor=Y.+Zhenauthor=L.+W.+R.+Fongauthor=Y.+Qiaoauthor=X.+Liauthor=Z.+Chenauthor=C.+Stephanauthor=W.+Dengauthor=R.+Yeauthor=W.+Jiangauthor=S.+Zhangauthor=Y.+Yuauthor=M.+C.+Hungauthor=J.+Chenauthor=S.+H.+Lin&title=Tankyrase+disrupts+metabolic+homeostasis+and+promotes+tumorigenesis+by+inhibiting+LKB1-AMPK+signalling&doi=10.1038%2Fs41467-019-12377-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Tankyrase disrupts metabolic homeostasis and promotes tumorigenesis by inhibiting LKB1-AMPK signalling</span></div><div class="casAuthors">Li Nan; Wang Yifan; Neri Shinya; Qiao Yawei; Li Xu; Chen Zhen; Ye Rui; Chen Junjie; Lin Steven H; Wang Yifan; Fong Lon Wolf R; Ye Rui; Hung Mien-Chie; Chen Junjie; Lin Steven H; Wang Yifan; Deng Weiye; Jiang Wen; Zhen Yuanli; Yu Yonghao; Fong Lon Wolf R; Zhang Shuxing; Li Xu; Stephan Clifford; Deng Weiye; Jiang Wen; Lin Steven H; Hung Mien-Chie</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4363</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The LKB1/AMPK pathway plays a major role in cellular homeostasis and tumor suppression.  Down-regulation of LKB1/AMPK occurs in several human cancers and has been implicated in metabolic diseases.  However, the precise upstream regulation of LKB1-AMPK pathway is largely unknown.  Here, we report that AMPK activation by LKB1 is regulated by tankyrases.  Tankyrases interact with and ribosylate LKB1, promoting its K63-linked ubiquitination by an E3 ligase RNF146, which blocks LKB1/STRAD/MO25 complex formation and LKB1 activation.  LKB1 activation by tankyrase inhibitors induces AMPK activation and suppresses tumorigenesis.  Similarly, the tankyrase inhibitor G007-LK effectively regulates liver metabolism and glycemic control in diabetic mice in a LKB1-dependent manner.  In patients with lung cancer, tankyrase levels negatively correlate with p-AMPK levels and poor survival.  Taken together, these findings suggest that tankyrase and RNF146 are major up-stream regulators of LKB1-AMPK pathway and provide another focus for cancer and metabolic disease therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTzEc3gtF2lsdenUz0lpNqnfW6udTcc2ea0hQa2b4SS7bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MnitFaisQ%253D%253D&md5=9cc4bd955f31f48a287cc1e9e513b2e6</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fs41467-019-12377-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-019-12377-1%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DNeri%26aufirst%3DS.%26aulast%3DZhen%26aufirst%3DY.%26aulast%3DFong%26aufirst%3DL.%2BW.%2BR.%26aulast%3DQiao%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DStephan%26aufirst%3DC.%26aulast%3DDeng%26aufirst%3DW.%26aulast%3DYe%26aufirst%3DR.%26aulast%3DJiang%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DHung%26aufirst%3DM.%2BC.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DS.%2BH.%26atitle%3DTankyrase%2520disrupts%2520metabolic%2520homeostasis%2520and%2520promotes%2520tumorigenesis%2520by%2520inhibiting%2520LKB1-AMPK%2520signalling%26jtitle%3DNat.%2520Commun.%26date%3D2019%26volume%3D10%26spage%3D4363%26doi%3D10.1038%2Fs41467-019-12377-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodge, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilgore, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amatruda, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lum, L.</span></span> <span> </span><span class="NLM_article-title">Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">100</span>– <span class="NLM_lpage">107</span>, <span class="refDoi"> DOI: 10.1038/nchembio.137</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.1038%2Fnchembio.137" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=19125156" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlWjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=100-107&author=B.+Chenauthor=M.+E.+Dodgeauthor=W.+Tangauthor=J.+Luauthor=Z.+Maauthor=C.+W.+Fanauthor=S.+Weiauthor=W.+Haoauthor=J.+Kilgoreauthor=N.+S.+Williamsauthor=M.+G.+Rothauthor=J.+F.+Amatrudaauthor=C.+Chenauthor=L.+Lum&title=Small+molecule-mediated+disruption+of+Wnt-dependent+signaling+in+tissue+regeneration+and+cancer&doi=10.1038%2Fnchembio.137"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer</span></div><div class="casAuthors">Chen, Baozhi; Dodge, Michael E.; Tang, Wei; Lu, Jianming; Ma, Zhiqiang; Fan, Chih-Wei; Wei, Shuguang; Hao, Wayne; Kilgore, Jessica; Williams, Noelle S.; Roth, Michael G.; Amatruda, James F.; Chen, Chuo; Lum, Lawrence</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">100-107</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The pervasive influence of secreted Wnt signaling proteins in tissue homeostasis and tumorigenesis has galvanized efforts to identify small mols. that target Wnt-mediated cellular responses.  By screening a diverse synthetic chem. library, we have discovered two new classes of small mols. that disrupt Wnt pathway responses; whereas one class inhibits the activity of Porcupine, a membrane-bound acyltransferase that is essential to the prodn. of Wnt proteins, the other abrogates destruction of Axin proteins, which are suppressors of Wnt/β-catenin pathway activity.  With these small mols., we establish a chem. genetic approach for studying Wnt pathway responses and stem cell function in adult tissue.  We achieve transient, reversible suppression of Wnt/β-catenin pathway response in vivo, and we establish a mechanism-based approach to target cancerous cell growth.  The signal transduction mechanisms shown here to be chem. tractable addnl. contribute to Wnt-independent signal transduction pathways and thus could be broadly exploited for chem. genetics and therapeutic goals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAMJCu3QDiYrVg90H21EOLACvtfcHk0liCMnLdT_TV7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlWjtw%253D%253D&md5=32516a31ce8f691b654ee33c0df83bc5</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.137%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DB.%26aulast%3DDodge%26aufirst%3DM.%2BE.%26aulast%3DTang%26aufirst%3DW.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DFan%26aufirst%3DC.%2BW.%26aulast%3DWei%26aufirst%3DS.%26aulast%3DHao%26aufirst%3DW.%26aulast%3DKilgore%26aufirst%3DJ.%26aulast%3DWilliams%26aufirst%3DN.%2BS.%26aulast%3DRoth%26aufirst%3DM.%2BG.%26aulast%3DAmatruda%26aufirst%3DJ.%2BF.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DLum%26aufirst%3DL.%26atitle%3DSmall%2520molecule-mediated%2520disruption%2520of%2520Wnt-dependent%2520signaling%2520in%2520tissue%2520regeneration%2520and%2520cancer%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2009%26volume%3D5%26spage%3D100%26epage%3D107%26doi%3D10.1038%2Fnchembio.137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waaler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machon, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tumova, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korinek, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulsen, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedersen, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eide, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machonova, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gradl, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voronkov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Kries, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauss, S.</span></span> <span> </span><span class="NLM_article-title">A novel tankyrase inhibitor decreases canonical Wnt signaling in colon carcinoma cells and reduces tumor growth in conditional APC mutant mice</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">2822</span>– <span class="NLM_lpage">2832</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-11-3336</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.1158%2F0008-5472.CAN-11-3336" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=22440753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC38XnvVyjtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2012&pages=2822-2832&author=J.+Waalerauthor=O.+Machonauthor=L.+Tumovaauthor=H.+Dinhauthor=V.+Korinekauthor=S.+R.+Wilsonauthor=J.+E.+Paulsenauthor=N.+M.+Pedersenauthor=T.+J.+Eideauthor=O.+Machonovaauthor=D.+Gradlauthor=A.+Voronkovauthor=J.+P.+von+Kriesauthor=S.+Krauss&title=A+novel+tankyrase+inhibitor+decreases+canonical+Wnt+signaling+in+colon+carcinoma+cells+and+reduces+tumor+growth+in+conditional+APC+mutant+mice&doi=10.1158%2F0008-5472.CAN-11-3336"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Tankyrase Inhibitor Decreases Canonical Wnt Signaling in Colon Carcinoma Cells and Reduces Tumor Growth in Conditional APC Mutant Mice</span></div><div class="casAuthors">Waaler, Jo; Machon, Ondrej; Tumova, Lucie; Dinh, Huyen; Korinek, Vladimir; Wilson, Steven Ray; Paulsen, Jan Erik; Pedersen, Nina Marie; Eide, Tor J.; Machonova, Olga; Gradl, Dietmar; Voronkov, Andrey; von Kries, Jens Peter; Krauss, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2822-2832</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">This preclin. proof-of-concept study suggests a new strategy to treat colon cancer by increasing the degrdn. of β-catenin, which drives this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokQ3hrnF8gMLVg90H21EOLACvtfcHk0liCMnLdT_TV7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnvVyjtro%253D&md5=9814ad25dc1d5da6d9babaff8df19327</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-11-3336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-11-3336%26sid%3Dliteratum%253Aachs%26aulast%3DWaaler%26aufirst%3DJ.%26aulast%3DMachon%26aufirst%3DO.%26aulast%3DTumova%26aufirst%3DL.%26aulast%3DDinh%26aufirst%3DH.%26aulast%3DKorinek%26aufirst%3DV.%26aulast%3DWilson%26aufirst%3DS.%2BR.%26aulast%3DPaulsen%26aufirst%3DJ.%2BE.%26aulast%3DPedersen%26aufirst%3DN.%2BM.%26aulast%3DEide%26aufirst%3DT.%2BJ.%26aulast%3DMachonova%26aufirst%3DO.%26aulast%3DGradl%26aufirst%3DD.%26aulast%3DVoronkov%26aufirst%3DA.%26aulast%3Dvon%2BKries%26aufirst%3DJ.%2BP.%26aulast%3DKrauss%26aufirst%3DS.%26atitle%3DA%2520novel%2520tankyrase%2520inhibitor%2520decreases%2520canonical%2520Wnt%2520signaling%2520in%2520colon%2520carcinoma%2520cells%2520and%2520reduces%2520tumor%2520growth%2520in%2520conditional%2520APC%2520mutant%2520mice%26jtitle%3DCancer%2520Res.%26date%3D2012%26volume%3D72%26spage%3D2822%26epage%3D2832%26doi%3D10.1158%2F0008-5472.CAN-11-3336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Voronkov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holsworth, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waaler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ekblad, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perdreau-Dahl, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drewes, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopf, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morth, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauss, S.</span></span> <span> </span><span class="NLM_article-title">Structural basis and SAR for G007-LK, a lead stage 1,2,4-triazole based specific tankyrase 1/2 inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">3012</span>– <span class="NLM_lpage">3023</span>, <span class="refDoi"> DOI: 10.1021/jm4000566</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4000566" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjslGht7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3012-3023&author=A.+Voronkovauthor=D.+D.+Holsworthauthor=J.+Waalerauthor=S.+R.+Wilsonauthor=B.+Ekbladauthor=H.+Perdreau-Dahlauthor=H.+Dinhauthor=G.+Drewesauthor=C.+Hopfauthor=J.+P.+Morthauthor=S.+Krauss&title=Structural+basis+and+SAR+for+G007-LK%2C+a+lead+stage+1%2C2%2C4-triazole+based+specific+tankyrase+1%2F2+inhibitor&doi=10.1021%2Fjm4000566"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis and SAR for G007-LK, a Lead Stage 1,2,4-Triazole Based Specific Tankyrase 1/2 Inhibitor</span></div><div class="casAuthors">Voronkov, Andrew; Holsworth, Daniel D.; Waaler, Jo; Wilson, Steven R.; Ekblad, Bie; Perdreau-Dahl, Harmonie; Dinh, Huyen; Drewes, Gerard; Hopf, Carsten; Morth, Jens P.; Krauss, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3012-3023</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tankyrases 1 and 2 (TNKS1/2) are promising pharmacol. biotargets with possible applications for the development of novel anticancer therapeutics.  A focused structure-activity relationship study was conducted based on the tankyrase inhibitor JW74 (1).  Chem. analoging of 1 improved the 1,2,4-triazole based core and led to 4-{5-[(E)-2-{4-(2-chlorophenyl)-5-[5-(methylsulfonyl)pyridin-2-yl]-4H-1,2,4-triazol-3-yl}ethenyl]-1,3,4-oxadiazol-2-yl}benzonitrile (G007-LK), a potent, "rule of 5" compliant and a metabolically stable TNKS1/2 inhibitor.  G007-LK (66) displayed high selectivity toward tankyrases 1 and 2 with biochem. IC50 values of 46 nM and 25 nM, resp., and a cellular IC50 value of 50 nM combined with an excellent pharmacokinetic profile in mice.  The PARP domain of TNKS2 was cocrystd. with 66, and the X-ray structure was detd. at 2.8 Å resoln. in the space group P3221.  The structure revealed that 66 binds to unique structural features in the extended adenosine binding pocket which forms the structural basis for the compd.'s high target selectivity and specificity.  Our study provides a significantly optimized compd. for targeting TNKS1/2 in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvUxhCxkLuYbVg90H21EOLACvtfcHk0lhoB4WS5ZEe4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjslGht7o%253D&md5=f2bee61f0fdc326e3e798b3705072e9d</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm4000566&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4000566%26sid%3Dliteratum%253Aachs%26aulast%3DVoronkov%26aufirst%3DA.%26aulast%3DHolsworth%26aufirst%3DD.%2BD.%26aulast%3DWaaler%26aufirst%3DJ.%26aulast%3DWilson%26aufirst%3DS.%2BR.%26aulast%3DEkblad%26aufirst%3DB.%26aulast%3DPerdreau-Dahl%26aufirst%3DH.%26aulast%3DDinh%26aufirst%3DH.%26aulast%3DDrewes%26aufirst%3DG.%26aulast%3DHopf%26aufirst%3DC.%26aulast%3DMorth%26aufirst%3DJ.%2BP.%26aulast%3DKrauss%26aufirst%3DS.%26atitle%3DStructural%2520basis%2520and%2520SAR%2520for%2520G007-LK%252C%2520a%2520lead%2520stage%25201%252C2%252C4-triazole%2520based%2520specific%2520tankyrase%25201%252F2%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3012%26epage%3D3023%26doi%3D10.1021%2Fjm4000566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bregman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman-Perez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaydin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teffera, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egge, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullady, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newcomb, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serafino, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strathdee, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turci, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimauro, E. F.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel, induced-pocket binding oxazolidinones as potent, selective, and orally bioavailable tankyrase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">4320</span>– <span class="NLM_lpage">4342</span>, <span class="refDoi"> DOI: 10.1021/jm4000038</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4000038" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC3sXotV2ksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4320-4342&author=H.+Bregmanauthor=N.+Chakkaauthor=A.+Guzman-Perezauthor=H.+Gunaydinauthor=Y.+Guauthor=X.+Huangauthor=V.+Berryauthor=J.+Liuauthor=Y.+Tefferaauthor=L.+Huangauthor=B.+Eggeauthor=E.+L.+Mulladyauthor=S.+Schneiderauthor=P.+S.+Andrewsauthor=A.+Mishraauthor=J.+Newcombauthor=R.+Serafinoauthor=C.+A.+Strathdeeauthor=S.+M.+Turciauthor=C.+Wilsonauthor=E.+F.+Dimauro&title=Discovery+of+novel%2C+induced-pocket+binding+oxazolidinones+as+potent%2C+selective%2C+and+orally+bioavailable+tankyrase+inhibitors&doi=10.1021%2Fjm4000038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel, Induced-Pocket Binding Oxazolidinones as Potent, Selective, and Orally Bioavailable Tankyrase Inhibitors</span></div><div class="casAuthors">Bregman, Howard; Chakka, Nagasree; Guzman-Perez, Angel; Gunaydin, Hakan; Gu, Yan; Huang, Xin; Berry, Virginia; Liu, Jingzhou; Teffera, Yohannes; Huang, Liyue; Egge, Bryan; Mullady, Erin L.; Schneider, Steve; Andrews, Paul S.; Mishra, Ankita; Newcomb, John; Serafino, Randy; Strathdee, Craig A.; Turci, Susan M.; Wilson, Cindy; DiMauro, Erin F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4320-4342</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tankyrase (TNKS) is a poly-ADP-ribosylating protein (PARP) whose activity suppresses cellular axin protein levels and elevates β-catenin concns., resulting in increased oncogene expression.  The inhibition of tankyrase (TNKS1 and 2) may reduce the levels of β-catenin-mediated transcription and inhibit tumorigenesis.  Compd. I is a previously described moderately potent tankyrase inhibitor that suffers from poor pharmacokinetic properties.  Herein, we describe the utilization of structure-based design and mol. modeling toward novel, potent, and selective tankyrase inhibitors with improved pharmacokinetic properties (II, III).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNxO4sATmyjbVg90H21EOLACvtfcHk0lhoB4WS5ZEe4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXotV2ksLs%253D&md5=c22d14a6a93ab185e3c13ccd04af9451</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm4000038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4000038%26sid%3Dliteratum%253Aachs%26aulast%3DBregman%26aufirst%3DH.%26aulast%3DChakka%26aufirst%3DN.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DBerry%26aufirst%3DV.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DTeffera%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DEgge%26aufirst%3DB.%26aulast%3DMullady%26aufirst%3DE.%2BL.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DAndrews%26aufirst%3DP.%2BS.%26aulast%3DMishra%26aufirst%3DA.%26aulast%3DNewcomb%26aufirst%3DJ.%26aulast%3DSerafino%26aufirst%3DR.%26aulast%3DStrathdee%26aufirst%3DC.%2BA.%26aulast%3DTurci%26aufirst%3DS.%2BM.%26aulast%3DWilson%26aufirst%3DC.%26aulast%3DDimauro%26aufirst%3DE.%2BF.%26atitle%3DDiscovery%2520of%2520novel%252C%2520induced-pocket%2520binding%2520oxazolidinones%2520as%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520tankyrase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4320%26epage%3D4342%26doi%3D10.1021%2Fjm4000038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anumala, U. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waaler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nkizinkiko, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ignatev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazarow, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindemann, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murthy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obaji, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majouga, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonov, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Kries, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehtio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauss, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nazare, M.</span></span> <span> </span><span class="NLM_article-title">Discovery of a novel series of tankyrase inhibitors by a hybridization approach</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">10013</span>– <span class="NLM_lpage">10025</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00883</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00883" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVCksrnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=10013-10025&author=U.+R.+Anumalaauthor=J.+Waalerauthor=Y.+Nkizinkikoauthor=A.+Ignatevauthor=K.+Lazarowauthor=P.+Lindemannauthor=P.+A.+Olsenauthor=S.+Murthyauthor=E.+Obajiauthor=A.+G.+Majougaauthor=S.+Leonovauthor=J.+P.+von+Kriesauthor=L.+Lehtioauthor=S.+Kraussauthor=M.+Nazare&title=Discovery+of+a+novel+series+of+tankyrase+inhibitors+by+a+hybridization+approach&doi=10.1021%2Facs.jmedchem.7b00883"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Novel Series of Tankyrase Inhibitors by a Hybridization Approach</span></div><div class="casAuthors">Anumala, Upendra Rao; Waaler, Jo; Nkizinkiko, Yves; Ignatev, Alexander; Lazarow, Katina; Lindemann, Peter; Olsen, Petter Angell; Murthy, Sudarshan; Obaji, Ezeogo; Majouga, Alexander G.; Leonov, Sergey; von Kries, Jens Peter; Lehtioe, Lari; Krauss, Stefan; Nazare, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10013-10025</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A structure-guided hybridization approach using two privileged substructures gave instant access to a new series of tankyrase inhibitors.  The identified inhibitor 16 (1-(trans-3-(4-(2-Chlorophenyl)-5-(pyrimidin-4-yl)-4H-1,2,4-triazol-3-yl)cyclobutyl)-2,3-dihydro-2-oxo-1H-benzimidazole-5-carbonitrile) displays high target affinity on tankyrase 1 and 2 with biochem. and cellular IC50 values of 29 nM, 6.3 nM and 19 nM, resp., and high selectivity toward other poly (ADP-ribose) polymerase enzymes.  The identified inhibitor shows a favorable in vitro ADME profile as well as good oral bioavailability in mice, rats, and dogs.  Crit. for the approach was the utilization of an appropriate linker between 1,2,4-triazole and benzimidazolone moieties, whereby a cyclobutyl linker displayed superior affinity compared to a cyclohexane and Ph linker.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaOvTL0NvY8bVg90H21EOLACvtfcHk0ljnEfUELsiNFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVCksrnJ&md5=d6bf8c8d971a158cdddc7d1c84b5144c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00883&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00883%26sid%3Dliteratum%253Aachs%26aulast%3DAnumala%26aufirst%3DU.%2BR.%26aulast%3DWaaler%26aufirst%3DJ.%26aulast%3DNkizinkiko%26aufirst%3DY.%26aulast%3DIgnatev%26aufirst%3DA.%26aulast%3DLazarow%26aufirst%3DK.%26aulast%3DLindemann%26aufirst%3DP.%26aulast%3DOlsen%26aufirst%3DP.%2BA.%26aulast%3DMurthy%26aufirst%3DS.%26aulast%3DObaji%26aufirst%3DE.%26aulast%3DMajouga%26aufirst%3DA.%2BG.%26aulast%3DLeonov%26aufirst%3DS.%26aulast%3Dvon%2BKries%26aufirst%3DJ.%2BP.%26aulast%3DLehtio%26aufirst%3DL.%26aulast%3DKrauss%26aufirst%3DS.%26aulast%3DNazare%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520series%2520of%2520tankyrase%2520inhibitors%2520by%2520a%2520hybridization%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D10013%26epage%3D10025%26doi%3D10.1021%2Facs.jmedchem.7b00883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bregman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman-Perez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaydin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teffera, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egge, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullady, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newcomb, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serafino, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strathdee, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turci, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMauro, E. F.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel, induced-pocket binding oxazolidinones as potent, selective, and orally bioavailable tankyrase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">4320</span>– <span class="NLM_lpage">4342</span>, <span class="refDoi"> DOI: 10.1021/jm4000038</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4000038" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC3sXotV2ksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4320-4342&author=H.+Bregmanauthor=N.+Chakkaauthor=A.+Guzman-Perezauthor=H.+Gunaydinauthor=Y.+Guauthor=X.+Huangauthor=V.+Berryauthor=J.+Liuauthor=Y.+Tefferaauthor=L.+Huangauthor=B.+Eggeauthor=E.+L.+Mulladyauthor=S.+Schneiderauthor=P.+S.+Andrewsauthor=A.+Mishraauthor=J.+Newcombauthor=R.+Serafinoauthor=C.+A.+Strathdeeauthor=S.+M.+Turciauthor=C.+Wilsonauthor=E.+F.+DiMauro&title=Discovery+of+novel%2C+induced-pocket+binding+oxazolidinones+as+potent%2C+selective%2C+and+orally+bioavailable+tankyrase+inhibitors&doi=10.1021%2Fjm4000038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel, Induced-Pocket Binding Oxazolidinones as Potent, Selective, and Orally Bioavailable Tankyrase Inhibitors</span></div><div class="casAuthors">Bregman, Howard; Chakka, Nagasree; Guzman-Perez, Angel; Gunaydin, Hakan; Gu, Yan; Huang, Xin; Berry, Virginia; Liu, Jingzhou; Teffera, Yohannes; Huang, Liyue; Egge, Bryan; Mullady, Erin L.; Schneider, Steve; Andrews, Paul S.; Mishra, Ankita; Newcomb, John; Serafino, Randy; Strathdee, Craig A.; Turci, Susan M.; Wilson, Cindy; DiMauro, Erin F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4320-4342</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tankyrase (TNKS) is a poly-ADP-ribosylating protein (PARP) whose activity suppresses cellular axin protein levels and elevates β-catenin concns., resulting in increased oncogene expression.  The inhibition of tankyrase (TNKS1 and 2) may reduce the levels of β-catenin-mediated transcription and inhibit tumorigenesis.  Compd. I is a previously described moderately potent tankyrase inhibitor that suffers from poor pharmacokinetic properties.  Herein, we describe the utilization of structure-based design and mol. modeling toward novel, potent, and selective tankyrase inhibitors with improved pharmacokinetic properties (II, III).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNxO4sATmyjbVg90H21EOLACvtfcHk0ljnEfUELsiNFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXotV2ksLs%253D&md5=c22d14a6a93ab185e3c13ccd04af9451</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm4000038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4000038%26sid%3Dliteratum%253Aachs%26aulast%3DBregman%26aufirst%3DH.%26aulast%3DChakka%26aufirst%3DN.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DBerry%26aufirst%3DV.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DTeffera%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DEgge%26aufirst%3DB.%26aulast%3DMullady%26aufirst%3DE.%2BL.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DAndrews%26aufirst%3DP.%2BS.%26aulast%3DMishra%26aufirst%3DA.%26aulast%3DNewcomb%26aufirst%3DJ.%26aulast%3DSerafino%26aufirst%3DR.%26aulast%3DStrathdee%26aufirst%3DC.%2BA.%26aulast%3DTurci%26aufirst%3DS.%2BM.%26aulast%3DWilson%26aufirst%3DC.%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26atitle%3DDiscovery%2520of%2520novel%252C%2520induced-pocket%2520binding%2520oxazolidinones%2520as%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520tankyrase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4320%26epage%3D4342%26doi%3D10.1021%2Fjm4000038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haikarainen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waaler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ignatev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nkizinkiko, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkannagari, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obaji, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauss, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehtio, L.</span></span> <span> </span><span class="NLM_article-title">Development and structural analysis of adenosine site binding tankyrase inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">328</span>– <span class="NLM_lpage">333</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.12.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.1016%2Fj.bmcl.2015.12.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=26706174" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVClurnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=328-333&author=T.+Haikarainenauthor=J.+Waalerauthor=A.+Ignatevauthor=Y.+Nkizinkikoauthor=H.+Venkannagariauthor=E.+Obajiauthor=S.+Kraussauthor=L.+Lehtio&title=Development+and+structural+analysis+of+adenosine+site+binding+tankyrase+inhibitors&doi=10.1016%2Fj.bmcl.2015.12.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Development and structural analysis of adenosine site binding tankyrase inhibitors</span></div><div class="casAuthors">Haikarainen, Teemu; Waaler, Jo; Ignatev, Alexander; Nkizinkiko, Yves; Venkannagari, Harikanth; Obaji, Ezeogo; Krauss, Stefan; Lehtio, Lari</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">328-333</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Tankyrases 1 and 2, the specialized members of the ARTD protein family, are druggable biotargets whose inhibition may have therapeutic potential against cancer, metabolic disease, fibrotic disease, fibrotic wound healing and HSV viral infections.  We have previously identified a novel tankyrase inhibitor scaffold, JW55, and showed that it reduces mouse colon adenoma formation in vivo.  Here we expanded the scaffold and profiled the selectivity of the compds. against a panel of human ARTDs.  The scaffold also enables a fine modulation of selectivity towards either tankyrase 1 or tankyrase 2.  In order to get insight about the binding mode of the inhibitors, we solved crystal structures of the compds. in complex with tankyrase 2.  The compds. bind to the adenosine pocket of the catalytic domain and cause changes in the protein structure that are modulated by the chem. modifications of the compds.  The structural anal. allows further rational development of this compd. class as a potent and selective tankyrase inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1PL4ynXO_w7Vg90H21EOLACvtfcHk0lhCir_Bc76mNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVClurnK&md5=3ea16aeed0c29adf13e112b7c5f9d796</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.12.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.12.018%26sid%3Dliteratum%253Aachs%26aulast%3DHaikarainen%26aufirst%3DT.%26aulast%3DWaaler%26aufirst%3DJ.%26aulast%3DIgnatev%26aufirst%3DA.%26aulast%3DNkizinkiko%26aufirst%3DY.%26aulast%3DVenkannagari%26aufirst%3DH.%26aulast%3DObaji%26aufirst%3DE.%26aulast%3DKrauss%26aufirst%3DS.%26aulast%3DLehtio%26aufirst%3DL.%26atitle%3DDevelopment%2520and%2520structural%2520analysis%2520of%2520adenosine%2520site%2520binding%2520tankyrase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D328%26epage%3D333%26doi%3D10.1016%2Fj.bmcl.2015.12.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nkizinkiko, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suneel Kumar, B. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeankumar, V. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haikarainen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koivunen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madhuri, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yogeeswari, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkannagari, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obaji, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pihlajaniemi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sriram, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehtio, L.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent and selective nonplanar tankyrase inhibiting nicotinamide mimics</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">4139</span>– <span class="NLM_lpage">4149</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.06.063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.1016%2Fj.bmc.2015.06.063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=26183543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFehsr%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=4139-4149&author=Y.+Nkizinkikoauthor=B.+V.+Suneel+Kumarauthor=V.+U.+Jeankumarauthor=T.+Haikarainenauthor=J.+Koivunenauthor=C.+Madhuriauthor=P.+Yogeeswariauthor=H.+Venkannagariauthor=E.+Obajiauthor=T.+Pihlajaniemiauthor=D.+Sriramauthor=L.+Lehtio&title=Discovery+of+potent+and+selective+nonplanar+tankyrase+inhibiting+nicotinamide+mimics&doi=10.1016%2Fj.bmc.2015.06.063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of potent and selective nonplanar tankyrase inhibiting nicotinamide mimics</span></div><div class="casAuthors">Nkizinkiko, Yves; Suneel Kumar, B. V. S.; Jeankumar, Variam Ullas; Haikarainen, Teemu; Koivunen, Jarkko; Madhuri, Chanduri; Yogeeswari, Perumal; Venkannagari, Harikanth; Obaji, Ezeogo; Pihlajaniemi, Taina; Sriram, Dharmarajan; Lehtio, Lari</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4139-4149</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Diphtheria toxin-like ADP-ribosyltransferases catalyze a posttranslational modification, ADP-ribosylation and form a protein family of 17 members in humans.  Two of the family members, tankyrases 1 and 2, are involved in several cellular processes including mitosis and Wnt/β-catenin signaling pathway.  They are often over-expressed in cancer cells and have been linked with the survival of cancer cells making them potential therapeutic targets.  In this study, the authors identified nine tankyrase inhibitors through virtual and in vitro screening.  Crystal structures of tankyrase 2 with the compds. showed that they bind to the nicotinamide binding site of the catalytic domain.  Based on the co-crystal structures the authors designed and synthesized a series of tetrahydroquinazolin-4-one and pyridopyrimidin-4-one analogs and were subsequently able to improve the potency of a hit compd. almost 100-fold (from 11 μM to 150 nM).  The most potent compds. were selective towards tankyrases over a panel of other human ARTD enzymes.  They also inhibited Wnt/β-catenin pathway in a cell-based reporter assay demonstrating the potential usefulness of the identified new scaffolds for further development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpylPKok8psxrVg90H21EOLACvtfcHk0lhCir_Bc76mNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFehsr%252FJ&md5=1e163b9b7620e0ff66c9d41915849ad0</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.06.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.06.063%26sid%3Dliteratum%253Aachs%26aulast%3DNkizinkiko%26aufirst%3DY.%26aulast%3DSuneel%2BKumar%26aufirst%3DB.%2BV.%26aulast%3DJeankumar%26aufirst%3DV.%2BU.%26aulast%3DHaikarainen%26aufirst%3DT.%26aulast%3DKoivunen%26aufirst%3DJ.%26aulast%3DMadhuri%26aufirst%3DC.%26aulast%3DYogeeswari%26aufirst%3DP.%26aulast%3DVenkannagari%26aufirst%3DH.%26aulast%3DObaji%26aufirst%3DE.%26aulast%3DPihlajaniemi%26aufirst%3DT.%26aulast%3DSriram%26aufirst%3DD.%26aulast%3DLehtio%26aufirst%3DL.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520selective%2520nonplanar%2520tankyrase%2520inhibiting%2520nicotinamide%2520mimics%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D4139%26epage%3D4149%26doi%3D10.1016%2Fj.bmc.2015.06.063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McGonigle, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolber-Simonds, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ackermann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Twine, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shie, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miu, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moniz, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomoto, K.</span></span> <span> </span><span class="NLM_article-title">E7449: A dual inhibitor of PARP1/2 and tankyrase1/2 inhibits growth of DNA repair deficient tumors and antagonizes Wnt signaling</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">41307</span>– <span class="NLM_lpage">41323</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.5846</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.18632%2Foncotarget.5846" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=26513298" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A280%3ADC%252BC28zmsFajsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=41307-41323&author=S.+McGonigleauthor=Z.+Chenauthor=J.+Wuauthor=P.+Changauthor=D.+Kolber-Simondsauthor=K.+Ackermannauthor=N.+C.+Twineauthor=J.+L.+Shieauthor=J.+T.+Miuauthor=K.+C.+Huangauthor=G.+A.+Monizauthor=K.+Nomoto&title=E7449%3A+A+dual+inhibitor+of+PARP1%2F2+and+tankyrase1%2F2+inhibits+growth+of+DNA+repair+deficient+tumors+and+antagonizes+Wnt+signaling&doi=10.18632%2Foncotarget.5846"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">E7449: A dual inhibitor of PARP1/2 and tankyrase1/2 inhibits growth of DNA repair deficient tumors and antagonizes Wnt signaling</span></div><div class="casAuthors">McGonigle Sharon; Chen Zhihong; Wu Jiayi; Kolber-Simonds Donna; Ackermann Karen; Twine Natalie C; Shie Jue-Lon; Miu Jingzang Tao; Huang Kuan-Chun; Nomoto Kenichi; Chang Paul; Chang Paul; Miu Jingzang Tao; Moniz George A; Moniz George A</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">41307-23</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Inhibition of Poly(ADP-ribose) Polymerase1 (PARP1) impairs DNA damage repair, and early generation PARP1/2 inhibitors (olaparib, niraparib, etc.) have demonstrated clinical proof of concept for cancer treatment.  Here, we describe the development of the novel PARP inhibitor E7449, a potent PARP1/2 inhibitor that also inhibits PARP5a/5b, otherwise known as tankyrase1 and 2 (TNKS1 and 2), important regulators of canonical Wnt/β-catenin signaling.  E7449 inhibits PARP enzymatic activity and additionally traps PARP1 onto damaged DNA; a mechanism previously shown to augment cytotoxicity.  Cells deficient in DNA repair pathways beyond homologous recombination were sensitive to E7449 treatment.  Chemotherapy was potentiated by E7449 and single agent had significant antitumor activity in BRCA-deficient xenografts.  Additionally, E7449 inhibited Wnt/β-catenin signaling in colon cancer cell lines, likely through TNKS inhibition.  Consistent with this possibility, E7449 stabilized axin and TNKS proteins resulting in β-catenin de-stabilization and significantly altered expression of Wnt target genes.  Notably, hair growth mediated by Wnt signaling was inhibited by E7449.  A pharmacodynamic effect of E7449 on Wnt target genes was observed in tumors, although E7449 lacked single agent antitumor activity in vivo, a finding typical for selective TNKS inhibitors.  E7449 antitumor activity was increased through combination with MEK inhibition.  Particularly noteworthy was the lack of toxicity, most significantly the lack of intestinal toxicity reported for other TNKS inhibitors.  E7449 represents a novel dual PARP1/2 and TNKS1/2 inhibitor which has the advantage of targeting Wnt/β-catenin signaling addicted tumors.  E7449 is currently in early clinical development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcScNmr1n8UDWbrIbt-tGZmxfW6udTcc2eYFHtNDLA_ovLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28zmsFajsA%253D%253D&md5=8e0ce94993305253e4b5d76355583498</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.5846&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.5846%26sid%3Dliteratum%253Aachs%26aulast%3DMcGonigle%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DP.%26aulast%3DKolber-Simonds%26aufirst%3DD.%26aulast%3DAckermann%26aufirst%3DK.%26aulast%3DTwine%26aufirst%3DN.%2BC.%26aulast%3DShie%26aufirst%3DJ.%2BL.%26aulast%3DMiu%26aufirst%3DJ.%2BT.%26aulast%3DHuang%26aufirst%3DK.%2BC.%26aulast%3DMoniz%26aufirst%3DG.%2BA.%26aulast%3DNomoto%26aufirst%3DK.%26atitle%3DE7449%253A%2520A%2520dual%2520inhibitor%2520of%2520PARP1%252F2%2520and%2520tankyrase1%252F2%2520inhibits%2520growth%2520of%2520DNA%2520repair%2520deficient%2520tumors%2520and%2520antagonizes%2520Wnt%2520signaling%26jtitle%3DOncotarget%26date%3D2015%26volume%3D6%26spage%3D41307%26epage%3D41323%26doi%3D10.18632%2Foncotarget.5846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paine, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nathubhai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woon, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sunderland, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahon, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lloyd, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haikarainen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narwal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehtio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Threadgill, M. D.</span></span> <span> </span><span class="NLM_article-title">Exploration of the nicotinamide-binding site of the tankyrases, identifying 3-arylisoquinolin-1-ones as potent and selective inhibitors in vitro</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">5891</span>– <span class="NLM_lpage">5908</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.06.061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.1016%2Fj.bmc.2015.06.061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=26189030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFemu7vK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=5891-5908&author=H.+A.+Paineauthor=A.+Nathubhaiauthor=E.+C.+Woonauthor=P.+T.+Sunderlandauthor=P.+J.+Woodauthor=M.+F.+Mahonauthor=M.+D.+Lloydauthor=A.+S.+Thompsonauthor=T.+Haikarainenauthor=M.+Narwalauthor=L.+Lehtioauthor=M.+D.+Threadgill&title=Exploration+of+the+nicotinamide-binding+site+of+the+tankyrases%2C+identifying+3-arylisoquinolin-1-ones+as+potent+and+selective+inhibitors+in+vitro&doi=10.1016%2Fj.bmc.2015.06.061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Exploration of the nicotinamide-binding site of the tankyrases, identifying 3-arylisoquinolin-1-ones as potent and selective inhibitors in vitro</span></div><div class="casAuthors">Paine, Helen A.; Nathubhai, Amit; Woon, Esther C. Y.; Sunderland, Peter T.; Wood, Pauline J.; Mahon, Mary F.; Lloyd, Matthew D.; Thompson, Andrew S.; Haikarainen, Teemu; Narwal, Mohit; Lehtio, Lari; Threadgill, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5891-5908</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Tankyrases-1 and -2 (TNKS-1 and TNKS-2) have three cellular roles which make them important targets in cancer.  Using NAD+ as a substrate, they poly(ADP-ribosyl)ate TRF1 (regulating lengths of telomeres), NuMA (facilitating mitosis) and axin (in wnt/β-catenin signaling).  Using mol. modeling and the structure of the weak inhibitor 5-aminoiso quinolin-1-one, 3-aryl-5-substituted-isoquinolin-1-ones were designed as inhibitors to explore the structure-activity relationships (SARs) for binding and to define the shape of a hydrophobic cavity in the active site.  5-Amino-3-arylisoquinolinones were synthesized by Suzuki-Miyaura coupling of arylboronic acids to 3-bromo-1-methoxy-5-nitro-isoquinoline, redn. and O-demethylation.  3-Aryl-5-methylisoquinolin-1-ones, 3-aryl-5-fluoroisoquinolin-1-ones and 3-aryl-5-methoxyisoquinolin-1-ones were accessed by deprotonation of 3-substituted-N,N,2-trimethylbenzamides and quench with an appropriate benzonitrile.  SAR around the isoquinolinone core showed that aryl was required at the 3-position, optimally with a para-substituent.  Small meta-substituents were tolerated but groups in the ortho-positions reduced or abolished activity.  This was not due to lack of coplanarity of the rings, as shown by the potency of 4,5-dimethyl-3-phenylisoquinolin-1-one.  Me and methoxy were optimal at the 5-position.  SAR was rationalized by modeling and by crystal structures of examples with TNKS-2.  The 3-aryl unit was located in a large hydrophobic cavity and the para-substituents projected into a tunnel leading to the exterior.  Potency against TNKS-1 paralleled potency against TNKS-2.  Most inhibitors were highly selective for TNKSs over PARP-1 and PARP-2.  A range of highly potent and selective inhibitors is now available for cellular studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqorPYvLKQ94bVg90H21EOLACvtfcHk0ljrX8IJUpbuzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFemu7vK&md5=a0c5d0ca6be15f5a565e66ba201d0c57</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.06.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.06.061%26sid%3Dliteratum%253Aachs%26aulast%3DPaine%26aufirst%3DH.%2BA.%26aulast%3DNathubhai%26aufirst%3DA.%26aulast%3DWoon%26aufirst%3DE.%2BC.%26aulast%3DSunderland%26aufirst%3DP.%2BT.%26aulast%3DWood%26aufirst%3DP.%2BJ.%26aulast%3DMahon%26aufirst%3DM.%2BF.%26aulast%3DLloyd%26aufirst%3DM.%2BD.%26aulast%3DThompson%26aufirst%3DA.%2BS.%26aulast%3DHaikarainen%26aufirst%3DT.%26aulast%3DNarwal%26aufirst%3DM.%26aulast%3DLehtio%26aufirst%3DL.%26aulast%3DThreadgill%26aufirst%3DM.%2BD.%26atitle%3DExploration%2520of%2520the%2520nicotinamide-binding%2520site%2520of%2520the%2520tankyrases%252C%2520identifying%25203-arylisoquinolin-1-ones%2520as%2520potent%2520and%2520selective%2520inhibitors%2520in%2520vitro%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D5891%26epage%3D5908%26doi%3D10.1016%2Fj.bmc.2015.06.061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ferri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liscio, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asciutti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sardella, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macchiarulo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camaioni, E.</span></span> <span> </span><span class="NLM_article-title">Targeting Wnt-driven cancers: Discovery of novel tankyrase inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>142</i></span>,  <span class="NLM_fpage">506</span>– <span class="NLM_lpage">522</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.09.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.1016%2Fj.ejmech.2017.09.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=29107427" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslentbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2017&pages=506-522&author=M.+Ferriauthor=P.+Liscioauthor=A.+Carottiauthor=S.+Asciuttiauthor=R.+Sardellaauthor=A.+Macchiaruloauthor=E.+Camaioni&title=Targeting+Wnt-driven+cancers%3A+Discovery+of+novel+tankyrase+inhibitors&doi=10.1016%2Fj.ejmech.2017.09.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Wnt-driven cancers: Discovery of novel tankyrase inhibitors</span></div><div class="casAuthors">Ferri, Martina; Liscio, Paride; Carotti, Andrea; Asciutti, Stefania; Sardella, Roccaldo; Macchiarulo, Antonio; Camaioni, Emidio</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">506-522</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  Recent years have seen substantially heightened interest in the discovery of tankyrase inhibitors (TNKSi) as new promising anticancer agents.  In this framework, the aim of this review article is focused on the description of potent TNKSi also endowed with disruptor activity toward the Wnt/β-catenin signaling pathway.  Beginning with an overview of the most characterized TNKSi deriving from several drug design approaches and classifying them on the basis of the mol. interactions with the target, the authors discuss only those ones acting against Wnt cancer cell lines.  In addn., comprehensive structure property relationships (SPR) emerging from the hit evolution processes and preclin. results are provided.  The authors then review the most promising TNKSi hitherto reported in literature, acting in vivo models of Wnt-driven cancers.  Some out-looks on current issues and future directions in this field are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAs1ycCxVwl7Vg90H21EOLACvtfcHk0lgIlRoEScPMyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslentbbJ&md5=9b4d843e6bb7ccdea56f9e9c8b70d18c</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.09.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.09.030%26sid%3Dliteratum%253Aachs%26aulast%3DFerri%26aufirst%3DM.%26aulast%3DLiscio%26aufirst%3DP.%26aulast%3DCarotti%26aufirst%3DA.%26aulast%3DAsciutti%26aufirst%3DS.%26aulast%3DSardella%26aufirst%3DR.%26aulast%3DMacchiarulo%26aufirst%3DA.%26aulast%3DCamaioni%26aufirst%3DE.%26atitle%3DTargeting%2520Wnt-driven%2520cancers%253A%2520Discovery%2520of%2520novel%2520tankyrase%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D142%26spage%3D506%26epage%3D522%26doi%3D10.1016%2Fj.ejmech.2017.09.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mizutani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yashiroda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muramatsu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chikada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsumura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirai, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukami, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seimiya, H.</span></span> <span> </span><span class="NLM_article-title">RK-287107, a potent and specific tankyrase inhibitor, blocks colorectal cancer cell growth in a preclinical model</span>. <i>Cancer Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">4003</span>– <span class="NLM_lpage">4014</span>, <span class="refDoi"> DOI: 10.1111/cas.13805</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.1111%2Fcas.13805" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=30238564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFKju7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2018&pages=4003-4014&author=A.+Mizutaniauthor=Y.+Yashirodaauthor=Y.+Muramatsuauthor=H.+Yoshidaauthor=T.+Chikadaauthor=T.+Tsumuraauthor=M.+Okueauthor=F.+Shiraiauthor=T.+Fukamiauthor=M.+Yoshidaauthor=H.+Seimiya&title=RK-287107%2C+a+potent+and+specific+tankyrase+inhibitor%2C+blocks+colorectal+cancer+cell+growth+in+a+preclinical+model&doi=10.1111%2Fcas.13805"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">RK-287107, a potent and specific tankyrase inhibitor, blocks colorectal cancer cell growth in a preclinical model</span></div><div class="casAuthors">Mizutani, Anna; Yashiroda, Yoko; Muramatsu, Yukiko; Yoshida, Haruka; Chikada, Tsubasa; Tsumura, Takeshi; Okue, Masayuki; Shirai, Fumiyuki; Fukami, Takehiro; Yoshida, Minoru; Seimiya, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4003-4014</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1349-7006</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Tankyrase poly(ADP-ribosyl)ates (PARylates) Axin, a neg. regulator of β-catenin.  This post-translational modification causes ubiquitin-dependent degrdn. of Axin, resulting in β-catenin accumulation.  Tankyrase inhibitors downregulate β-catenin and suppress the growth of APC-mutated colorectal cancer cells.  Herein, we report a novel tankyrase-specific inhibitor RK-287107, which inhibits tankyrase-1 and -2 four- and eight-fold more potently, resp., than G007-LK, a tankyrase inhibitor that has been previously reported as effective in mouse xenograft models.  RK-287107 causes Axin2 accumulation and downregulates β-catenin, T-cell factor/lymphoid enhancer factor reporter activity and the target gene expression in colorectal cancer cells harboring the shortly truncated APC mutations.  Consistently, RK-287107 inhibits the growth of APC-mutated (β-catenin-dependent) colorectal cancer COLO-320DM and SW403 cells but not the APC-wild (β-catenin-independent) colorectal cancer RKO cells.  I.p. or oral administration of RK-287107 suppresses COLO-320DM tumor growth in NOD-SCID mice.  Rates of tumor growth inhibition showed good correlation with the behavior of pharmacodynamic biomarkers, such as Axin2 accumulation and MYC downregulation.  These observations indicate that RK-287107 exerts a proof-of-concept antitumor effect, and thus may have potential for tankyrase-directed mol. cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7zgbenLgRqbVg90H21EOLACvtfcHk0lgIlRoEScPMyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFKju7zI&md5=4e7bae4fa3689bd43abe0ea399024686</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1111%2Fcas.13805&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcas.13805%26sid%3Dliteratum%253Aachs%26aulast%3DMizutani%26aufirst%3DA.%26aulast%3DYashiroda%26aufirst%3DY.%26aulast%3DMuramatsu%26aufirst%3DY.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DChikada%26aufirst%3DT.%26aulast%3DTsumura%26aufirst%3DT.%26aulast%3DOkue%26aufirst%3DM.%26aulast%3DShirai%26aufirst%3DF.%26aulast%3DFukami%26aufirst%3DT.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DSeimiya%26aufirst%3DH.%26atitle%3DRK-287107%252C%2520a%2520potent%2520and%2520specific%2520tankyrase%2520inhibitor%252C%2520blocks%2520colorectal%2520cancer%2520cell%2520growth%2520in%2520a%2520preclinical%2520model%26jtitle%3DCancer%2520Sci.%26date%3D2018%26volume%3D109%26spage%3D4003%26epage%3D4014%26doi%3D10.1111%2Fcas.13805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buchstaller, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anlauf, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorsch, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leuthner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musil, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radtki, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritzert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohdich, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esdar, C.</span></span> <span> </span><span class="NLM_article-title">Discovery and optimization of 2-arylquinazolin-4-ones into a potent and selective tankyrase inhibitor modulating Wnt pathway activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">7897</span>– <span class="NLM_lpage">7909</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00656</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00656" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFWms7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=7897-7909&author=H.+P.+Buchstallerauthor=U.+Anlaufauthor=D.+Dorschauthor=D.+Kuhnauthor=M.+Lehmannauthor=B.+Leuthnerauthor=D.+Musilauthor=D.+Radtkiauthor=C.+Ritzertauthor=F.+Rohdichauthor=R.+Schneiderauthor=C.+Esdar&title=Discovery+and+optimization+of+2-arylquinazolin-4-ones+into+a+potent+and+selective+tankyrase+inhibitor+modulating+Wnt+pathway+activity&doi=10.1021%2Facs.jmedchem.9b00656"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Optimization of 2-Arylquinazolin-4-ones into a Potent and Selective Tankyrase Inhibitor Modulating Wnt Pathway Activity</span></div><div class="casAuthors">Buchstaller, Hans-Peter; Anlauf, Uwe; Dorsch, Dieter; Kuhn, Daniel; Lehmann, Martin; Leuthner, Birgitta; Musil, Djordje; Radtki, Daniela; Ritzert, Claudio; Rohdich, Felix; Schneider, Richard; Esdar, Christina</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7897-7909</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tankyrases 1 and 2 (TNKS1/2) are promising pharmacol. targets which recently gained interest for anticancer therapy in Wnt pathway dependent tumors.  2-Aryl-quinazolinones were identified and optimized into potent tankyrase inhibitors through SAR exploration around the quinazolinone core and the 4'-position of the Ph residue.  These efforts were supported by anal. of TNKS X-ray and Watermap structures and resulted in compd. 5k(I), a potent, selective tankyrase inhibitor with favorable pharmacokinetic properties.  The X-ray structure of I in complex with TNKS1 was solved and confirmed the design hypothesis.  Modulation of Wnt pathway activity was demonstrated with this compd. in a colorectal xenograft model in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrl6p_xrETB-bVg90H21EOLACvtfcHk0lhyvTcSuyYKqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFWms7bI&md5=7fcc6c91c6e614482386af2094675837</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00656%26sid%3Dliteratum%253Aachs%26aulast%3DBuchstaller%26aufirst%3DH.%2BP.%26aulast%3DAnlauf%26aufirst%3DU.%26aulast%3DDorsch%26aufirst%3DD.%26aulast%3DKuhn%26aufirst%3DD.%26aulast%3DLehmann%26aufirst%3DM.%26aulast%3DLeuthner%26aufirst%3DB.%26aulast%3DMusil%26aufirst%3DD.%26aulast%3DRadtki%26aufirst%3DD.%26aulast%3DRitzert%26aufirst%3DC.%26aulast%3DRohdich%26aufirst%3DF.%26aulast%3DSchneider%26aufirst%3DR.%26aulast%3DEsdar%26aufirst%3DC.%26atitle%3DDiscovery%2520and%2520optimization%2520of%25202-arylquinazolin-4-ones%2520into%2520a%2520potent%2520and%2520selective%2520tankyrase%2520inhibitor%2520modulating%2520Wnt%2520pathway%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D7897%26epage%3D7909%26doi%3D10.1021%2Facs.jmedchem.9b00656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nathubhai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haikarainen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koivunen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murthy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koumanov, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lloyd, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holman, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pihlajaniemi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tosh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehtio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Threadgill, M. D.</span></span> <span> </span><span class="NLM_article-title">Highly potent and isoform selective dual site binding tankyrase/Wnt signaling inhibitors that increase cellular glucose uptake and have antiproliferative activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">814</span>– <span class="NLM_lpage">820</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01574</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01574" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFSgu77O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=814-820&author=A.+Nathubhaiauthor=T.+Haikarainenauthor=J.+Koivunenauthor=S.+Murthyauthor=F.+Koumanovauthor=M.+D.+Lloydauthor=G.+D.+Holmanauthor=T.+Pihlajaniemiauthor=D.+Toshauthor=L.+Lehtioauthor=M.+D.+Threadgill&title=Highly+potent+and+isoform+selective+dual+site+binding+tankyrase%2FWnt+signaling+inhibitors+that+increase+cellular+glucose+uptake+and+have+antiproliferative+activity&doi=10.1021%2Facs.jmedchem.6b01574"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Highly Potent and Isoform Selective Dual Site Binding Tankyrase/Wnt Signaling Inhibitors That Increase Cellular Glucose Uptake and Have Antiproliferative Activity</span></div><div class="casAuthors">Nathubhai, Amit; Haikarainen, Teemu; Koivunen, Jarkko; Murthy, Sudarshan; Koumanov, Francoise; Lloyd, Matthew D.; Holman, Geoffrey D.; Pihlajaniemi, Taina; Tosh, David; Lehtio, Lari; Threadgill, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">814-820</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Compds. 13 and 14 were evaluated against eleven PARP isoforms to reveal that both 13 and 14 were more potent and isoform-selective towards inhibiting tankyrases (TNKSs) than the "std." inhibitor 1 (XAV939)5, i.e. IC50 = 100 pM vs. TNKS2 and IC50 = 6.5 μM vs. PARP1 for 14.  In cellular assays, 13 and 14 inhibited Wnt-signaling, enhanced insulin-stimulated glucose uptake and inhibited the proliferation of DLD-1 colorectal adenocarcinoma cells to a greater extent than 1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeH2cfPlBFBLVg90H21EOLACvtfcHk0lhyvTcSuyYKqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFSgu77O&md5=2eb1a9ae15a5b9402b730e67f1ba3d79</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01574%26sid%3Dliteratum%253Aachs%26aulast%3DNathubhai%26aufirst%3DA.%26aulast%3DHaikarainen%26aufirst%3DT.%26aulast%3DKoivunen%26aufirst%3DJ.%26aulast%3DMurthy%26aufirst%3DS.%26aulast%3DKoumanov%26aufirst%3DF.%26aulast%3DLloyd%26aufirst%3DM.%2BD.%26aulast%3DHolman%26aufirst%3DG.%2BD.%26aulast%3DPihlajaniemi%26aufirst%3DT.%26aulast%3DTosh%26aufirst%3DD.%26aulast%3DLehtio%26aufirst%3DL.%26aulast%3DThreadgill%26aufirst%3DM.%2BD.%26atitle%3DHighly%2520potent%2520and%2520isoform%2520selective%2520dual%2520site%2520binding%2520tankyrase%252FWnt%2520signaling%2520inhibitors%2520that%2520increase%2520cellular%2520glucose%2520uptake%2520and%2520have%2520antiproliferative%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D814%26epage%3D820%26doi%3D10.1021%2Facs.jmedchem.6b01574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez-Vega, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mina, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armenia, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatila, W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luna, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimitriadoy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kantheti, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saghafinia, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakravarty, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daian, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foltz, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shmulevich, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heins, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochoa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kundra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kandoth, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bahceci, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dervishi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dogrusoz, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laird, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Way, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greene, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iavarone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bivona, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazar, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammer, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giordano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwong, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McArthur, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tward, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frederick, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCormick, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyerson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Allen, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherniack, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciriello, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sander, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, N.</span></span> <span> </span><span class="NLM_article-title">Oncogenic signaling pathways in the cancer genome atlas</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>173</i></span>,  <span class="NLM_fpage">321</span>– <span class="NLM_lpage">337</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2018.03.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.1016%2Fj.cell.2018.03.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=29625050" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC1cXntFahsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=2018&pages=321-337&author=F.+Sanchez-Vegaauthor=M.+Minaauthor=J.+Armeniaauthor=W.+K.+Chatilaauthor=A.+Lunaauthor=K.+C.+Laauthor=S.+Dimitriadoyauthor=D.+L.+Liuauthor=H.+S.+Kanthetiauthor=S.+Saghafiniaauthor=D.+Chakravartyauthor=F.+Daianauthor=Q.+Gaoauthor=M.+H.+Baileyauthor=W.+W.+Liangauthor=S.+M.+Foltzauthor=I.+Shmulevichauthor=L.+Dingauthor=Z.+Heinsauthor=A.+Ochoaauthor=B.+Grossauthor=J.+Gaoauthor=H.+Zhangauthor=R.+Kundraauthor=C.+Kandothauthor=I.+Bahceciauthor=L.+Dervishiauthor=U.+Dogrusozauthor=W.+Zhouauthor=H.+Shenauthor=P.+W.+Lairdauthor=G.+P.+Wayauthor=C.+S.+Greeneauthor=H.+Liangauthor=Y.+Xiaoauthor=C.+Wangauthor=A.+Iavaroneauthor=A.+H.+Bergerauthor=T.+G.+Bivonaauthor=A.+J.+Lazarauthor=G.+D.+Hammerauthor=T.+Giordanoauthor=L.+N.+Kwongauthor=G.+McArthurauthor=C.+Huangauthor=A.+D.+Twardauthor=M.+J.+Frederickauthor=F.+McCormickauthor=M.+Meyersonauthor=E.+M.+Van+Allenauthor=A.+D.+Cherniackauthor=G.+Cirielloauthor=C.+Sanderauthor=N.+Schultz&title=Oncogenic+signaling+pathways+in+the+cancer+genome+atlas&doi=10.1016%2Fj.cell.2018.03.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Oncogenic signaling pathways in the cancer genome atlas</span></div><div class="casAuthors">Sanchez-Vega, Francisco; Mina, Marco; Armenia, Joshua; Chatila, Walid K.; Luna, Augustin; La, Konnor C.; Dimitriadoy, Sofia; Liu, David L.; Kantheti, Havish S.; Saghafinia, Sadegh; Chakravarty, Debyani; Daian, Foysal; Gao, Qingsong; Bailey, Matthew H.; Liang, Wen-Wei; Foltz, Steven M.; Shmulevich, Ilya; Ding, Li; Heins, Zachary; Ochoa, Angelica; Gross, Benjamin; Gao, Jianjiong; Zhang, Hongxin; Kundra, Ritika; Kandoth, Cyriac; Bahceci, Istemi; Dervishi, Leonard; Dogrusoz, Ugur; Zhou, Wanding; Shen, Hui; Laird, Peter W.; Way, Gregory P.; Greene, Casey S.; Liang, Han; Xiao, Yonghong; Wang, Chen; Iavarone, Antonio; Berger, Alice H.; Bivona, Trever G.; Lazar, Alexander J.; Hammer, Gary D.; Giordano, Thomas; Kwong, Lawrence N.; McArthur, Grant; Huang, Chenfei; Tward, Aaron D.; Frederick, Mitchell J.; McCormick, Frank; Meyerson, Matthew; Van Allen, Eliezer M.; Cherniack, Andrew D.; Ciriello, Giovanni; Sander, Chris; Schultz, Nikolaus</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">173</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">321-337.e10</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Genetic alterations in signaling pathways that control cell-cycle progression, apoptosis, and cell growth are common hallmarks of cancer, but the extent, mechanisms, and co-occurrence of alterations in these pathways differ between individual tumors and tumor types.  Using mutations, copy-no. changes, mRNA expression, gene fusions and DNA methylation in 9125 tumors profiled by The Cancer Genome Atlas (TCGA), we analyzed the mechanisms and patterns of somatic alterations in ten canonical pathways: cell cycle, Hippo, Myc, Notch, Nrf2, PI-3-Kinase/Akt, RTK-RAS, TGFβ signaling, p53 and β-catenin/Wnt.  We charted the detailed landscape of pathway alterations in 33 cancer types, stratified into 64 subtypes, and identified patterns of co-occurrence and mutual exclusivity.  Eighty-nine percent of tumors had at least one driver alteration in these pathways, and 57% percent of tumors had at least one alteration potentially targetable by currently available drugs.  Thirty percent of tumors had multiple targetable alterations, indicating opportunities for combination therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqv_ggbxuypEbVg90H21EOLACvtfcHk0lhv_pY5KQ26lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXntFahsrs%253D&md5=3677d3a77b12767c828f48eb80d71141</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2018.03.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2018.03.035%26sid%3Dliteratum%253Aachs%26aulast%3DSanchez-Vega%26aufirst%3DF.%26aulast%3DMina%26aufirst%3DM.%26aulast%3DArmenia%26aufirst%3DJ.%26aulast%3DChatila%26aufirst%3DW.%2BK.%26aulast%3DLuna%26aufirst%3DA.%26aulast%3DLa%26aufirst%3DK.%2BC.%26aulast%3DDimitriadoy%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DD.%2BL.%26aulast%3DKantheti%26aufirst%3DH.%2BS.%26aulast%3DSaghafinia%26aufirst%3DS.%26aulast%3DChakravarty%26aufirst%3DD.%26aulast%3DDaian%26aufirst%3DF.%26aulast%3DGao%26aufirst%3DQ.%26aulast%3DBailey%26aufirst%3DM.%2BH.%26aulast%3DLiang%26aufirst%3DW.%2BW.%26aulast%3DFoltz%26aufirst%3DS.%2BM.%26aulast%3DShmulevich%26aufirst%3DI.%26aulast%3DDing%26aufirst%3DL.%26aulast%3DHeins%26aufirst%3DZ.%26aulast%3DOchoa%26aufirst%3DA.%26aulast%3DGross%26aufirst%3DB.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DKundra%26aufirst%3DR.%26aulast%3DKandoth%26aufirst%3DC.%26aulast%3DBahceci%26aufirst%3DI.%26aulast%3DDervishi%26aufirst%3DL.%26aulast%3DDogrusoz%26aufirst%3DU.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DShen%26aufirst%3DH.%26aulast%3DLaird%26aufirst%3DP.%2BW.%26aulast%3DWay%26aufirst%3DG.%2BP.%26aulast%3DGreene%26aufirst%3DC.%2BS.%26aulast%3DLiang%26aufirst%3DH.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DIavarone%26aufirst%3DA.%26aulast%3DBerger%26aufirst%3DA.%2BH.%26aulast%3DBivona%26aufirst%3DT.%2BG.%26aulast%3DLazar%26aufirst%3DA.%2BJ.%26aulast%3DHammer%26aufirst%3DG.%2BD.%26aulast%3DGiordano%26aufirst%3DT.%26aulast%3DKwong%26aufirst%3DL.%2BN.%26aulast%3DMcArthur%26aufirst%3DG.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DTward%26aufirst%3DA.%2BD.%26aulast%3DFrederick%26aufirst%3DM.%2BJ.%26aulast%3DMcCormick%26aufirst%3DF.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DVan%2BAllen%26aufirst%3DE.%2BM.%26aulast%3DCherniack%26aufirst%3DA.%2BD.%26aulast%3DCiriello%26aufirst%3DG.%26aulast%3DSander%26aufirst%3DC.%26aulast%3DSchultz%26aufirst%3DN.%26atitle%3DOncogenic%2520signaling%2520pathways%2520in%2520the%2520cancer%2520genome%2520atlas%26jtitle%3DCell%26date%3D2018%26volume%3D173%26spage%3D321%26epage%3D337%26doi%3D10.1016%2Fj.cell.2018.03.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nusse, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clevers, H.</span></span> <span> </span><span class="NLM_article-title">Wnt/beta-catenin signaling, disease, and emerging therapeutic modalities</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>169</i></span>,  <span class="NLM_fpage">985</span>– <span class="NLM_lpage">999</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2017.05.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.1016%2Fj.cell.2017.05.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=28575679" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpt1agsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2017&pages=985-999&author=R.+Nusseauthor=H.+Clevers&title=Wnt%2Fbeta-catenin+signaling%2C+disease%2C+and+emerging+therapeutic+modalities&doi=10.1016%2Fj.cell.2017.05.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Wnt/β-catenin signaling, disease, and emerging therapeutic modalities</span></div><div class="casAuthors">Nusse, Roel; Clevers, Hans</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">985-999</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The WNT signal transduction cascade is a main regulator of development throughout the animal kingdom.  Wnts are also key drivers of most types of tissue stem cells in adult mammals.  Unsurprisingly, mutated Wnt pathway components are causative to multiple growth-related pathologies and to cancer.  Here, we describe the core Wnt/β-catenin signaling pathway, how it controls stem cells, and contributes to disease.  Finally, we discuss strategies for Wnt-based therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnL11nCbSs8LVg90H21EOLACvtfcHk0lhv_pY5KQ26lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpt1agsro%253D&md5=869cc558296677481527ac138f68fbb0</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2017.05.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2017.05.016%26sid%3Dliteratum%253Aachs%26aulast%3DNusse%26aufirst%3DR.%26aulast%3DClevers%26aufirst%3DH.%26atitle%3DWnt%252Fbeta-catenin%2520signaling%252C%2520disease%252C%2520and%2520emerging%2520therapeutic%2520modalities%26jtitle%3DCell%26date%3D2017%26volume%3D169%26spage%3D985%26epage%3D999%26doi%3D10.1016%2Fj.cell.2017.05.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krishnamurthy, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurzrock, R.</span></span> <span> </span><span class="NLM_article-title">Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors</span>. <i>Cancer Treat. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">50</span>– <span class="NLM_lpage">60</span>, <span class="refDoi"> DOI: 10.1016/j.ctrv.2017.11.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.1016%2Fj.ctrv.2017.11.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=29169144" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvValtbnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2018&pages=50-60&author=N.+Krishnamurthyauthor=R.+Kurzrock&title=Targeting+the+Wnt%2Fbeta-catenin+pathway+in+cancer%3A+Update+on+effectors+and+inhibitors&doi=10.1016%2Fj.ctrv.2017.11.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors</span></div><div class="casAuthors">Krishnamurthy, Nithya; Kurzrock, Razelle</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Treatment Reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">50-60</span>CODEN:
                <span class="NLM_cas:coden">CTREDJ</span>;
        ISSN:<span class="NLM_cas:issn">0305-7372</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The Wnt/beta-catenin pathway is a family of proteins that is implicated in many vital cellular functions like stem cell regeneration and organogenesis.  Several intra-cellular signal transduction pathways are induced by Wnt, notably the Wnt/beta-catenin dependent pathway or canonical pathway and the non-canonical or beta-catenin-independent pathway, the latter includes the Wnt/Ca2+ and Planar Cell Polarity pathway (PCP).  Wnt activation occurs at the intestinal crypt floor, and is crit. to optimal maintenance of stem cells.  Colorectal cancers show evidence of Wnt signaling pathway activation and this is assocd. with loss of function of the tumor regulator APC.  Wnt activation has been obsd. in breast, lung, and hematopoietic malignancies and contributes to tumor recurrence.  The Wnt pathway cross talks with the Notch and Sonic Hedgehog pathways, which has implications for therapeutic interventions in cancers.  There are significant challenges in targeting the Wnt pathway, including finding agents that are efficacious without damaging the system of normal somatic stem cell function in cellular repair and tissue homeostasis.  Here, we comprehensively review the Wnt pathway and its interactions with the Notch and Sonic Hedgehog pathways.  We present the state of the field in effectors and inhibitors of Wnt signaling, including updates on clin. trials in various cancers with inhibitors of Wnt, Notch, and Sonic Hedgehog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqHbcA6nGH3rVg90H21EOLACvtfcHk0ljbSw3w343z4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvValtbnF&md5=1a46da27b4932cbd31695e004a48b3c2</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.ctrv.2017.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ctrv.2017.11.002%26sid%3Dliteratum%253Aachs%26aulast%3DKrishnamurthy%26aufirst%3DN.%26aulast%3DKurzrock%26aufirst%3DR.%26atitle%3DTargeting%2520the%2520Wnt%252Fbeta-catenin%2520pathway%2520in%2520cancer%253A%2520Update%2520on%2520effectors%2520and%2520inhibitors%26jtitle%3DCancer%2520Treat.%2520Rev.%26date%3D2018%26volume%3D62%26spage%3D50%26epage%3D60%26doi%3D10.1016%2Fj.ctrv.2017.11.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lau, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callow, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waaler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boggs, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blake, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnuson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sambrone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schutten, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Firestein, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machon, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korinek, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merchant, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polakis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holsworth, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauss, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, M.</span></span> <span> </span><span class="NLM_article-title">A Novel Tankyrase small-molecule inhibitor suppresses APC mutation-driven colorectal tumor growth</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">3132</span>– <span class="NLM_lpage">3144</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-12-4562</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.1158%2F0008-5472.CAN-12-4562" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=23539443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsFejsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=3132-3144&author=T.+Lauauthor=E.+Chanauthor=M.+Callowauthor=J.+Waalerauthor=J.+Boggsauthor=R.+A.+Blakeauthor=S.+Magnusonauthor=A.+Sambroneauthor=M.+Schuttenauthor=R.+Firesteinauthor=O.+Machonauthor=V.+Korinekauthor=E.+Chooauthor=D.+Diazauthor=M.+Merchantauthor=P.+Polakisauthor=D.+D.+Holsworthauthor=S.+Kraussauthor=M.+Costa&title=A+Novel+Tankyrase+small-molecule+inhibitor+suppresses+APC+mutation-driven+colorectal+tumor+growth&doi=10.1158%2F0008-5472.CAN-12-4562"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Tankyrase Small-Molecule Inhibitor Suppresses APC Mutation-Driven Colorectal Tumor Growth</span></div><div class="casAuthors">Lau, Ted; Chan, Emily; Callow, Marinella; Waaler, Jo; Boggs, Jason; Blake, Robert A.; Magnuson, Steven; Sambrone, Amy; Schutten, Melissa; Firestein, Ron; Machon, Ondrej; Korinek, Vladimir; Choo, Edna; Diaz, Dolores; Merchant, Mark; Polakis, Paul; Holsworth, Daniel D.; Krauss, Stefan; Costa, Mike</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3132-3144</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Most colorectal cancers (CRC) are initiated by mutations of APC, leading to increased β-catenin-mediated signaling.  However, continued requirement of Wnt/P-catenin signaling for tumor progression in the context of acquired KRAS and other mutations is less well-established.  To attenuate Wnt/β-catenin signaling in tumors, we have developed potent and specific small-mol. tankyrase inhibitors, G007-LK and G244-LM, that reduce Wnt./p-catenin signaling by preventing poly(ADP-ribosyl)ation-dependent AXIN degrdn., thereby promoting β-catenin destabilization.  We show that novel tankyrase inhibitors completely block ligand-driven Wnt/β-catenin signaling in cell culture and display approx. 50% inhibition of APC mutation-driven signaling in most CRC cell lines.  It was previously unknown whether the level of AXIN protein stabilization by tankyrase inhibition is sufficient to impact tumor growth in the absence of normal APC activity.  Compd. G007-LK displays favorable pharmacokinetic properties and inhibits in vivo tumor growth in a subset of APC-mutant CRC xenograft models.  In the xenograft model most sensitive to tankyrase inhibitor, COLO-320DM, G007-LK inhibits cell-cycle progression, reduces colony formation, and induces differentiation, suggesting that β-catenin-dependent maintenance of an undifferentiated state may be blocked by tankyrase inhibition.  The full potential of the antitumor activity of G007-LK may be limited by intestinal toxicity assocd. with inhibition of Wnt/β-catenin signaling and cell proliferation in intestinal crypts.  These results establish proof-of-concept antitumor efficacy for tankyrase inhibitors in APC-mutant CRC models and uncover potential diagnostic and safety concerns to be overcome as tankyrase inhibitors are advanced into the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbDZ01XGjOaLVg90H21EOLACvtfcHk0lgYapYhAU-NwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsFejsbo%253D&md5=9f1d7b05b92ba8df593ccca9e7ea2cdf</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-12-4562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-12-4562%26sid%3Dliteratum%253Aachs%26aulast%3DLau%26aufirst%3DT.%26aulast%3DChan%26aufirst%3DE.%26aulast%3DCallow%26aufirst%3DM.%26aulast%3DWaaler%26aufirst%3DJ.%26aulast%3DBoggs%26aufirst%3DJ.%26aulast%3DBlake%26aufirst%3DR.%2BA.%26aulast%3DMagnuson%26aufirst%3DS.%26aulast%3DSambrone%26aufirst%3DA.%26aulast%3DSchutten%26aufirst%3DM.%26aulast%3DFirestein%26aufirst%3DR.%26aulast%3DMachon%26aufirst%3DO.%26aulast%3DKorinek%26aufirst%3DV.%26aulast%3DChoo%26aufirst%3DE.%26aulast%3DDiaz%26aufirst%3DD.%26aulast%3DMerchant%26aufirst%3DM.%26aulast%3DPolakis%26aufirst%3DP.%26aulast%3DHolsworth%26aufirst%3DD.%2BD.%26aulast%3DKrauss%26aufirst%3DS.%26aulast%3DCosta%26aufirst%3DM.%26atitle%3DA%2520Novel%2520Tankyrase%2520small-molecule%2520inhibitor%2520suppresses%2520APC%2520mutation-driven%2520colorectal%2520tumor%2520growth%26jtitle%3DCancer%2520Res.%26date%3D2013%26volume%3D73%26spage%3D3132%26epage%3D3144%26doi%3D10.1158%2F0008-5472.CAN-12-4562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martins-Neves, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paiva-Oliveira, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fontes-Ribeiro, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bovee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cleton-Jansen, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomes, C. M. F.</span></span> <span> </span><span class="NLM_article-title">IWR-1, a tankyrase inhibitor, attenuates Wnt/beta-catenin signaling in cancer stem-like cells and inhibits in vivo the growth of a subcutaneous human osteosarcoma xenograft</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>414</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">15</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2017.11.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.1016%2Fj.canlet.2017.11.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=29126913" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVSiu7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=414&publication_year=2018&pages=1-15&author=S.+R.+Martins-Nevesauthor=D.+I.+Paiva-Oliveiraauthor=C.+Fontes-Ribeiroauthor=J.+Boveeauthor=A.+M.+Cleton-Jansenauthor=C.+M.+F.+Gomes&title=IWR-1%2C+a+tankyrase+inhibitor%2C+attenuates+Wnt%2Fbeta-catenin+signaling+in+cancer+stem-like+cells+and+inhibits+in+vivo+the+growth+of+a+subcutaneous+human+osteosarcoma+xenograft&doi=10.1016%2Fj.canlet.2017.11.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">IWR-1, a tankyrase inhibitor, attenuates Wnt/β-catenin signaling in cancer stem-like cells and inhibits in vivo the growth of a subcutaneous human osteosarcoma xenograft</span></div><div class="casAuthors">Martins-Neves, Sara R.; Paiva-Oliveira, Daniela I.; Fontes-Ribeiro, Carlos; Bovee, Judith V. M. G.; Cleton-Jansen, Anne-Marie; Gomes, Celia M. F.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">414</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-15</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Wnt/β-catenin or canonical Wnt signaling pathway regulates the self-renewal of cancer stem-like cells (CSCs) and is involved in tumor progression and chemotherapy resistance.  Previously, we reported that this pathway is activated in a subset of osteosarcoma CSCs and that doxorubicin induced stemness properties in differentiated cells through Wnt/β-catenin activation.  Here, we investigated whether pharmacol. Wnt/β-catenin inhibition, using a tankyrase inhibitor (IWR-1), might constitute a strategy to target CSCs and improve chemotherapy efficacy in osteosarcoma.  IWR-1 was specifically cytotoxic for osteosarcoma CSCs.  IWR-1 impaired spheres' self-renewal capacity by compromising landmark steps of the canonical Wnt signaling, namely translocation of β-catenin to the nucleus and subsequent TCF/LEF activation and expression of Wnt/β-catenin downstream targets.  IWR-1 also hampered the activity and expression of key stemness-related markers.  In vitro, IWR-1 induced apoptosis of osteosarcoma spheres and combined with doxorubicin elicited synergistic cytotoxicity, reversing spheres' resistance to this drug.  In vivo, IWR-1 co-administration with doxorubicin substantially decreased tumor progression, assocd. with specific down-regulation of TCF/LEF transcriptional activity, nuclear β-catenin and expression of the putative CSC marker Sox2.  We suggest that targeting the Wnt/β-catenin pathway can eliminate CSCs populations in osteosarcoma.  Combining conventional chemotherapy with Wnt/β-catenin inhibition may ameliorate therapeutic outcomes, by eradicating the aggressive osteosarcoma CSCs and reducing drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocG-gCNsSkwbVg90H21EOLACvtfcHk0lgYapYhAU-NwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVSiu7fK&md5=c3aa5ed1a5fa31daa1d180ed72394202</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2017.11.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2017.11.004%26sid%3Dliteratum%253Aachs%26aulast%3DMartins-Neves%26aufirst%3DS.%2BR.%26aulast%3DPaiva-Oliveira%26aufirst%3DD.%2BI.%26aulast%3DFontes-Ribeiro%26aufirst%3DC.%26aulast%3DBovee%26aufirst%3DJ.%26aulast%3DCleton-Jansen%26aufirst%3DA.%2BM.%26aulast%3DGomes%26aufirst%3DC.%2BM.%2BF.%26atitle%3DIWR-1%252C%2520a%2520tankyrase%2520inhibitor%252C%2520attenuates%2520Wnt%252Fbeta-catenin%2520signaling%2520in%2520cancer%2520stem-like%2520cells%2520and%2520inhibits%2520in%2520vivo%2520the%2520growth%2520of%2520a%2520subcutaneous%2520human%2520osteosarcoma%2520xenograft%26jtitle%3DCancer%2520Lett.%26date%3D2018%26volume%3D414%26spage%3D1%26epage%3D15%26doi%3D10.1016%2Fj.canlet.2017.11.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Solberg, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waaler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lund, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mygland, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauss, S.</span></span> <span> </span><span class="NLM_article-title">Tankyrase inhibition enhances the antiproliferative effect of PI3K and EGFR inhibition, mutually affecting beta-catenin and AKT signaling in colorectal cancer</span>. <i>Mol. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">543</span>– <span class="NLM_lpage">553</span>, <span class="refDoi"> DOI: 10.1158/1541-7786.MCR-17-0362</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.1158%2F1541-7786.MCR-17-0362" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=29222171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjslKrsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2018&pages=543-553&author=N.+T.+Solbergauthor=J.+Waalerauthor=K.+Lundauthor=L.+Myglandauthor=P.+A.+Olsenauthor=S.+Krauss&title=Tankyrase+inhibition+enhances+the+antiproliferative+effect+of+PI3K+and+EGFR+inhibition%2C+mutually+affecting+beta-catenin+and+AKT+signaling+in+colorectal+cancer&doi=10.1158%2F1541-7786.MCR-17-0362"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">TANKYRASE Inhibition Enhances the Antiproliferative Effect of PI3K and EGFR Inhibition, Mutually Affecting β-CATENIN and AKT Signaling in Colorectal Cancer</span></div><div class="casAuthors">Solberg, Nina T.; Waaler, Jo; Lund, Kaja; Mygland, Line; Olsen, Petter A.; Krauss, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">543-553</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Overactivation of the WNT/β-CATENIN signaling axis is a common denominator in colorectal cancer.  Currently, there is no available WNT inhibitor in clin. practice.  Although TANKYRASE (TNKS) inhibitors have been proposed as promising candidates, there are many colorectal cancer models that do not respond pos. to TNKS inhibition in vitro and in vivo.  Therefore, a combinatorial therapeutic approach combining a TNKS inhibitor (G007-LK) with PI3K (BKM120) and EGFR (erlotinib) inhibitors in colorectal cancer was investigated.  The data demonstrate that TNKS inhibition enhances the effect of PI3K and EGFR inhibition in the TNKS inhibitor-sensitive COLO320DM, and in the nonsensitive HCT-15 cell line.  In both cell lines, combined TNKS/PI3K/EGFR inhibition is more effective at reducing growth than a dual TNKS/MEK inhibition.  TNKS/PI3K/EGFR inhibition affected in a context-dependent manner components of the WNT/β-CATENIN, AKT/mTOR, EGFR, and RAS signaling pathways.  TNKS/PI3K/EGFR inhibition also efficiently reduced growth of both COLO320DM and HCT-15 tumor xenografts in vivo.  At the highest doses, tumor xenograft growth was halted without affecting the body wt. of the tested animals.  Implications: Combining TNKS inhibitors with PI3K and EGFR inhibition may expand the therapeutic arsenal against colorectal cancers.  Mol Cancer Res; 16(3); 543-53. ©2017 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7Sw_hfRxRmLVg90H21EOLACvtfcHk0lgq7dQjoVOj1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjslKrsLw%253D&md5=bef581a05e452a6ea13d79b66dc65470</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1158%2F1541-7786.MCR-17-0362&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1541-7786.MCR-17-0362%26sid%3Dliteratum%253Aachs%26aulast%3DSolberg%26aufirst%3DN.%2BT.%26aulast%3DWaaler%26aufirst%3DJ.%26aulast%3DLund%26aufirst%3DK.%26aulast%3DMygland%26aufirst%3DL.%26aulast%3DOlsen%26aufirst%3DP.%2BA.%26aulast%3DKrauss%26aufirst%3DS.%26atitle%3DTankyrase%2520inhibition%2520enhances%2520the%2520antiproliferative%2520effect%2520of%2520PI3K%2520and%2520EGFR%2520inhibition%252C%2520mutually%2520affecting%2520beta-catenin%2520and%2520AKT%2520signaling%2520in%2520colorectal%2520cancer%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2018%26volume%3D16%26spage%3D543%26epage%3D553%26doi%3D10.1158%2F1541-7786.MCR-17-0362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waaler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mygland, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tveita, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strand, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solberg, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aizenshtadt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fauskanger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lund, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brinch, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lycke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dybing, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nygaard, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boe, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heintz, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hovig, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammarstrom, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corthay, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauss, S.</span></span> <span> </span><span class="NLM_article-title">Tankyrase inhibition sensitizes melanoma to PD-1 immune checkpoint blockade in syngeneic mouse models</span>. <i>Commun. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">196</span>, <span class="refDoi"> DOI: 10.1038/s42003-020-0916-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.1038%2Fs42003-020-0916-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=32332858" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BB3cXotlaqsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2020&pages=196&author=J.+Waalerauthor=L.+Myglandauthor=A.+Tveitaauthor=M.+F.+Strandauthor=N.+T.+Solbergauthor=P.+A.+Olsenauthor=A.+Aizenshtadtauthor=M.+Fauskangerauthor=K.+Lundauthor=S.+A.+Brinchauthor=M.+Lyckeauthor=E.+Dybingauthor=V.+Nygaardauthor=S.+L.+Boeauthor=K.+M.+Heintzauthor=E.+Hovigauthor=C.+Hammarstromauthor=A.+Corthayauthor=S.+Krauss&title=Tankyrase+inhibition+sensitizes+melanoma+to+PD-1+immune+checkpoint+blockade+in+syngeneic+mouse+models&doi=10.1038%2Fs42003-020-0916-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Tankyrase inhibition sensitizes melanoma to PD-1 immune checkpoint blockade in syngeneic mouse models</span></div><div class="casAuthors">Waaler, Jo; Mygland, Line; Tveita, Anders; Strand, Martin Frank; Solberg, Nina Therese; Olsen, Petter Angell; Aizenshtadt, Aleksandra; Fauskanger, Marte; Lund, Kaja; Brinch, Shoshy Alam; Lycke, Max; Dybing, Elisabeth; Nygaard, Vegard; Boee, Sigurd Laeines; Heintz, Karen-Marie; Hovig, Eivind; Hammarstrom, Clara; Corthay, Alexandre; Krauss, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Communications Biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">196</span>CODEN:
                <span class="NLM_cas:coden">CBOIDQ</span>;
        ISSN:<span class="NLM_cas:issn">2399-3642</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Abstr.: The development of immune checkpoint inhibitors represents a major breakthrough in cancer therapy.  Nevertheless, a substantial no. of patients fail to respond to checkpoint pathway blockade.  Evidence for WNT/β-catenin signaling-mediated immune evasion is found in a subset of cancers including melanoma.  Currently, there are no therapeutic strategies available for targeting WNT/β-catenin signaling.  Here we show that a specific small-mol. tankyrase inhibitor, G007-LK, decreases WNT/β-catenin and YAP signaling in the syngeneic murine B16-F10 and Clone M-3 melanoma models and sensitizes the tumors to anti-PD-1 immune checkpoint therapy.  Mechanistically, we demonstrate that the synergistic effect of tankyrase and checkpoint inhibitor treatment is dependent on loss of β-catenin in the tumor cells, anti-PD-1-stimulated infiltration of T cells into the tumor and induction of an IFNγ- and CD8+ T cell-mediated anti-tumor immune response.  Our study uncovers a combinatorial therapeutical strategy using tankyrase inhibition to overcome β-catenin-mediated resistance to immune checkpoint blockade in melanoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodvTrOGe9EiLVg90H21EOLACvtfcHk0lgq7dQjoVOj1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXotlaqsL4%253D&md5=727d28f79bd8c9b5df056477837c3857</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fs42003-020-0916-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs42003-020-0916-2%26sid%3Dliteratum%253Aachs%26aulast%3DWaaler%26aufirst%3DJ.%26aulast%3DMygland%26aufirst%3DL.%26aulast%3DTveita%26aufirst%3DA.%26aulast%3DStrand%26aufirst%3DM.%2BF.%26aulast%3DSolberg%26aufirst%3DN.%2BT.%26aulast%3DOlsen%26aufirst%3DP.%2BA.%26aulast%3DAizenshtadt%26aufirst%3DA.%26aulast%3DFauskanger%26aufirst%3DM.%26aulast%3DLund%26aufirst%3DK.%26aulast%3DBrinch%26aufirst%3DS.%2BA.%26aulast%3DLycke%26aufirst%3DM.%26aulast%3DDybing%26aufirst%3DE.%26aulast%3DNygaard%26aufirst%3DV.%26aulast%3DBoe%26aufirst%3DS.%2BL.%26aulast%3DHeintz%26aufirst%3DK.%2BM.%26aulast%3DHovig%26aufirst%3DE.%26aulast%3DHammarstrom%26aufirst%3DC.%26aulast%3DCorthay%26aufirst%3DA.%26aulast%3DKrauss%26aufirst%3DS.%26atitle%3DTankyrase%2520inhibition%2520sensitizes%2520melanoma%2520to%2520PD-1%2520immune%2520checkpoint%2520blockade%2520in%2520syngeneic%2520mouse%2520models%26jtitle%3DCommun.%2520Biol.%26date%3D2020%26volume%3D3%26spage%3D196%26doi%3D10.1038%2Fs42003-020-0916-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mito, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagasu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kittaka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sone, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morita, Y.</span></span> <span> </span><span class="NLM_article-title">Pharmacological inhibition of tankyrase induces bone loss in mice by increasing osteoclastogenesis</span>. <i>Bone</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>106</i></span>,  <span class="NLM_fpage">156</span>– <span class="NLM_lpage">166</span>, <span class="refDoi"> DOI: 10.1016/j.bone.2017.10.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.1016%2Fj.bone.2017.10.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=29055830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslChs7nE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2018&pages=156-166&author=S.+Fujitaauthor=T.+Mukaiauthor=T.+Mitoauthor=S.+Kodamaauthor=A.+Nagasuauthor=M.+Kittakaauthor=T.+Soneauthor=Y.+Uekiauthor=Y.+Morita&title=Pharmacological+inhibition+of+tankyrase+induces+bone+loss+in+mice+by+increasing+osteoclastogenesis&doi=10.1016%2Fj.bone.2017.10.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological inhibition of tankyrase induces bone loss in mice by increasing osteoclastogenesis</span></div><div class="casAuthors">Fujita, Shunichi; Mukai, Tomoyuki; Mito, Takafumi; Kodama, Shoko; Nagasu, Akiko; Kittaka, Mizuho; Sone, Teruki; Ueki, Yasuyoshi; Morita, Yoshitaka</div><div class="citationInfo"><span class="NLM_cas:title">Bone (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">156-166</span>CODEN:
                <span class="NLM_cas:coden">BONEDL</span>;
        ISSN:<span class="NLM_cas:issn">1873-2763</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Tankyrase is a poly (ADP-ribose) polymerase that leads to ubiquitination and degrdn. of target proteins.  Since tankyrase inhibitors suppress the degrdn. of AXIN protein, a neg. regulator of the canonical Wnt pathway, they effectively act as Wnt inhibitors.  Small mol. tankyrase inhibitors are being investigated as drug candidates for cancer and fibrotic diseases, in which the Wnt pathways are aberrantly activated.  Tankyrase is also reported to degrade the adaptor protein SH3BP2 (SH3 domain-binding protein 2).  We have previously shown that SH3BP2 gain-of-function mutation enhances receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclastogenesis in murine bone marrow-derived macrophages (BMMs).  Although the interaction between tankyrase and SH3BP2 has been reported, it is not clear whether and how the inhibition of tankyrase affects bone cells and bone mass.  Here, we have demonstrated that tankyrase inhibitors (IWR-1, XAV939, and G007-LK) enhanced RANKL-induced osteoclast formation and function in murine BMMs and human peripheral blood mononuclear cells through the accumulation of SH3BP2, subsequent phosphorylation of SYK, and nuclear translocation of NFATc1.  Tankyrase inhibitors also enhanced osteoblast differentiation and maturation, represented by increased expression of osteoblast-assocd. genes accompanied by the accumulation of SH3BP2 protein and enhanced nuclear translocation of ABL, TAZ, and Runx2 in primary osteoblasts.  Most importantly, pharmacol. inhibition of tankyrase in mice significantly decreased tibia and lumbar vertebrae bone vols. in assocn. with increased nos. of osteoclasts.  Our findings uncover the role of tankyrase inhibition in bone cells and highlight the potential adverse effects of the inhibitor on bone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZ0uHmDycCArVg90H21EOLACvtfcHk0lgq7dQjoVOj1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslChs7nE&md5=158b18c4cc176ef826a8cf2ca2a32009</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bone.2017.10.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bone.2017.10.017%26sid%3Dliteratum%253Aachs%26aulast%3DFujita%26aufirst%3DS.%26aulast%3DMukai%26aufirst%3DT.%26aulast%3DMito%26aufirst%3DT.%26aulast%3DKodama%26aufirst%3DS.%26aulast%3DNagasu%26aufirst%3DA.%26aulast%3DKittaka%26aufirst%3DM.%26aulast%3DSone%26aufirst%3DT.%26aulast%3DUeki%26aufirst%3DY.%26aulast%3DMorita%26aufirst%3DY.%26atitle%3DPharmacological%2520inhibition%2520of%2520tankyrase%2520induces%2520bone%2520loss%2520in%2520mice%2520by%2520increasing%2520osteoclastogenesis%26jtitle%3DBone%26date%3D2018%26volume%3D106%26spage%3D156%26epage%3D166%26doi%3D10.1016%2Fj.bone.2017.10.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Norum, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skarpen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brech, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuiper, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waaler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauss, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorlie, T.</span></span> <span> </span><span class="NLM_article-title">The tankyrase inhibitor G007-LK inhibits small intestine LGR5(+) stem cell proliferation without altering tissue morphology</span>. <i>Biol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">3</span>, <span class="refDoi"> DOI: 10.1186/s40659-017-0151-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.1186%2Fs40659-017-0151-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=29316982" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmslOqtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2018&pages=3&author=J.+H.+Norumauthor=E.+Skarpenauthor=A.+Brechauthor=R.+Kuiperauthor=J.+Waalerauthor=S.+Kraussauthor=T.+Sorlie&title=The+tankyrase+inhibitor+G007-LK+inhibits+small+intestine+LGR5%28%2B%29+stem+cell+proliferation+without+altering+tissue+morphology&doi=10.1186%2Fs40659-017-0151-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">The tankyrase inhibitor G007-LK inhibits small intestine LGR5+ stem cell proliferation without altering tissue morphology</span></div><div class="casAuthors">Norum, Jens Henrik; Skarpen, Ellen; Brech, Andreas; Kuiper, Raoul; Waaler, Jo; Krauss, Stefan; Soerlie, Therese</div><div class="citationInfo"><span class="NLM_cas:title">Biological Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3/1-3/13</span>CODEN:
                <span class="NLM_cas:coden">BESEEB</span>;
        ISSN:<span class="NLM_cas:issn">0717-6287</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: The WNT pathway regulates intestinal stem cells and is frequently disrupted in intestinal adenomas.  The pathway contains several potential biotargets for interference, including the poly-ADP ribosyltransferase enzymes tankyrase1 and 2.  LGR5 is a known WNT pathway target gene and marker of intestinal stem cells.  The LGR5+ stem cells are located in the crypt base and capable of regenerating all intestinal epithelial cell lineages.  Results: We treated Lgr5-EGFP-Ires-CreERT2;R26R-Confetti mice with the tankyrase inhibitor G007-LK for up to 3 wk to assess the effect on duodenal stem cell homeostasis and on the integrity of intestinal epithelium.  At the administered doses, G007-LK treatment inhibited WNT signalling in LGR5+ stem cells and reduced the no. and distribution of cells traced from duodenal LGR5+ stem cells.  However, the gross morphol. of the duodenum remained unaltered and G007-LK-treated mice showed no signs of wt. loss or any other visible morphol. changes.  The inhibitory effect on LGR5+ stem cell proliferation was reversible.  Conclusion: We show that the tankyrase inhibitor G007-LK is well tolerated by the mice, although proliferation of the LGR5+ intestinal stem cells was inhibited.  Our observations suggest the presence of a tankyrase inhibitor-resistant cell population in the duodenum, able to rescue tissue integrity in the presence of G007-LK-mediated inhibition of the WNT signalling dependent LGR5+ intestinal epithelial stem cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw_ndzjfN9-rVg90H21EOLACvtfcHk0lhVJsmI5lGSGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmslOqtrw%253D&md5=e469fae6f5bfc912de008d41d403dbaa</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1186%2Fs40659-017-0151-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs40659-017-0151-6%26sid%3Dliteratum%253Aachs%26aulast%3DNorum%26aufirst%3DJ.%2BH.%26aulast%3DSkarpen%26aufirst%3DE.%26aulast%3DBrech%26aufirst%3DA.%26aulast%3DKuiper%26aufirst%3DR.%26aulast%3DWaaler%26aufirst%3DJ.%26aulast%3DKrauss%26aufirst%3DS.%26aulast%3DSorlie%26aufirst%3DT.%26atitle%3DThe%2520tankyrase%2520inhibitor%2520G007-LK%2520inhibits%2520small%2520intestine%2520LGR5%2528%252B%2529%2520stem%2520cell%2520proliferation%2520without%2520altering%2520tissue%2520morphology%26jtitle%3DBiol.%2520Res.%26date%3D2018%26volume%3D51%26spage%3D3%26doi%3D10.1186%2Fs40659-017-0151-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waaler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machon, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Kries, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundenes, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wedlich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gradl, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulsen, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machonova, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dembinski, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauss, S.</span></span> <span> </span><span class="NLM_article-title">Novel synthetic antagonists of canonical Wnt signaling inhibit colorectal cancer cell growth</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">197</span>– <span class="NLM_lpage">205</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-10-1282</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.1158%2F0008-5472.CAN-10-1282" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=21199802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovFOh" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2011&pages=197-205&author=J.+Waalerauthor=O.+Machonauthor=J.+P.+von+Kriesauthor=S.+R.+Wilsonauthor=E.+Lundenesauthor=D.+Wedlichauthor=D.+Gradlauthor=J.+E.+Paulsenauthor=O.+Machonovaauthor=J.+L.+Dembinskiauthor=H.+Dinhauthor=S.+Krauss&title=Novel+synthetic+antagonists+of+canonical+Wnt+signaling+inhibit+colorectal+cancer+cell+growth&doi=10.1158%2F0008-5472.CAN-10-1282"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Synthetic Antagonists of Canonical Wnt Signaling Inhibit Colorectal Cancer Cell Growth</span></div><div class="casAuthors">Waaler, Jo; Machon, Ondrej; von Kries, Jens Peter; Wilson, Steven Ray; Lundenes, Elsa; Wedlich, Doris; Gradl, Dietmar; Paulsen, Jan Erik; Machonova, Olga; Dembinski, Jennifer L.; Dinh, Huyen; Krauss, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">197-205</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Canonical Wnt signaling is deregulated in several types of human cancer where it plays a central role in tumor cell growth and progression.  Here we report the identification of 2 new small mols. that specifically inhibit canonical Wnt pathway at the level of the destruction complex.  Specificity was verified in various cellular reporter systems, a Xenopus double-axis formation assay and a gene expression profile anal.  In human colorectal cancer (CRC) cells, the new compds. JW67 and JW74 rapidly reduced active β-catenin with a subsequent downregulation of Wnt target genes, including AXIN2, SP5, and NKD1.  Notably, AXIN2 protein levels were strongly increased after compd. exposure.  Long-term treatment with JW74 inhibited the growth of tumor cells in both a mouse xenograft model of CRC and in ApcMin mice (multiple intestinal neoplasia, Min).  Our findings rationalize further preclin. and clin. evaluation of these new compds. as novel modalities for cancer treatment.  Cancer Res; 71(1); 197-205.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpW6zbK2VV5PbVg90H21EOLACvtfcHk0lhVJsmI5lGSGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovFOh&md5=e641536f7aea88b75d5cacc8b10458ab</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-10-1282&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-10-1282%26sid%3Dliteratum%253Aachs%26aulast%3DWaaler%26aufirst%3DJ.%26aulast%3DMachon%26aufirst%3DO.%26aulast%3Dvon%2BKries%26aufirst%3DJ.%2BP.%26aulast%3DWilson%26aufirst%3DS.%2BR.%26aulast%3DLundenes%26aufirst%3DE.%26aulast%3DWedlich%26aufirst%3DD.%26aulast%3DGradl%26aufirst%3DD.%26aulast%3DPaulsen%26aufirst%3DJ.%2BE.%26aulast%3DMachonova%26aufirst%3DO.%26aulast%3DDembinski%26aufirst%3DJ.%2BL.%26aulast%3DDinh%26aufirst%3DH.%26aulast%3DKrauss%26aufirst%3DS.%26atitle%3DNovel%2520synthetic%2520antagonists%2520of%2520canonical%2520Wnt%2520signaling%2520inhibit%2520colorectal%2520cancer%2520cell%2520growth%26jtitle%3DCancer%2520Res.%26date%3D2011%26volume%3D71%26spage%3D197%26epage%3D205%26doi%3D10.1158%2F0008-5472.CAN-10-1282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krauss, S.</span>; <span class="NLM_string-name">Nazare, M.</span>; <span class="NLM_string-name">Anumala, U.</span>; <span class="NLM_string-name">Lethio, L.</span>; <span class="NLM_string-name">Waaler, J.</span>; <span class="NLM_string-name">Holsworth, D.</span>; <span class="NLM_string-name">Wegert, A.</span>; <span class="NLM_string-name">Leenders, R.</span></span> <span> </span><span class="NLM_article-title">Triazole derivates as tankyrase inhibitors</span>. <span class="NLM_patent">WO/2018/118868</span>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=S.+Krauss&author=M.+Nazare&author=U.+Anumala&author=L.+Lethio&author=J.+Waaler&author=D.+Holsworth&author=A.+Wegert&author=R.+Leenders&title=Triazole+derivates+as+tankyrase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKrauss%26aufirst%3DS.%26atitle%3DTriazole%2520derivates%2520as%2520tankyrase%2520inhibitors%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sugane, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tobe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamaguchi, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimada, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeno, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyata, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimizuka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsukamoto, S.</span></span> <span> </span><span class="NLM_article-title">Atropisomeric 4-phenyl-4H-1,2,4-triazoles as selective glycine transporter 1 inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">5744</span>– <span class="NLM_lpage">5756</span>, <span class="refDoi"> DOI: 10.1021/jm400383w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400383w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVKqtLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5744-5756&author=T.+Suganeauthor=T.+Tobeauthor=W.+Hamaguchiauthor=I.+Shimadaauthor=K.+Maenoauthor=J.+Miyataauthor=T.+Suzukiauthor=T.+Kimizukaauthor=S.+Sakamotoauthor=S.+Tsukamoto&title=Atropisomeric+4-phenyl-4H-1%2C2%2C4-triazoles+as+selective+glycine+transporter+1+inhibitors&doi=10.1021%2Fjm400383w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Atropisomeric 4-Phenyl-4H-1,2,4-triazoles as Selective Glycine Transporter 1 Inhibitors</span></div><div class="casAuthors">Sugane, Takashi; Tobe, Takahiko; Hamaguchi, Wataru; Shimada, Itsuro; Maeno, Kyoichi; Miyata, Junji; Suzuki, Takeshi; Kimizuka, Tetsuya; Sakamoto, Shuichi; Tsukamoto, Shin-ichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5744-5756</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of trisubstituted 4H-1,2,4-triazoles was synthesized and evaluated aiming to increase their activity and selectivity as glycine transporter 1 (GlyT1) inhibitors.  Structure-activity relationship exploration resulted in the identification of 3-[3-ethyl-5-(6-phenylpyridin-3-yl)-4H-1,2,4-triazol-4-yl]-2-methylbenzonitrile (I) with markedly higher selectivity for GlyT1.  Physiochem. studies revealed that the compd. I exists as a stable pair of atropisomers under physiol. conditions.  These atropisomers were successfully sepd. to obtain active enantiomer (R)-I, which displayed favorable pharmacokinetic properties, as well as pos. results in the mice Y-maze test.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqM-2SGK3g_mrVg90H21EOLACvtfcHk0lhT3v58oPC1XA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVKqtLvN&md5=c3218bd9ccae1f172f6d995e089a1a74</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm400383w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400383w%26sid%3Dliteratum%253Aachs%26aulast%3DSugane%26aufirst%3DT.%26aulast%3DTobe%26aufirst%3DT.%26aulast%3DHamaguchi%26aufirst%3DW.%26aulast%3DShimada%26aufirst%3DI.%26aulast%3DMaeno%26aufirst%3DK.%26aulast%3DMiyata%26aufirst%3DJ.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DKimizuka%26aufirst%3DT.%26aulast%3DSakamoto%26aufirst%3DS.%26aulast%3DTsukamoto%26aufirst%3DS.%26atitle%3DAtropisomeric%25204-phenyl-4H-1%252C2%252C4-triazoles%2520as%2520selective%2520glycine%2520transporter%25201%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5744%26epage%3D5756%26doi%3D10.1021%2Fjm400383w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laplante, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fader, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fandrick, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fandrick, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hucke, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemper, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, P. J.</span></span> <span> </span><span class="NLM_article-title">Assessing atropisomer axial chirality in drug discovery and development</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">7005</span>– <span class="NLM_lpage">7022</span>, <span class="refDoi"> DOI: 10.1021/jm200584g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200584g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFygu7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7005-7022&author=S.+R.+Laplanteauthor=L.+D.+Faderauthor=K.+R.+Fandrickauthor=D.+R.+Fandrickauthor=O.+Huckeauthor=R.+Kemperauthor=S.+P.+Millerauthor=P.+J.+Edwards&title=Assessing+atropisomer+axial+chirality+in+drug+discovery+and+development&doi=10.1021%2Fjm200584g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Assessing Atropisomer Axial Chirality in Drug Discovery and Development</span></div><div class="casAuthors">LaPlante, Steven R.; Fader, Lee D.; Fandrick, Keith R.; Fandrick, Daniel R.; Hucke, Oliver; Kemper, Ray; Miller, Stephen P. F.; Edwards, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7005-7022</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQ8uS-SDx68bVg90H21EOLACvtfcHk0lhT3v58oPC1XA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFygu7zN&md5=6b44135b3871d2460fba4b3246b899e3</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm200584g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200584g%26sid%3Dliteratum%253Aachs%26aulast%3DLaplante%26aufirst%3DS.%2BR.%26aulast%3DFader%26aufirst%3DL.%2BD.%26aulast%3DFandrick%26aufirst%3DK.%2BR.%26aulast%3DFandrick%26aufirst%3DD.%2BR.%26aulast%3DHucke%26aufirst%3DO.%26aulast%3DKemper%26aufirst%3DR.%26aulast%3DMiller%26aufirst%3DS.%2BP.%26aulast%3DEdwards%26aufirst%3DP.%2BJ.%26atitle%3DAssessing%2520atropisomer%2520axial%2520chirality%2520in%2520drug%2520discovery%2520and%2520development%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7005%26epage%3D7022%26doi%3D10.1021%2Fjm200584g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Narwal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fallarero, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vuorela, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehtio, L.</span></span> <span> </span><span class="NLM_article-title">Homogeneous screening assay for human tankyrase</span>. <i>J. Biomol. Screening</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">593</span>– <span class="NLM_lpage">604</span>, <span class="refDoi"> DOI: 10.1177/1087057112436558</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.1177%2F1087057112436558" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=22357873" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC38XpvVShtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=593-604&author=M.+Narwalauthor=A.+Fallareroauthor=P.+Vuorelaauthor=L.+Lehtio&title=Homogeneous+screening+assay+for+human+tankyrase&doi=10.1177%2F1087057112436558"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Homogeneous screening assay for human tankyrase</span></div><div class="casAuthors">Narwal, Mohit; Fallarero, Adyary; Vuorela, Pia; Lehtio, Lari</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">593-604</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Tankyrase, a member of human PARP protein super-family, catalyzes a covalent post-translational modification of substrate proteins.  This modification, poly(ADP-ribos)ylation, leads to changes in protein interactions and modifies downstream signaling events.  Tankyrase 1 is a potential drug target due to its functions in telomere homeostasis and in Wnt signaling.  We describe here optimization and application of an activity-based homogenous assay for tankyrase inhibitors in a high-throughput screening format.  The method measures the consumption of substrate by the chem. conversion of the remaining NAD+ into a stable fluorescent condensation product.  Conditions were optimized to measure the enzymic auto-modification of a recombinant catalytic fragment of tankyrase 1.  The fluorescence assay is inexpensive, operationally easy and performs well according to the statistical anal. (Z'= 0.7).  A validatory screen with a natural product library confirmed suitability of the assay for finding new tankyrase inhibitors.  Flavone was the most potent (IC50=325 nM) hit from the natural compds.  A flavone deriv., apigenin, and iso-Pr gallate showed potency on the micromolar range, but displayed over 30-fold selectivity for tankyrase over the studied isoenzymes PARP1 and PARP2.  The assay is robust and will be useful for screening new tankyrase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdAQgc8t_53rVg90H21EOLACvtfcHk0lhZMEsmeLLo8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpvVShtLg%253D&md5=e5736a4723ceff0fe1fc072ab9bac977</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1177%2F1087057112436558&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057112436558%26sid%3Dliteratum%253Aachs%26aulast%3DNarwal%26aufirst%3DM.%26aulast%3DFallarero%26aufirst%3DA.%26aulast%3DVuorela%26aufirst%3DP.%26aulast%3DLehtio%26aufirst%3DL.%26atitle%3DHomogeneous%2520screening%2520assay%2520for%2520human%2520tankyrase%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2012%26volume%3D17%26spage%3D593%26epage%3D604%26doi%3D10.1177%2F1087057112436558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Venkannagari, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fallarero, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feijs, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luscher, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehtio, L.</span></span> <span> </span><span class="NLM_article-title">Activity-based assay for human mono-ADP-ribosyltransferases ARTD7/PARP15 and ARTD10/PARP10 aimed at screening and profiling inhibitors</span>. <i>Eur. J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">148</span>– <span class="NLM_lpage">156</span>, <span class="refDoi"> DOI: 10.1016/j.ejps.2013.02.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.1016%2Fj.ejps.2013.02.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=23485441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmvF2gtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2013&pages=148-156&author=H.+Venkannagariauthor=A.+Fallareroauthor=K.+L.+Feijsauthor=B.+Luscherauthor=L.+Lehtio&title=Activity-based+assay+for+human+mono-ADP-ribosyltransferases+ARTD7%2FPARP15+and+ARTD10%2FPARP10+aimed+at+screening+and+profiling+inhibitors&doi=10.1016%2Fj.ejps.2013.02.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Activity-based assay for human mono-ADP-ribosyltransferases ARTD7/PARP15 and ARTD10/PARP10 aimed at screening and profiling inhibitors</span></div><div class="casAuthors">Venkannagari, Harikanth; Fallarero, Adyary; Feijs, Karla L. H.; Luscher, Bernhard; Lehtio, Lari</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">148-156</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Poly(ADP-ribose) polymerases (PARPs) or diphtheria toxin like ADP-ribosyl transferases (ARTDs) are enzymes that catalyze the covalent modification of proteins by attachment of ADP-ribose units to the target amino acid residues or to the growing chain of ADP-ribose.  A subclass of the ARTD superfamily consists of mono-ADP-ribosyl transferases that are thought to modify themselves and other substrate proteins by covalently adding only a single ADP-ribose moiety to the target.  Many of the ARTD enzymes are either established or potential drug targets and a functional activity assay for them will be a valuable tool to identify selective inhibitors for each enzyme.  Existing assays are not directly applicable for screening of inhibitors due to the different nature of the reaction and different target mols.  We modified and applied a fluorescence-based assay previously described for PARP1/ARTD1 and tankyrase/ARTD5 for screening of PARP10/ARTD10 and PARP15/ARTD7 inhibitors.  The assay measures the amt. of NAD+ present after chem. converting it to a fluorescent analog.  We demonstrate that by using an excess of a recombinant acceptor protein the performance of the activity-based assay is excellent for screening of compd. libraries.  The assay is homogenous and cost effective, making it possible to test relatively large compd. libraries.  This method can be used to screen inhibitors of mono-ARTDs and profile inhibitors of the enzyme class.  The assay was optimized for ARTD10 and ARTD7, but it can be directly applied to other mono-ARTDs of the ARTD superfamily.  Profiling of known ARTD inhibitors against ARTD10 and ARTD7 in a validatory screening identified the best inhibitors with submicromolar potencies.  Only few of the tested ARTD inhibitors were potent, implicating that there is a need to screen new compd. scaffolds.  This is needed to create small mols. that could serve as biol. probes and potential starting points for drug discovery projects against mono-ARTDs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDu0JDVu3v47Vg90H21EOLACvtfcHk0lhZMEsmeLLo8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmvF2gtbo%253D&md5=f5c61569372452cabeb8b3c5100de258</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2013.02.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2013.02.012%26sid%3Dliteratum%253Aachs%26aulast%3DVenkannagari%26aufirst%3DH.%26aulast%3DFallarero%26aufirst%3DA.%26aulast%3DFeijs%26aufirst%3DK.%2BL.%26aulast%3DLuscher%26aufirst%3DB.%26aulast%3DLehtio%26aufirst%3DL.%26atitle%3DActivity-based%2520assay%2520for%2520human%2520mono-ADP-ribosyltransferases%2520ARTD7%252FPARP15%2520and%2520ARTD10%252FPARP10%2520aimed%2520at%2520screening%2520and%2520profiling%2520inhibitors%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2013%26volume%3D49%26spage%3D148%26epage%3D156%26doi%3D10.1016%2Fj.ejps.2013.02.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Venkannagari, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verheugd, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koivunen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haikarainen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obaji, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashok, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narwal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pihlajaniemi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luscher, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehtio, L.</span></span> <span> </span><span class="NLM_article-title">Small-molecule chemical probe rescues cells from mono-ADP-Ribosyltransferase ARTD10/PARP10-induced apoptosis and sensitizes cancer cells to DNA damage</span>. <i>Cell Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1251</span>– <span class="NLM_lpage">1260</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2016.08.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.1016%2Fj.chembiol.2016.08.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=27667561" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFGru73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2016&pages=1251-1260&author=H.+Venkannagariauthor=P.+Verheugdauthor=J.+Koivunenauthor=T.+Haikarainenauthor=E.+Obajiauthor=Y.+Ashokauthor=M.+Narwalauthor=T.+Pihlajaniemiauthor=B.+Luscherauthor=L.+Lehtio&title=Small-molecule+chemical+probe+rescues+cells+from+mono-ADP-Ribosyltransferase+ARTD10%2FPARP10-induced+apoptosis+and+sensitizes+cancer+cells+to+DNA+damage&doi=10.1016%2Fj.chembiol.2016.08.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Small-Molecule Chemical Probe Rescues Cells from Mono-ADP-Ribosyltransferase ARTD10/PARP10-Induced Apoptosis and Sensitizes Cancer Cells to DNA Damage</span></div><div class="casAuthors">Venkannagari, Harikanth; Verheugd, Patricia; Koivunen, Jarkko; Haikarainen, Teemu; Obaji, Ezeogo; Ashok, Yashwanth; Narwal, Mohit; Pihlajaniemi, Taina; Luscher, Bernhard; Lehtio, Lari</div><div class="citationInfo"><span class="NLM_cas:title">Cell Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1251-1260</span>CODEN:
                <span class="NLM_cas:coden">CCBEBM</span>;
        ISSN:<span class="NLM_cas:issn">2451-9448</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Members of the human diphtheria toxin-like ADP-ribosyltransferase (ARTD or PARP) family play important roles in regulating biol. activities by mediating either a mono-ADP-ribosylation (MARylation) of a substrate or a poly-ADP-ribosylation (PARylation).  ARTD10/PARP10 belongs to the MARylating ARTDs (mARTDs) subfamily, and plays important roles in biol. processes that range from cellular signaling, DNA repair, and cell proliferation to immune response.  Despite their biol. and disease relevance, no selective inhibitors for mARTDs are available.  Here we describe a small-mol. ARTD10 inhibitor, OUL35, a selective and potent inhibitor for this enzyme.  We characterize its selectivity profile, model its binding, and demonstrate activity in HeLa cells where OUL35 rescued cells from ARTD10 induced cell death.  Using OUL35 as a cell biol. tool we show that ARTD10 inhibition sensitizes the cells to the hydroxyurea-induced genotoxic stress.  Our study supports the proposed role of ARTD10 in DNA-damage repair and provides a tool compd. for selective inhibition of ARTD10-mediated MARylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJe0TpYzqU7rVg90H21EOLACvtfcHk0licthiq4DT0zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFGru73O&md5=101c3a4cde945ed863fa5df6a1efc84e</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2016.08.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2016.08.012%26sid%3Dliteratum%253Aachs%26aulast%3DVenkannagari%26aufirst%3DH.%26aulast%3DVerheugd%26aufirst%3DP.%26aulast%3DKoivunen%26aufirst%3DJ.%26aulast%3DHaikarainen%26aufirst%3DT.%26aulast%3DObaji%26aufirst%3DE.%26aulast%3DAshok%26aufirst%3DY.%26aulast%3DNarwal%26aufirst%3DM.%26aulast%3DPihlajaniemi%26aufirst%3DT.%26aulast%3DLuscher%26aufirst%3DB.%26aulast%3DLehtio%26aufirst%3DL.%26atitle%3DSmall-molecule%2520chemical%2520probe%2520rescues%2520cells%2520from%2520mono-ADP-Ribosyltransferase%2520ARTD10%252FPARP10-induced%2520apoptosis%2520and%2520sensitizes%2520cancer%2520cells%2520to%2520DNA%2520damage%26jtitle%3DCell%2520Chem.%2520Biol.%26date%3D2016%26volume%3D23%26spage%3D1251%26epage%3D1260%26doi%3D10.1016%2Fj.chembiol.2016.08.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murthy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desantis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verheugd, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maksimainen, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkannagari, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massari, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashok, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obaji, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nkizinkinko, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luscher, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabarrini, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehtio, L.</span></span> <span> </span><span class="NLM_article-title">4-(Phenoxy) and 4-(benzyloxy)benzamides as potent and selective inhibitors of mono-ADP-ribosyltransferase PARP10/ARTD10</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>156</i></span>,  <span class="NLM_fpage">93</span>– <span class="NLM_lpage">102</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.06.047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.1016%2Fj.ejmech.2018.06.047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=30006177" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1yju7%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=2018&pages=93-102&author=S.+Murthyauthor=J.+Desantisauthor=P.+Verheugdauthor=M.+M.+Maksimainenauthor=H.+Venkannagariauthor=S.+Massariauthor=Y.+Ashokauthor=E.+Obajiauthor=Y.+Nkizinkinkoauthor=B.+Luscherauthor=O.+Tabarriniauthor=L.+Lehtio&title=4-%28Phenoxy%29+and+4-%28benzyloxy%29benzamides+as+potent+and+selective+inhibitors+of+mono-ADP-ribosyltransferase+PARP10%2FARTD10&doi=10.1016%2Fj.ejmech.2018.06.047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">4-(Phenoxy) and 4-(benzyloxy)benzamides as potent and selective inhibitors of mono-ADP-ribosyltransferase PARP10/ARTD10</span></div><div class="casAuthors">Murthy, Sudarshan; Desantis, Jenny; Verheugd, Patricia; Maksimainen, Mirko M.; Venkannagari, Harikanth; Massari, Serena; Ashok, Yashwanth; Obaji, Ezeogo; Nkizinkinko, Yves; Luscher, Bernhard; Tabarrini, Oriana; Lehtio, Lari</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">93-102</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Human Diphtheria toxin-like ADP-ribosyltranferases (ARTD) 10 is an enzyme carrying out mono-ADP-ribosylation of a range of cellular proteins and affecting their activities.  It shuttles between cytoplasm and nucleus and influences signaling events in both compartments, such as nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) signaling and S phase DNA repair.  Furthermore, overexpression of ARTD10 induces cell death.  We recently reported on the discovery of a hit compd., OUL35 (compd. 1), with 330nM potency and remarkable selectivity towards ARTD10 over other enzymes in the human protein family.  Here we aimed at establishing a structure-activity relationship of the OUL35 scaffold, by evaluating an array of 4-phenoxybenzamide derivs.  By exploring modifications on the linker between the arom. rings, we identified also a 4-(benzyloxy)benzamide deriv., compd. 32, which is potent (IC50=230nM) and selective, and like OUL35 was able to rescue HeLa cells from ARTD10-induced cell death.  Evaluation of an enlarged series of derivs. produced detailed knowledge on the structural requirements for ARTD10 inhibition and allowed the discovery of further tool compds. with submicromolar cellular potency that will help in understanding the roles of ARTD10 in biol. systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrDFZOg0euI7Vg90H21EOLACvtfcHk0licthiq4DT0zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1yju7%252FM&md5=79a23a4fa33acfdcf2f1db44f98b218b</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.06.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.06.047%26sid%3Dliteratum%253Aachs%26aulast%3DMurthy%26aufirst%3DS.%26aulast%3DDesantis%26aufirst%3DJ.%26aulast%3DVerheugd%26aufirst%3DP.%26aulast%3DMaksimainen%26aufirst%3DM.%2BM.%26aulast%3DVenkannagari%26aufirst%3DH.%26aulast%3DMassari%26aufirst%3DS.%26aulast%3DAshok%26aufirst%3DY.%26aulast%3DObaji%26aufirst%3DE.%26aulast%3DNkizinkinko%26aufirst%3DY.%26aulast%3DLuscher%26aufirst%3DB.%26aulast%3DTabarrini%26aufirst%3DO.%26aulast%3DLehtio%26aufirst%3DL.%26atitle%3D4-%2528Phenoxy%2529%2520and%25204-%2528benzyloxy%2529benzamides%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520mono-ADP-ribosyltransferase%2520PARP10%252FARTD10%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D156%26spage%3D93%26epage%3D102%26doi%3D10.1016%2Fj.ejmech.2018.06.047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kabsch, W.</span></span> <span> </span><span class="NLM_article-title">Xds</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1107/S0907444909047337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.1107%2FS0907444909047337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=20124692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=125-132&author=W.+Kabsch&title=Xds&doi=10.1107%2FS0907444909047337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Software XDS for image rotation, recognition and crystal symmetry assignment</span></div><div class="casAuthors">Kabsch, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The usage and control of recent modifications of the program package XDS for the processing of rotation images are described in the context of previous versions.  New features include automatic detn. of spot size and reflecting range and recognition and assignment of crystal symmetry.  Moreover, the limitations of earlier package versions on the no. of correction/scaling factors and the representation of pixel contents have been removed.  Large program parts have been restructured for parallel processing so that the quality and completeness of collected data can be assessed soon after measurement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv5AyUw00DYbVg90H21EOLACvtfcHk0li-sveju-DZwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D&md5=1aa9a38aeb3ce95af4ffb7d8b8a142bd</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1107%2FS0907444909047337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909047337%26sid%3Dliteratum%253Aachs%26aulast%3DKabsch%26aufirst%3DW.%26atitle%3DXds%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D125%26epage%3D132%26doi%3D10.1107%2FS0907444909047337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storoni, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span> <span> </span><span class="NLM_article-title">Phaser crystallographic software</span>. <i>J. Appl. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">658</span>– <span class="NLM_lpage">674</span>, <span class="refDoi"> DOI: 10.1107/S0021889807021206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.1107%2FS0021889807021206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=19461840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2007&pages=658-674&author=A.+J.+McCoyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adamsauthor=M.+D.+Winnauthor=L.+C.+Storoniauthor=R.+J.+Read&title=Phaser+crystallographic+software&doi=10.1107%2FS0021889807021206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Phaser crystallographic software</span></div><div class="casAuthors">McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.; Winn, Martyn D.; Storoni, Laurent C.; Read, Randy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">658-674</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phaser is a program for phasing macromol. crystal structures by both mol. replacement and exptl. phasing methods.  The novel phasing algorithms implemented in Phaser have been developed using max. likelihood and multivariate statistics.  For mol. replacement, the new algorithms have proved to be significantly better than traditional methods in discriminating correct solns. from noise, and for single-wavelength anomalous dispersion exptl. phasing, the new algorithms, which account for correlations between F+ and F-, give better phases (lower mean phase error with respect to the phases given by the refined structure) than those that use mean F and anomalous differences ΔF.  One of the design concepts of Phaser was that it be capable of a high degree of automation.  To this end, Phaser (written in C++) can be called directly from Python, although it can also be called using traditional CCP4 keyword-style input.  Phaser is a platform for future development of improved phasing methods and their release, including source code, to the crystallog. community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPeVyjN_FMGbVg90H21EOLACvtfcHk0li-sveju-DZwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D&md5=c63b722ae97e0a74e6a5a079d388f09f</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1107%2FS0021889807021206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889807021206%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DStoroni%26aufirst%3DL.%2BC.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26atitle%3DPhaser%2520crystallographic%2520software%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2007%26volume%3D40%26spage%3D658%26epage%3D674%26doi%3D10.1107%2FS0021889807021206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K.</span></span> <span> </span><span class="NLM_article-title">Coot: model-building tools for molecular graphics</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2126</span>– <span class="NLM_lpage">2132</span>, <span class="refDoi"> DOI: 10.1107/S0907444904019158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.1107%2FS0907444904019158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=15572765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=2126-2132&author=P.+Emsleyauthor=K.+Cowtan&title=Coot%3A+model-building+tools+for+molecular+graphics&doi=10.1107%2FS0907444904019158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Coot: model-building tools for molecular graphics</span></div><div class="casAuthors">Emsley, Paul; Cowtan, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">2126-2132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">CCP4mg is a project that aims to provide a general-purpose tool for structural biologists, providing tools for x-ray structure soln., structure comparison and anal., and publication-quality graphics.  The map-fitting tools are available as a stand-alone package, distributed as 'Coot'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMisM42468k7Vg90H21EOLACvtfcHk0ljbrZI_bwE0cQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P&md5=1be390f3bb6fd584468499ad0921161e</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1107%2FS0907444904019158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904019158%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DCoot%253A%2520model-building%2520tools%2520for%2520molecular%2520graphics%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D2126%26epage%3D2132%26doi%3D10.1107%2FS0907444904019158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murshudov, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skubak, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lebedev, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pannu, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steiner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholls, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vagin, A. A.</span></span> <span> </span><span class="NLM_article-title">REFMAC5 for the refinement of macromolecular crystal structures</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">355</span>– <span class="NLM_lpage">367</span>, <span class="refDoi"> DOI: 10.1107/S0907444911001314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.1107%2FS0907444911001314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=21460454" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=355-367&author=G.+N.+Murshudovauthor=P.+Skubakauthor=A.+A.+Lebedevauthor=N.+S.+Pannuauthor=R.+A.+Steinerauthor=R.+A.+Nichollsauthor=M.+D.+Winnauthor=F.+Longauthor=A.+A.+Vagin&title=REFMAC5+for+the+refinement+of+macromolecular+crystal+structures&doi=10.1107%2FS0907444911001314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">REFMAC5 for the refinement of macromolecular crystal structures</span></div><div class="casAuthors">Murshudov, Garib N.; Skubak, Pavol; Lebedev, Andrey A.; Pannu, Navraj S.; Steiner, Roberto A.; Nicholls, Robert A.; Winn, Martyn D.; Long, Fei; Vagin, Alexei A.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">355-367</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">This paper describes various components of the macromol. crystallog. refinement program REFMAC5, which is distributed as part of the CCP4 suite.  REFMAC5 utilizes different likelihood functions depending on the diffraction data employed (amplitudes or intensities), the presence of twinning and the availability of SAD/SIRAS exptl. diffraction data.  To ensure chem. and structural integrity of the refined model, REFMAC5 offers several classes of restraints and choices of model parameterization.  Reliable models at resolns. at least as low as 4 Å can be achieved thanks to low-resoln. refinement tools such as secondary-structure restraints, restraints to known homologous structures, automatic global and local NCS restraints, 'jelly-body' restraints and the use of novel long-range restraints on at. displacement parameters (ADPs) based on the Kullback-Leibler divergence.  REFMAC5 addnl. offers TLS parameterization and, when high-resoln. data are available, fast refinement of anisotropic ADPs.  Refinement in the presence of twinning is performed in a fully automated fashion.  REFMAC5 is a flexible and highly optimized refinement package that is ideally suited for refinement across the entire resoln. spectrum encountered in macromol. crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5Jq-i2qIq5rVg90H21EOLACvtfcHk0ljbrZI_bwE0cQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqtbk%253D&md5=f8f3202d246908500057ad7c71015b7b</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1107%2FS0907444911001314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444911001314%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DSkubak%26aufirst%3DP.%26aulast%3DLebedev%26aufirst%3DA.%2BA.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DSteiner%26aufirst%3DR.%2BA.%26aulast%3DNicholls%26aufirst%3DR.%2BA.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DLong%26aufirst%3DF.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26atitle%3DREFMAC5%2520for%2520the%2520refinement%2520of%2520macromolecular%2520crystal%2520structures%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D355%26epage%3D367%26doi%3D10.1107%2FS0907444911001314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 5 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Thi Phuong Le, Igor Rončević, Martin Dračínský, Ivana Císařová, Veronika Šolínová, Václav Kašička, <span class="NLM_string-name hlFld-ContribAuthor">Jiří Kaleta</span>. </span><span class="cited-content_cbyCitation_article-title">Polyhalogenated Bicyclo[1.1.1]pentane-1,3-dicarboxylic Acids. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2021</strong>, Article ASAP.</span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.1c01020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.1c01020%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DPolyhalogenated%252BBicyclo%25255B1.1.1%25255Dpentane-1%25252C3-dicarboxylic%252BAcids%26aulast%3DLe%26aufirst%3DThi%2BPhuong%26date%3D2021%26date%3D2021%26date%3D30042021%26volume%3D0%26issue%3D0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Esteban  Zamudio-Martinez</span>, <span class="hlFld-ContribAuthor ">Ana Belén  Herrera-Campos</span>, <span class="hlFld-ContribAuthor ">Alberto  Muñoz</span>, <span class="hlFld-ContribAuthor ">José Manuel  Rodríguez-Vargas</span>, <span class="hlFld-ContribAuthor ">F. Javier  Oliver</span>. </span><span class="cited-content_cbyCitation_article-title">Tankyrases as modulators of pro-tumoral functions: molecular insights and therapeutic opportunities. </span><span class="cited-content_cbyCitation_journal-name">Journal of Experimental & Clinical Cancer Research</span><span> <strong>2021,</strong> <em>40 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13046-021-01950-6" title="DOI URL">https://doi.org/10.1186/s13046-021-01950-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13046-021-01950-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13046-021-01950-6%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Experimental%2520%2526%2520Clinical%2520Cancer%2520Research%26atitle%3DTankyrases%252Bas%252Bmodulators%252Bof%252Bpro-tumoral%252Bfunctions%25253A%252Bmolecular%252Binsights%252Band%252Btherapeutic%252Bopportunities%26aulast%3DZamudio-Martinez%26aufirst%3DEsteban%26date%3D2021%26date%3D2021%26volume%3D40%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Line  Mygland</span>, <span class="hlFld-ContribAuthor ">Shoshy Alam  Brinch</span>, <span class="hlFld-ContribAuthor ">Martin Frank  Strand</span>, <span class="hlFld-ContribAuthor ">Petter Angell  Olsen</span>, <span class="hlFld-ContribAuthor ">Aleksandra  Aizenshtadt</span>, <span class="hlFld-ContribAuthor ">Kaja  Lund</span>, <span class="hlFld-ContribAuthor ">Nina Therese  Solberg</span>, <span class="hlFld-ContribAuthor ">Max  Lycke</span>, <span class="hlFld-ContribAuthor ">Tor Espen  Thorvaldsen</span>, <span class="hlFld-ContribAuthor ">Sandra  Espada</span>, <span class="hlFld-ContribAuthor ">Dorna  Misaghian</span>, <span class="hlFld-ContribAuthor ">Christian M.  Page</span>, <span class="hlFld-ContribAuthor ">Oleg  Agafonov</span>, <span class="hlFld-ContribAuthor ">Ståle  Nygård</span>, <span class="hlFld-ContribAuthor ">Nai-Wen  Chi</span>, <span class="hlFld-ContribAuthor ">Eva  Lin</span>, <span class="hlFld-ContribAuthor ">Jenille  Tan</span>, <span class="hlFld-ContribAuthor ">Yihong  Yu</span>, <span class="hlFld-ContribAuthor ">Mike  Costa</span>, <span class="hlFld-ContribAuthor ">Stefan  Krauss</span>, <span class="hlFld-ContribAuthor ">Jo  Waaler</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of response signatures for tankyrase inhibitor treatment in tumor cell lines. </span><span class="cited-content_cbyCitation_journal-name">iScience</span><span> <strong>2021,</strong> <em>24 </em>
                                    (7)
                                     , 102807. <a href="https://doi.org/10.1016/j.isci.2021.102807" title="DOI URL">https://doi.org/10.1016/j.isci.2021.102807</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.isci.2021.102807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.isci.2021.102807%26sid%3Dliteratum%253Aachs%26jtitle%3DiScience%26atitle%3DIdentification%252Bof%252Bresponse%252Bsignatures%252Bfor%252Btankyrase%252Binhibitor%252Btreatment%252Bin%252Btumor%252Bcell%252Blines%26aulast%3DMygland%26aufirst%3DLine%26date%3D2021%26volume%3D24%26issue%3D7%26spage%3D102807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Garri  Manasaryan</span>, <span class="hlFld-ContribAuthor ">Dmitry  Suplatov</span>, <span class="hlFld-ContribAuthor ">Sergey  Pushkarev</span>, <span class="hlFld-ContribAuthor ">Viktor  Drobot</span>, <span class="hlFld-ContribAuthor ">Alexander  Kuimov</span>, <span class="hlFld-ContribAuthor ">Vytas  Švedas</span>, <span class="hlFld-ContribAuthor ">Dmitry  Nilov</span>. </span><span class="cited-content_cbyCitation_article-title">Bioinformatic Analysis of the Nicotinamide Binding Site in Poly(ADP-Ribose) Polymerase Family Proteins. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2021,</strong> <em>13 </em>
                                    (6)
                                     , 1201. <a href="https://doi.org/10.3390/cancers13061201" title="DOI URL">https://doi.org/10.3390/cancers13061201</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers13061201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers13061201%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DBioinformatic%252BAnalysis%252Bof%252Bthe%252BNicotinamide%252BBinding%252BSite%252Bin%252BPoly%252528ADP-Ribose%252529%252BPolymerase%252BFamily%252BProteins%26aulast%3DManasaryan%26aufirst%3DGarri%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D6%26spage%3D1201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kirsten Strømme  Kierulf-Vieira</span>, <span class="hlFld-ContribAuthor ">Cecilie Jonsgar  Sandberg</span>, <span class="hlFld-ContribAuthor ">Jo  Waaler</span>, <span class="hlFld-ContribAuthor ">Kaja  Lund</span>, <span class="hlFld-ContribAuthor ">Erlend  Skaga</span>, <span class="hlFld-ContribAuthor ">Birthe Mikkelsen  Saberniak</span>, <span class="hlFld-ContribAuthor ">Ioannis  Panagopoulos</span>, <span class="hlFld-ContribAuthor ">Petter  Brandal</span>, <span class="hlFld-ContribAuthor ">Stefan  Krauss</span>, <span class="hlFld-ContribAuthor ">Iver Arne  Langmoen</span>, <span class="hlFld-ContribAuthor ">Einar Osland  Vik-Mo</span>. </span><span class="cited-content_cbyCitation_article-title">A Small-Molecule Tankyrase Inhibitor Reduces Glioma Stem Cell Proliferation and Sphere Formation. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2020,</strong> <em>12 </em>
                                    (6)
                                     , 1630. <a href="https://doi.org/10.3390/cancers12061630" title="DOI URL">https://doi.org/10.3390/cancers12061630</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers12061630&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers12061630%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DA%252BSmall-Molecule%252BTankyrase%252BInhibitor%252BReduces%252BGlioma%252BStem%252BCell%252BProliferation%252Band%252BSphere%252BFormation%26aulast%3DKierulf-Vieira%26aufirst%3DKirsten%2BStr%25C3%25B8mme%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D6%26spage%3D1630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00208/20210315/images/medium/jm0c00208_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00208/20210315/images/large/jm0c00208_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00208&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00208/20210315/images/medium/jm0c00208_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00208/20210315/images/large/jm0c00208_0001.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Lead compound <b>1</b> and the building blocks defined as West (red), South (blue), East (green), and linker (pink).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00208/20210315/images/large/jm0c00208_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00208&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00208/20210315/images/medium/jm0c00208_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00208/20210315/images/large/jm0c00208_0006.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. (a, Left) Synthesis of Targets with South and West Variations and (b, Right) Synthesis of Targets with East Variations</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00208/20210315/images/large/jm0c00208_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00208&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00208/20210315/images/medium/jm0c00208_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00208/20210315/images/large/jm0c00208_0007.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of <b>18</b> and <b>51</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00208/20210315/images/large/jm0c00208_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00208&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00208/20210315/images/medium/jm0c00208_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00208/20210315/images/large/jm0c00208_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (a) Selected key compounds in the optimization campaign and respective TNKS2 and HEK293 IC<sub>50</sub> values. Mean ± SD values for three independent experiments are shown. Moieties are in color when differing from <b>1</b>. (b) ADME data of key compounds. (c) Cellular efficacy and mouse po PK 5 mg/kg of the short-listed compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00208/20210315/images/large/jm0c00208_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00208&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00208/20210315/images/medium/jm0c00208_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00208/20210315/images/large/jm0c00208_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Cocrystal structures of TNKS2 with inhibitors. (a) Binding mode of <b>105</b> with TNKS2 catalytic domain (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6TKN">6TKN</a>). (b) Binding mode of <b>13</b> with TNKS2 catalytic domain (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6TG4">6TG4</a>). (c) Binding mode of <b>10</b> with TNKS2 catalytic domain (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6TKM">6TKM</a>). (d) Binding mode of <b>88</b> with TNKS2 catalytic domain (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6TKS">6TKS</a>). The dashed lines in black represent hydrogen bonds, and the red spheres represent water molecules. The σ<sub>A</sub> weighted 2<i>F</i><sub>o</sub> – <i>F</i><sub>c</sub> electron density maps around the ligands are contoured at (1.4–1.7)σ. Structures were solved with molecular replacement using the structure of TNKS2 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NOB">5NOB</a>) as a starting model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00208/20210315/images/large/jm0c00208_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00208&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00208/20210315/images/medium/jm0c00208_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00208/20210315/images/large/jm0c00208_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Atropisomerism of <b>1</b> (stereochemistry arbitrarily assigned) on chiral SFC and TNKS2 and HEK293 IC<sub>50</sub> values.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00208/20210315/images/large/jm0c00208_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00208&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00208/20210315/images/medium/jm0c00208_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00208/20210315/images/large/jm0c00208_0005.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. <b>13</b> can inhibit WNT/β<i>-</i>catenin signaling activity and act as an antiproliferative agent in COLO 320DM cells. (a) Representative immunoblots of cytoplasmic TNKS1/2, AXIN1, AXIN2 and cytoplasmic and nuclear transcriptionally active β<i>-</i>catenin (non-phospho) and β-catenin. Actin or lamin B1 document equals protein loading, and ∗ indicates that the same actin immunoblot is used as loading control for both AXIN2 and β<i>-</i>catenin. For (a) and (b), control = 0.01% DMSO. (b) Real-time RT-qPCR analyses of WNT/β<i>-</i>catenin signaling target genes (<i>AXIN2</i>, <i>DKK1</i>, <i>NKD1</i>, and <i>APCDD1</i>). For (b) and (c), ANOVA tests (Holm–Sidak method, versus control) are indicated by ∗∗∗ (<i>P</i> < 0.001), and ANOVA on ranks tests (Tukeys test versus control) are indicated by † (<i>P</i> < 0.05). Mean values ± standard deviations for combined data from a minimum of three independent experiments with three replicates each are shown. (c) MTS colorimetric cell growth assay for various doses of 13 in APC<sup>mutated</sup> COLO 320DM (black) and APC<sup>wild-type</sup> RKO (gray) cells. Control = 0. 1% DMSO. Dotted lines depict 50% (GI<sub>50</sub>) and 25% (GI<sub>25</sub>) growth inhibition levels. Mean values ± standard deviations for one representative experiment out of three independent experiments are shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-13/acs.jmedchem.0c00208/20210315/images/large/jm0c00208_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00208&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i54">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68671" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68671" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 41 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haikarainen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauss, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehtio, L.</span></span> <span> </span><span class="NLM_article-title">Tankyrases: structure, function and therapeutic implications in cancer</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">6472</span>– <span class="NLM_lpage">6488</span>, <span class="refDoi"> DOI: 10.2174/1381612820666140630101525</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.2174%2F1381612820666140630101525" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=24975604" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVGgtLfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=6472-6488&author=T.+Haikarainenauthor=S.+Kraussauthor=L.+Lehtio&title=Tankyrases%3A+structure%2C+function+and+therapeutic+implications+in+cancer&doi=10.2174%2F1381612820666140630101525"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Tankyrases: Structure, Function and Therapeutic Implications in Cancer</span></div><div class="casAuthors">Haikarainen, Teemu; Krauss, Stefan; Lehtio, Lari</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">6472-6488</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Several cellular signaling pathways are regulated by ADP-ribosylation, a posttranslational modification catalyzed by members of the ARTD superfamily.  Tankyrases are distinguishable from the rest of this family by their unique domain organization, notably the sterile alpha motif responsible for oligomerization and ankyrin repeats mediating protein-protein interactions.  Tankyrases are involved in various cellular functions, such as telomere homeostasis, Wnt/β -catenin signaling, glucose metab., and cell cycle progression.  In these processes, Tankyrases regulate the interactions and stability of target proteins by poly (ADP-ribosyl)ation.  Modified proteins are subsequently recognized by the E3 ubiquitin ligase RNF146, poly-ubiquitinated and predominantly guided to 26S proteasomal degrdn.  Several small mol. inhibitors have been described for Tankyrases; they compete with the co-substrate NAD+ for binding to the ARTD catalytic domain.  The recent, highly potent and selective inhibitors possess several properties of lead compds. and can be used for proof-of-concept studies in cancer and other Tankyrase linked diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotYUovVf-x6LVg90H21EOLACvtfcHk0lhWqXwhqYqwVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVGgtLfN&md5=ced27d2889d245696043a8cfa891166c</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.2174%2F1381612820666140630101525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612820666140630101525%26sid%3Dliteratum%253Aachs%26aulast%3DHaikarainen%26aufirst%3DT.%26aulast%3DKrauss%26aufirst%3DS.%26aulast%3DLehtio%26aufirst%3DL.%26atitle%3DTankyrases%253A%2520structure%252C%2520function%2520and%2520therapeutic%2520implications%2520in%2520cancer%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2014%26volume%3D20%26spage%3D6472%26epage%3D6488%26doi%3D10.2174%2F1381612820666140630101525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishina, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stegmeier, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michaud, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charlat, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiellette, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiessner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hild, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mickanin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myer, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fazal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomlinson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serluca, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shultz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schirle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlegl, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghidelli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fawell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirschner, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lengauer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finan, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tallarico, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouwmeester, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cong, F.</span></span> <span> </span><span class="NLM_article-title">Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>461</i></span>,  <span class="NLM_fpage">614</span>– <span class="NLM_lpage">620</span>, <span class="refDoi"> DOI: 10.1038/nature08356</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.1038%2Fnature08356" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=19759537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFentbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=461&publication_year=2009&pages=614-620&author=S.+M.+Huangauthor=Y.+M.+Mishinaauthor=S.+Liuauthor=A.+Cheungauthor=F.+Stegmeierauthor=G.+A.+Michaudauthor=O.+Charlatauthor=E.+Wielletteauthor=Y.+Zhangauthor=S.+Wiessnerauthor=M.+Hildauthor=X.+Shiauthor=C.+J.+Wilsonauthor=C.+Mickaninauthor=V.+Myerauthor=A.+Fazalauthor=R.+Tomlinsonauthor=F.+Serlucaauthor=W.+Shaoauthor=H.+Chengauthor=M.+Shultzauthor=C.+Rauauthor=M.+Schirleauthor=J.+Schleglauthor=S.+Ghidelliauthor=S.+Fawellauthor=C.+Luauthor=D.+Curtisauthor=M.+W.+Kirschnerauthor=C.+Lengauerauthor=P.+M.+Finanauthor=J.+A.+Tallaricoauthor=T.+Bouwmeesterauthor=J.+A.+Porterauthor=A.+Bauerauthor=F.+Cong&title=Tankyrase+inhibition+stabilizes+axin+and+antagonizes+Wnt+signalling&doi=10.1038%2Fnature08356"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling</span></div><div class="casAuthors">Huang, Shih-Min A.; Mishina, Yuji M.; Liu, Shanming; Cheung, Atwood; Stegmeier, Frank; Michaud, Gregory A.; Charlat, Olga; Wiellette, Elizabeth; Zhang, Yue; Wiessner, Stephanie; Hild, Marc; Shi, Xiaoying; Wilson, Christopher J.; Mickanin, Craig; Myer, Vic; Fazal, Aleem; Tomlinson, Ronald; Serluca, Fabrizio; Shao, Wenlin; Cheng, Hong; Shultz, Michael; Rau, Christina; Schirle, Markus; Schlegl, Judith; Ghidelli, Sonja; Fawell, Stephen; Lu, Chris; Curtis, Daniel; Kirschner, Marc W.; Lengauer, Christoph; Finan, Peter M.; Tallarico, John A.; Bouwmeester, Tewis; Porter, Jeffery A.; Bauer, Andreas; Cong, Feng</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">461</span>
        (<span class="NLM_cas:issue">7264</span>),
    <span class="NLM_cas:pages">614-620</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The stability of the Wnt pathway transcription factor β-catenin is tightly regulated by the multi-subunit destruction complex.  Deregulated Wnt pathway activity has been implicated in many cancers, making this pathway an attractive target for anticancer therapies.  However, the development of targeted Wnt pathway inhibitors has been hampered by the limited no. of pathway components that are amenable to small mol. inhibition.  Here, we used a chem. genetic screen to identify a small mol., XAV939, which selectively inhibits β-catenin-mediated transcription.  XAV939 stimulates β-catenin degrdn. by stabilizing axin, the concn.-limiting component of the destruction complex.  Using a quant. chem. proteomic approach, we discovered that XAV939 stabilizes axin by inhibiting the poly-ADP-ribosylating enzymes tankyrase 1 and tankyrase 2.  Both tankyrase isoforms interact with a highly conserved domain of axin and stimulate its degrdn. through the ubiquitin-proteasome pathway.  Thus, our study provides new mechanistic insights into the regulation of axin protein homeostasis and presents new avenues for targeted Wnt pathway therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom3c1M4OoOarVg90H21EOLACvtfcHk0lhke-7pxef0OQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFentbzP&md5=6a76dfa7ed2a57b29e0c1ee367bd652c</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnature08356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08356%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DS.%2BM.%26aulast%3DMishina%26aufirst%3DY.%2BM.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DCheung%26aufirst%3DA.%26aulast%3DStegmeier%26aufirst%3DF.%26aulast%3DMichaud%26aufirst%3DG.%2BA.%26aulast%3DCharlat%26aufirst%3DO.%26aulast%3DWiellette%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWiessner%26aufirst%3DS.%26aulast%3DHild%26aufirst%3DM.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DWilson%26aufirst%3DC.%2BJ.%26aulast%3DMickanin%26aufirst%3DC.%26aulast%3DMyer%26aufirst%3DV.%26aulast%3DFazal%26aufirst%3DA.%26aulast%3DTomlinson%26aufirst%3DR.%26aulast%3DSerluca%26aufirst%3DF.%26aulast%3DShao%26aufirst%3DW.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DShultz%26aufirst%3DM.%26aulast%3DRau%26aufirst%3DC.%26aulast%3DSchirle%26aufirst%3DM.%26aulast%3DSchlegl%26aufirst%3DJ.%26aulast%3DGhidelli%26aufirst%3DS.%26aulast%3DFawell%26aufirst%3DS.%26aulast%3DLu%26aufirst%3DC.%26aulast%3DCurtis%26aufirst%3DD.%26aulast%3DKirschner%26aufirst%3DM.%2BW.%26aulast%3DLengauer%26aufirst%3DC.%26aulast%3DFinan%26aufirst%3DP.%2BM.%26aulast%3DTallarico%26aufirst%3DJ.%2BA.%26aulast%3DBouwmeester%26aufirst%3DT.%26aulast%3DPorter%26aufirst%3DJ.%2BA.%26aulast%3DBauer%26aufirst%3DA.%26aulast%3DCong%26aufirst%3DF.%26atitle%3DTankyrase%2520inhibition%2520stabilizes%2520axin%2520and%2520antagonizes%2520Wnt%2520signalling%26jtitle%3DNature%26date%3D2009%26volume%3D461%26spage%3D614%26epage%3D620%26doi%3D10.1038%2Fnature08356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span> <span> </span><span class="NLM_article-title">Tankyrase inhibitors target YAP by stabilizing angiomotin family proteins</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">524</span>– <span class="NLM_lpage">532</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2015.09.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.1016%2Fj.celrep.2015.09.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=26456820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1CqtLjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2015&pages=524-532&author=W.+Wangauthor=N.+Liauthor=X.+Liauthor=M.+K.+Tranauthor=X.+Hanauthor=J.+Chen&title=Tankyrase+inhibitors+target+YAP+by+stabilizing+angiomotin+family+proteins&doi=10.1016%2Fj.celrep.2015.09.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Tankyrase Inhibitors Target YAP by Stabilizing Angiomotin Family Proteins</span></div><div class="casAuthors">Wang, Wenqi; Li, Nan; Li, Xu; Tran, My Kim; Han, Xin; Chen, Junjie</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">524-532</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">As the key effector in the Hippo pathway, YAP was identified as an oncoprotein whose expression is elevated in various human cancers.  However, the development of potentially therapeutic compds. targeting YAP has been slow and limited.  Here, we find that tankyrase inhibitors suppress YAP activity.  This effect is mediated by angiomotin (AMOT) family proteins.  Tankyrases assoc. with AMOT family proteins and promote their degrdn. through E3 ligase RNF146.  By antagonizing tankyrase activity, tankyrase inhibitors stabilize AMOT family proteins, thereby suppressing YAP oncogenic functions.  Together, our studies not only demonstrate the tankyrase-RNF146-AMOT axis as an upstream pathway regulating YAP but also reveal a therapeutic opportunity in targeting YAP for cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5bR3ZFLB_P7Vg90H21EOLACvtfcHk0lhke-7pxef0OQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1CqtLjK&md5=7bb440ebc97018d11035ebd295eb3e5e</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2015.09.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2015.09.014%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DTran%26aufirst%3DM.%2BK.%26aulast%3DHan%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DJ.%26atitle%3DTankyrase%2520inhibitors%2520target%2520YAP%2520by%2520stabilizing%2520angiomotin%2520family%2520proteins%26jtitle%3DCell%2520Rep.%26date%3D2015%26volume%3D13%26spage%3D524%26epage%3D532%26doi%3D10.1016%2Fj.celrep.2015.09.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bhardwaj, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueberheide, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S.</span></span> <span> </span><span class="NLM_article-title">Whole proteome analysis of human tankyrase knockout cells reveals targets of tankyrase-mediated degradation</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">2214</span>, <span class="refDoi"> DOI: 10.1038/s41467-017-02363-w</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.1038%2Fs41467-017-02363-w" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=29263426" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A280%3ADC%252BC1MzjslWhtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=2214&author=A.+Bhardwajauthor=Y.+Yangauthor=B.+Ueberheideauthor=S.+Smith&title=Whole+proteome+analysis+of+human+tankyrase+knockout+cells+reveals+targets+of+tankyrase-mediated+degradation&doi=10.1038%2Fs41467-017-02363-w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Whole proteome analysis of human tankyrase knockout cells reveals targets of tankyrase-mediated degradation</span></div><div class="casAuthors">Bhardwaj Amit; Smith Susan; Yang Yanling; Ueberheide Beatrix</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2214</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Tankyrase 1 and 2 are poly(ADP-ribose) polymerases that function in pathways critical to cancer cell growth.  Tankyrase-mediated PARylation marks protein targets for proteasomal degradation.  Here, we generate human knockout cell lines to examine cell function and interrogate the proteome.  We show that either tankyrase 1 or 2 is sufficient to maintain telomere length, but both are required to resolve telomere cohesion and maintain mitotic spindle integrity.  Quantitative analysis of the proteome of tankyrase double knockout cells using isobaric tandem mass tags reveals targets of degradation, including antagonists of the Wnt/β-catenin signaling pathway (NKD1, NKD2, and HectD1) and three (Notch 1, 2, and 3) of the four Notch receptors.  We show that tankyrases are required for Notch2 to exit the plasma membrane and enter the nucleus to activate transcription.  Considering that Notch signaling is commonly activated in cancer, tankyrase inhibitors may have therapeutic potential in targeting this pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcREMjSSm_naSOQ4Pl9hzjQhfW6udTcc2eYqqg7ip6THebntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MzjslWhtg%253D%253D&md5=923f6857cba7fd386c7ebc3e6857fae5</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fs41467-017-02363-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-017-02363-w%26sid%3Dliteratum%253Aachs%26aulast%3DBhardwaj%26aufirst%3DA.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DUeberheide%26aufirst%3DB.%26aulast%3DSmith%26aufirst%3DS.%26atitle%3DWhole%2520proteome%2520analysis%2520of%2520human%2520tankyrase%2520knockout%2520cells%2520reveals%2520targets%2520of%2520tankyrase-mediated%2520degradation%26jtitle%3DNat.%2520Commun.%26date%3D2017%26volume%3D8%26spage%3D2214%26doi%3D10.1038%2Fs41467-017-02363-w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M. K.</span></span> <span> </span><span class="NLM_article-title">Novel insight into the function of tankyrase</span>. <i>Oncol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">6895</span>– <span class="NLM_lpage">6902</span>, <span class="refDoi"> DOI: 10.3892/ol.2018.9551</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.3892%2Fol.2018.9551" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=30546421" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvVGhs7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2018&pages=6895-6902&author=M.+K.+Kim&title=Novel+insight+into+the+function+of+tankyrase&doi=10.3892%2Fol.2018.9551"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Novel insight into the function of tankyrase (review)</span></div><div class="casAuthors">Kim, Mi Kyung</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">6895-6902</span>CODEN:
                <span class="NLM_cas:coden">OLNEB5</span>;
        ISSN:<span class="NLM_cas:issn">1792-1082</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Tankyrases are multifunctional poly(ADP-ribose) polymerases that regulate a variety of cellular processes, including Wnt signaling, telomere maintenance and mitosis regulation.  Tankyrases interact with target proteins and regulate their interactions and stability through poly(ADP-ribosyl) ation.  In addn. to their roles in telomere maintenance and regulation of mitosis, tankyrase proteins regulate tumor suppressors, including AXIN, phosphatase and tensin homolog and angiomotin.  Therefore, tankyrases may be effective targets for cancer treatment.  Tankyrase inhibitors could affect a variety of carcinogenic pathways that promote uncontrolled proliferation, including Wnt, AKT, yes-assocd. protein, telomere maintenance and mitosis regulation.  Recently, novel aspects of the function and mechanism of tankyrases have been reported, and a no. of tankyrase inhibitors have been identified.  A combination of conventional chemotherapy agents with tankyrase inhibitors may have synergistic anticancer effects.  Therefore, it is expected that more advanced and improved tankyrase inhibitors will be developed, enabling novel therapeutic strategies against cancer and other tankyrase-assocd. diseases.  The present review discusses tankyrase function and the role of tankyrase inhibitors in the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoh_4RkO1ZDG7Vg90H21EOLACvtfcHk0lhke-7pxef0OQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvVGhs7jN&md5=a9e97dd985c969af20c63b5c7c3f4458</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.3892%2Fol.2018.9551&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fol.2018.9551%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DM.%2BK.%26atitle%3DNovel%2520insight%2520into%2520the%2520function%2520of%2520tankyrase%26jtitle%3DOncol.%2520Lett.%26date%3D2018%26volume%3D16%26spage%3D6895%26epage%3D6902%26doi%3D10.3892%2Fol.2018.9551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fong, L. W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S. H.</span></span> <span> </span><span class="NLM_article-title">Tankyrase disrupts metabolic homeostasis and promotes tumorigenesis by inhibiting LKB1-AMPK signalling</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">4363</span>, <span class="refDoi"> DOI: 10.1038/s41467-019-12377-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.1038%2Fs41467-019-12377-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=31554794" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A280%3ADC%252BB3MnitFaisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=4363&author=N.+Liauthor=Y.+Wangauthor=S.+Neriauthor=Y.+Zhenauthor=L.+W.+R.+Fongauthor=Y.+Qiaoauthor=X.+Liauthor=Z.+Chenauthor=C.+Stephanauthor=W.+Dengauthor=R.+Yeauthor=W.+Jiangauthor=S.+Zhangauthor=Y.+Yuauthor=M.+C.+Hungauthor=J.+Chenauthor=S.+H.+Lin&title=Tankyrase+disrupts+metabolic+homeostasis+and+promotes+tumorigenesis+by+inhibiting+LKB1-AMPK+signalling&doi=10.1038%2Fs41467-019-12377-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Tankyrase disrupts metabolic homeostasis and promotes tumorigenesis by inhibiting LKB1-AMPK signalling</span></div><div class="casAuthors">Li Nan; Wang Yifan; Neri Shinya; Qiao Yawei; Li Xu; Chen Zhen; Ye Rui; Chen Junjie; Lin Steven H; Wang Yifan; Fong Lon Wolf R; Ye Rui; Hung Mien-Chie; Chen Junjie; Lin Steven H; Wang Yifan; Deng Weiye; Jiang Wen; Zhen Yuanli; Yu Yonghao; Fong Lon Wolf R; Zhang Shuxing; Li Xu; Stephan Clifford; Deng Weiye; Jiang Wen; Lin Steven H; Hung Mien-Chie</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4363</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The LKB1/AMPK pathway plays a major role in cellular homeostasis and tumor suppression.  Down-regulation of LKB1/AMPK occurs in several human cancers and has been implicated in metabolic diseases.  However, the precise upstream regulation of LKB1-AMPK pathway is largely unknown.  Here, we report that AMPK activation by LKB1 is regulated by tankyrases.  Tankyrases interact with and ribosylate LKB1, promoting its K63-linked ubiquitination by an E3 ligase RNF146, which blocks LKB1/STRAD/MO25 complex formation and LKB1 activation.  LKB1 activation by tankyrase inhibitors induces AMPK activation and suppresses tumorigenesis.  Similarly, the tankyrase inhibitor G007-LK effectively regulates liver metabolism and glycemic control in diabetic mice in a LKB1-dependent manner.  In patients with lung cancer, tankyrase levels negatively correlate with p-AMPK levels and poor survival.  Taken together, these findings suggest that tankyrase and RNF146 are major up-stream regulators of LKB1-AMPK pathway and provide another focus for cancer and metabolic disease therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTzEc3gtF2lsdenUz0lpNqnfW6udTcc2ebeOYjsL7qHMLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MnitFaisQ%253D%253D&md5=9cc4bd955f31f48a287cc1e9e513b2e6</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fs41467-019-12377-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-019-12377-1%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DNeri%26aufirst%3DS.%26aulast%3DZhen%26aufirst%3DY.%26aulast%3DFong%26aufirst%3DL.%2BW.%2BR.%26aulast%3DQiao%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DStephan%26aufirst%3DC.%26aulast%3DDeng%26aufirst%3DW.%26aulast%3DYe%26aufirst%3DR.%26aulast%3DJiang%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DHung%26aufirst%3DM.%2BC.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DS.%2BH.%26atitle%3DTankyrase%2520disrupts%2520metabolic%2520homeostasis%2520and%2520promotes%2520tumorigenesis%2520by%2520inhibiting%2520LKB1-AMPK%2520signalling%26jtitle%3DNat.%2520Commun.%26date%3D2019%26volume%3D10%26spage%3D4363%26doi%3D10.1038%2Fs41467-019-12377-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodge, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilgore, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amatruda, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lum, L.</span></span> <span> </span><span class="NLM_article-title">Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">100</span>– <span class="NLM_lpage">107</span>, <span class="refDoi"> DOI: 10.1038/nchembio.137</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.1038%2Fnchembio.137" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=19125156" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlWjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=100-107&author=B.+Chenauthor=M.+E.+Dodgeauthor=W.+Tangauthor=J.+Luauthor=Z.+Maauthor=C.+W.+Fanauthor=S.+Weiauthor=W.+Haoauthor=J.+Kilgoreauthor=N.+S.+Williamsauthor=M.+G.+Rothauthor=J.+F.+Amatrudaauthor=C.+Chenauthor=L.+Lum&title=Small+molecule-mediated+disruption+of+Wnt-dependent+signaling+in+tissue+regeneration+and+cancer&doi=10.1038%2Fnchembio.137"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer</span></div><div class="casAuthors">Chen, Baozhi; Dodge, Michael E.; Tang, Wei; Lu, Jianming; Ma, Zhiqiang; Fan, Chih-Wei; Wei, Shuguang; Hao, Wayne; Kilgore, Jessica; Williams, Noelle S.; Roth, Michael G.; Amatruda, James F.; Chen, Chuo; Lum, Lawrence</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">100-107</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The pervasive influence of secreted Wnt signaling proteins in tissue homeostasis and tumorigenesis has galvanized efforts to identify small mols. that target Wnt-mediated cellular responses.  By screening a diverse synthetic chem. library, we have discovered two new classes of small mols. that disrupt Wnt pathway responses; whereas one class inhibits the activity of Porcupine, a membrane-bound acyltransferase that is essential to the prodn. of Wnt proteins, the other abrogates destruction of Axin proteins, which are suppressors of Wnt/β-catenin pathway activity.  With these small mols., we establish a chem. genetic approach for studying Wnt pathway responses and stem cell function in adult tissue.  We achieve transient, reversible suppression of Wnt/β-catenin pathway response in vivo, and we establish a mechanism-based approach to target cancerous cell growth.  The signal transduction mechanisms shown here to be chem. tractable addnl. contribute to Wnt-independent signal transduction pathways and thus could be broadly exploited for chem. genetics and therapeutic goals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAMJCu3QDiYrVg90H21EOLACvtfcHk0lg85TZslWeIzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlWjtw%253D%253D&md5=32516a31ce8f691b654ee33c0df83bc5</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.137%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DB.%26aulast%3DDodge%26aufirst%3DM.%2BE.%26aulast%3DTang%26aufirst%3DW.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DFan%26aufirst%3DC.%2BW.%26aulast%3DWei%26aufirst%3DS.%26aulast%3DHao%26aufirst%3DW.%26aulast%3DKilgore%26aufirst%3DJ.%26aulast%3DWilliams%26aufirst%3DN.%2BS.%26aulast%3DRoth%26aufirst%3DM.%2BG.%26aulast%3DAmatruda%26aufirst%3DJ.%2BF.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DLum%26aufirst%3DL.%26atitle%3DSmall%2520molecule-mediated%2520disruption%2520of%2520Wnt-dependent%2520signaling%2520in%2520tissue%2520regeneration%2520and%2520cancer%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2009%26volume%3D5%26spage%3D100%26epage%3D107%26doi%3D10.1038%2Fnchembio.137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waaler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machon, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tumova, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korinek, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulsen, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedersen, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eide, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machonova, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gradl, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voronkov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Kries, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauss, S.</span></span> <span> </span><span class="NLM_article-title">A novel tankyrase inhibitor decreases canonical Wnt signaling in colon carcinoma cells and reduces tumor growth in conditional APC mutant mice</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">2822</span>– <span class="NLM_lpage">2832</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-11-3336</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.1158%2F0008-5472.CAN-11-3336" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=22440753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC38XnvVyjtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2012&pages=2822-2832&author=J.+Waalerauthor=O.+Machonauthor=L.+Tumovaauthor=H.+Dinhauthor=V.+Korinekauthor=S.+R.+Wilsonauthor=J.+E.+Paulsenauthor=N.+M.+Pedersenauthor=T.+J.+Eideauthor=O.+Machonovaauthor=D.+Gradlauthor=A.+Voronkovauthor=J.+P.+von+Kriesauthor=S.+Krauss&title=A+novel+tankyrase+inhibitor+decreases+canonical+Wnt+signaling+in+colon+carcinoma+cells+and+reduces+tumor+growth+in+conditional+APC+mutant+mice&doi=10.1158%2F0008-5472.CAN-11-3336"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Tankyrase Inhibitor Decreases Canonical Wnt Signaling in Colon Carcinoma Cells and Reduces Tumor Growth in Conditional APC Mutant Mice</span></div><div class="casAuthors">Waaler, Jo; Machon, Ondrej; Tumova, Lucie; Dinh, Huyen; Korinek, Vladimir; Wilson, Steven Ray; Paulsen, Jan Erik; Pedersen, Nina Marie; Eide, Tor J.; Machonova, Olga; Gradl, Dietmar; Voronkov, Andrey; von Kries, Jens Peter; Krauss, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2822-2832</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">This preclin. proof-of-concept study suggests a new strategy to treat colon cancer by increasing the degrdn. of β-catenin, which drives this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokQ3hrnF8gMLVg90H21EOLACvtfcHk0lg85TZslWeIzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnvVyjtro%253D&md5=9814ad25dc1d5da6d9babaff8df19327</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-11-3336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-11-3336%26sid%3Dliteratum%253Aachs%26aulast%3DWaaler%26aufirst%3DJ.%26aulast%3DMachon%26aufirst%3DO.%26aulast%3DTumova%26aufirst%3DL.%26aulast%3DDinh%26aufirst%3DH.%26aulast%3DKorinek%26aufirst%3DV.%26aulast%3DWilson%26aufirst%3DS.%2BR.%26aulast%3DPaulsen%26aufirst%3DJ.%2BE.%26aulast%3DPedersen%26aufirst%3DN.%2BM.%26aulast%3DEide%26aufirst%3DT.%2BJ.%26aulast%3DMachonova%26aufirst%3DO.%26aulast%3DGradl%26aufirst%3DD.%26aulast%3DVoronkov%26aufirst%3DA.%26aulast%3Dvon%2BKries%26aufirst%3DJ.%2BP.%26aulast%3DKrauss%26aufirst%3DS.%26atitle%3DA%2520novel%2520tankyrase%2520inhibitor%2520decreases%2520canonical%2520Wnt%2520signaling%2520in%2520colon%2520carcinoma%2520cells%2520and%2520reduces%2520tumor%2520growth%2520in%2520conditional%2520APC%2520mutant%2520mice%26jtitle%3DCancer%2520Res.%26date%3D2012%26volume%3D72%26spage%3D2822%26epage%3D2832%26doi%3D10.1158%2F0008-5472.CAN-11-3336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Voronkov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holsworth, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waaler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ekblad, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perdreau-Dahl, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drewes, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopf, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morth, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauss, S.</span></span> <span> </span><span class="NLM_article-title">Structural basis and SAR for G007-LK, a lead stage 1,2,4-triazole based specific tankyrase 1/2 inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">3012</span>– <span class="NLM_lpage">3023</span>, <span class="refDoi"> DOI: 10.1021/jm4000566</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4000566" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjslGht7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3012-3023&author=A.+Voronkovauthor=D.+D.+Holsworthauthor=J.+Waalerauthor=S.+R.+Wilsonauthor=B.+Ekbladauthor=H.+Perdreau-Dahlauthor=H.+Dinhauthor=G.+Drewesauthor=C.+Hopfauthor=J.+P.+Morthauthor=S.+Krauss&title=Structural+basis+and+SAR+for+G007-LK%2C+a+lead+stage+1%2C2%2C4-triazole+based+specific+tankyrase+1%2F2+inhibitor&doi=10.1021%2Fjm4000566"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis and SAR for G007-LK, a Lead Stage 1,2,4-Triazole Based Specific Tankyrase 1/2 Inhibitor</span></div><div class="casAuthors">Voronkov, Andrew; Holsworth, Daniel D.; Waaler, Jo; Wilson, Steven R.; Ekblad, Bie; Perdreau-Dahl, Harmonie; Dinh, Huyen; Drewes, Gerard; Hopf, Carsten; Morth, Jens P.; Krauss, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3012-3023</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tankyrases 1 and 2 (TNKS1/2) are promising pharmacol. biotargets with possible applications for the development of novel anticancer therapeutics.  A focused structure-activity relationship study was conducted based on the tankyrase inhibitor JW74 (1).  Chem. analoging of 1 improved the 1,2,4-triazole based core and led to 4-{5-[(E)-2-{4-(2-chlorophenyl)-5-[5-(methylsulfonyl)pyridin-2-yl]-4H-1,2,4-triazol-3-yl}ethenyl]-1,3,4-oxadiazol-2-yl}benzonitrile (G007-LK), a potent, "rule of 5" compliant and a metabolically stable TNKS1/2 inhibitor.  G007-LK (66) displayed high selectivity toward tankyrases 1 and 2 with biochem. IC50 values of 46 nM and 25 nM, resp., and a cellular IC50 value of 50 nM combined with an excellent pharmacokinetic profile in mice.  The PARP domain of TNKS2 was cocrystd. with 66, and the X-ray structure was detd. at 2.8 Å resoln. in the space group P3221.  The structure revealed that 66 binds to unique structural features in the extended adenosine binding pocket which forms the structural basis for the compd.'s high target selectivity and specificity.  Our study provides a significantly optimized compd. for targeting TNKS1/2 in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvUxhCxkLuYbVg90H21EOLACvtfcHk0lh42Py79u-K5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjslGht7o%253D&md5=f2bee61f0fdc326e3e798b3705072e9d</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm4000566&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4000566%26sid%3Dliteratum%253Aachs%26aulast%3DVoronkov%26aufirst%3DA.%26aulast%3DHolsworth%26aufirst%3DD.%2BD.%26aulast%3DWaaler%26aufirst%3DJ.%26aulast%3DWilson%26aufirst%3DS.%2BR.%26aulast%3DEkblad%26aufirst%3DB.%26aulast%3DPerdreau-Dahl%26aufirst%3DH.%26aulast%3DDinh%26aufirst%3DH.%26aulast%3DDrewes%26aufirst%3DG.%26aulast%3DHopf%26aufirst%3DC.%26aulast%3DMorth%26aufirst%3DJ.%2BP.%26aulast%3DKrauss%26aufirst%3DS.%26atitle%3DStructural%2520basis%2520and%2520SAR%2520for%2520G007-LK%252C%2520a%2520lead%2520stage%25201%252C2%252C4-triazole%2520based%2520specific%2520tankyrase%25201%252F2%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3012%26epage%3D3023%26doi%3D10.1021%2Fjm4000566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bregman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman-Perez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaydin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teffera, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egge, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullady, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newcomb, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serafino, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strathdee, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turci, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimauro, E. F.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel, induced-pocket binding oxazolidinones as potent, selective, and orally bioavailable tankyrase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">4320</span>– <span class="NLM_lpage">4342</span>, <span class="refDoi"> DOI: 10.1021/jm4000038</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4000038" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC3sXotV2ksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4320-4342&author=H.+Bregmanauthor=N.+Chakkaauthor=A.+Guzman-Perezauthor=H.+Gunaydinauthor=Y.+Guauthor=X.+Huangauthor=V.+Berryauthor=J.+Liuauthor=Y.+Tefferaauthor=L.+Huangauthor=B.+Eggeauthor=E.+L.+Mulladyauthor=S.+Schneiderauthor=P.+S.+Andrewsauthor=A.+Mishraauthor=J.+Newcombauthor=R.+Serafinoauthor=C.+A.+Strathdeeauthor=S.+M.+Turciauthor=C.+Wilsonauthor=E.+F.+Dimauro&title=Discovery+of+novel%2C+induced-pocket+binding+oxazolidinones+as+potent%2C+selective%2C+and+orally+bioavailable+tankyrase+inhibitors&doi=10.1021%2Fjm4000038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel, Induced-Pocket Binding Oxazolidinones as Potent, Selective, and Orally Bioavailable Tankyrase Inhibitors</span></div><div class="casAuthors">Bregman, Howard; Chakka, Nagasree; Guzman-Perez, Angel; Gunaydin, Hakan; Gu, Yan; Huang, Xin; Berry, Virginia; Liu, Jingzhou; Teffera, Yohannes; Huang, Liyue; Egge, Bryan; Mullady, Erin L.; Schneider, Steve; Andrews, Paul S.; Mishra, Ankita; Newcomb, John; Serafino, Randy; Strathdee, Craig A.; Turci, Susan M.; Wilson, Cindy; DiMauro, Erin F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4320-4342</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tankyrase (TNKS) is a poly-ADP-ribosylating protein (PARP) whose activity suppresses cellular axin protein levels and elevates β-catenin concns., resulting in increased oncogene expression.  The inhibition of tankyrase (TNKS1 and 2) may reduce the levels of β-catenin-mediated transcription and inhibit tumorigenesis.  Compd. I is a previously described moderately potent tankyrase inhibitor that suffers from poor pharmacokinetic properties.  Herein, we describe the utilization of structure-based design and mol. modeling toward novel, potent, and selective tankyrase inhibitors with improved pharmacokinetic properties (II, III).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNxO4sATmyjbVg90H21EOLACvtfcHk0lh42Py79u-K5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXotV2ksLs%253D&md5=c22d14a6a93ab185e3c13ccd04af9451</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm4000038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4000038%26sid%3Dliteratum%253Aachs%26aulast%3DBregman%26aufirst%3DH.%26aulast%3DChakka%26aufirst%3DN.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DBerry%26aufirst%3DV.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DTeffera%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DEgge%26aufirst%3DB.%26aulast%3DMullady%26aufirst%3DE.%2BL.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DAndrews%26aufirst%3DP.%2BS.%26aulast%3DMishra%26aufirst%3DA.%26aulast%3DNewcomb%26aufirst%3DJ.%26aulast%3DSerafino%26aufirst%3DR.%26aulast%3DStrathdee%26aufirst%3DC.%2BA.%26aulast%3DTurci%26aufirst%3DS.%2BM.%26aulast%3DWilson%26aufirst%3DC.%26aulast%3DDimauro%26aufirst%3DE.%2BF.%26atitle%3DDiscovery%2520of%2520novel%252C%2520induced-pocket%2520binding%2520oxazolidinones%2520as%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520tankyrase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4320%26epage%3D4342%26doi%3D10.1021%2Fjm4000038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anumala, U. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waaler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nkizinkiko, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ignatev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazarow, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindemann, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murthy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obaji, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majouga, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonov, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Kries, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehtio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauss, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nazare, M.</span></span> <span> </span><span class="NLM_article-title">Discovery of a novel series of tankyrase inhibitors by a hybridization approach</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">10013</span>– <span class="NLM_lpage">10025</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00883</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00883" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVCksrnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=10013-10025&author=U.+R.+Anumalaauthor=J.+Waalerauthor=Y.+Nkizinkikoauthor=A.+Ignatevauthor=K.+Lazarowauthor=P.+Lindemannauthor=P.+A.+Olsenauthor=S.+Murthyauthor=E.+Obajiauthor=A.+G.+Majougaauthor=S.+Leonovauthor=J.+P.+von+Kriesauthor=L.+Lehtioauthor=S.+Kraussauthor=M.+Nazare&title=Discovery+of+a+novel+series+of+tankyrase+inhibitors+by+a+hybridization+approach&doi=10.1021%2Facs.jmedchem.7b00883"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Novel Series of Tankyrase Inhibitors by a Hybridization Approach</span></div><div class="casAuthors">Anumala, Upendra Rao; Waaler, Jo; Nkizinkiko, Yves; Ignatev, Alexander; Lazarow, Katina; Lindemann, Peter; Olsen, Petter Angell; Murthy, Sudarshan; Obaji, Ezeogo; Majouga, Alexander G.; Leonov, Sergey; von Kries, Jens Peter; Lehtioe, Lari; Krauss, Stefan; Nazare, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10013-10025</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A structure-guided hybridization approach using two privileged substructures gave instant access to a new series of tankyrase inhibitors.  The identified inhibitor 16 (1-(trans-3-(4-(2-Chlorophenyl)-5-(pyrimidin-4-yl)-4H-1,2,4-triazol-3-yl)cyclobutyl)-2,3-dihydro-2-oxo-1H-benzimidazole-5-carbonitrile) displays high target affinity on tankyrase 1 and 2 with biochem. and cellular IC50 values of 29 nM, 6.3 nM and 19 nM, resp., and high selectivity toward other poly (ADP-ribose) polymerase enzymes.  The identified inhibitor shows a favorable in vitro ADME profile as well as good oral bioavailability in mice, rats, and dogs.  Crit. for the approach was the utilization of an appropriate linker between 1,2,4-triazole and benzimidazolone moieties, whereby a cyclobutyl linker displayed superior affinity compared to a cyclohexane and Ph linker.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaOvTL0NvY8bVg90H21EOLACvtfcHk0lgFylqjj1AYaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVCksrnJ&md5=d6bf8c8d971a158cdddc7d1c84b5144c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00883&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00883%26sid%3Dliteratum%253Aachs%26aulast%3DAnumala%26aufirst%3DU.%2BR.%26aulast%3DWaaler%26aufirst%3DJ.%26aulast%3DNkizinkiko%26aufirst%3DY.%26aulast%3DIgnatev%26aufirst%3DA.%26aulast%3DLazarow%26aufirst%3DK.%26aulast%3DLindemann%26aufirst%3DP.%26aulast%3DOlsen%26aufirst%3DP.%2BA.%26aulast%3DMurthy%26aufirst%3DS.%26aulast%3DObaji%26aufirst%3DE.%26aulast%3DMajouga%26aufirst%3DA.%2BG.%26aulast%3DLeonov%26aufirst%3DS.%26aulast%3Dvon%2BKries%26aufirst%3DJ.%2BP.%26aulast%3DLehtio%26aufirst%3DL.%26aulast%3DKrauss%26aufirst%3DS.%26aulast%3DNazare%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520series%2520of%2520tankyrase%2520inhibitors%2520by%2520a%2520hybridization%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D10013%26epage%3D10025%26doi%3D10.1021%2Facs.jmedchem.7b00883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bregman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman-Perez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaydin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teffera, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egge, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullady, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newcomb, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serafino, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strathdee, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turci, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMauro, E. F.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel, induced-pocket binding oxazolidinones as potent, selective, and orally bioavailable tankyrase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">4320</span>– <span class="NLM_lpage">4342</span>, <span class="refDoi"> DOI: 10.1021/jm4000038</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4000038" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC3sXotV2ksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4320-4342&author=H.+Bregmanauthor=N.+Chakkaauthor=A.+Guzman-Perezauthor=H.+Gunaydinauthor=Y.+Guauthor=X.+Huangauthor=V.+Berryauthor=J.+Liuauthor=Y.+Tefferaauthor=L.+Huangauthor=B.+Eggeauthor=E.+L.+Mulladyauthor=S.+Schneiderauthor=P.+S.+Andrewsauthor=A.+Mishraauthor=J.+Newcombauthor=R.+Serafinoauthor=C.+A.+Strathdeeauthor=S.+M.+Turciauthor=C.+Wilsonauthor=E.+F.+DiMauro&title=Discovery+of+novel%2C+induced-pocket+binding+oxazolidinones+as+potent%2C+selective%2C+and+orally+bioavailable+tankyrase+inhibitors&doi=10.1021%2Fjm4000038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel, Induced-Pocket Binding Oxazolidinones as Potent, Selective, and Orally Bioavailable Tankyrase Inhibitors</span></div><div class="casAuthors">Bregman, Howard; Chakka, Nagasree; Guzman-Perez, Angel; Gunaydin, Hakan; Gu, Yan; Huang, Xin; Berry, Virginia; Liu, Jingzhou; Teffera, Yohannes; Huang, Liyue; Egge, Bryan; Mullady, Erin L.; Schneider, Steve; Andrews, Paul S.; Mishra, Ankita; Newcomb, John; Serafino, Randy; Strathdee, Craig A.; Turci, Susan M.; Wilson, Cindy; DiMauro, Erin F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4320-4342</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tankyrase (TNKS) is a poly-ADP-ribosylating protein (PARP) whose activity suppresses cellular axin protein levels and elevates β-catenin concns., resulting in increased oncogene expression.  The inhibition of tankyrase (TNKS1 and 2) may reduce the levels of β-catenin-mediated transcription and inhibit tumorigenesis.  Compd. I is a previously described moderately potent tankyrase inhibitor that suffers from poor pharmacokinetic properties.  Herein, we describe the utilization of structure-based design and mol. modeling toward novel, potent, and selective tankyrase inhibitors with improved pharmacokinetic properties (II, III).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNxO4sATmyjbVg90H21EOLACvtfcHk0lgFylqjj1AYaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXotV2ksLs%253D&md5=c22d14a6a93ab185e3c13ccd04af9451</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm4000038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4000038%26sid%3Dliteratum%253Aachs%26aulast%3DBregman%26aufirst%3DH.%26aulast%3DChakka%26aufirst%3DN.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DBerry%26aufirst%3DV.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DTeffera%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DEgge%26aufirst%3DB.%26aulast%3DMullady%26aufirst%3DE.%2BL.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DAndrews%26aufirst%3DP.%2BS.%26aulast%3DMishra%26aufirst%3DA.%26aulast%3DNewcomb%26aufirst%3DJ.%26aulast%3DSerafino%26aufirst%3DR.%26aulast%3DStrathdee%26aufirst%3DC.%2BA.%26aulast%3DTurci%26aufirst%3DS.%2BM.%26aulast%3DWilson%26aufirst%3DC.%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26atitle%3DDiscovery%2520of%2520novel%252C%2520induced-pocket%2520binding%2520oxazolidinones%2520as%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520tankyrase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4320%26epage%3D4342%26doi%3D10.1021%2Fjm4000038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haikarainen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waaler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ignatev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nkizinkiko, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkannagari, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obaji, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauss, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehtio, L.</span></span> <span> </span><span class="NLM_article-title">Development and structural analysis of adenosine site binding tankyrase inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">328</span>– <span class="NLM_lpage">333</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.12.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.1016%2Fj.bmcl.2015.12.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=26706174" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVClurnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=328-333&author=T.+Haikarainenauthor=J.+Waalerauthor=A.+Ignatevauthor=Y.+Nkizinkikoauthor=H.+Venkannagariauthor=E.+Obajiauthor=S.+Kraussauthor=L.+Lehtio&title=Development+and+structural+analysis+of+adenosine+site+binding+tankyrase+inhibitors&doi=10.1016%2Fj.bmcl.2015.12.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Development and structural analysis of adenosine site binding tankyrase inhibitors</span></div><div class="casAuthors">Haikarainen, Teemu; Waaler, Jo; Ignatev, Alexander; Nkizinkiko, Yves; Venkannagari, Harikanth; Obaji, Ezeogo; Krauss, Stefan; Lehtio, Lari</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">328-333</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Tankyrases 1 and 2, the specialized members of the ARTD protein family, are druggable biotargets whose inhibition may have therapeutic potential against cancer, metabolic disease, fibrotic disease, fibrotic wound healing and HSV viral infections.  We have previously identified a novel tankyrase inhibitor scaffold, JW55, and showed that it reduces mouse colon adenoma formation in vivo.  Here we expanded the scaffold and profiled the selectivity of the compds. against a panel of human ARTDs.  The scaffold also enables a fine modulation of selectivity towards either tankyrase 1 or tankyrase 2.  In order to get insight about the binding mode of the inhibitors, we solved crystal structures of the compds. in complex with tankyrase 2.  The compds. bind to the adenosine pocket of the catalytic domain and cause changes in the protein structure that are modulated by the chem. modifications of the compds.  The structural anal. allows further rational development of this compd. class as a potent and selective tankyrase inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1PL4ynXO_w7Vg90H21EOLACvtfcHk0lgFylqjj1AYaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVClurnK&md5=3ea16aeed0c29adf13e112b7c5f9d796</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.12.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.12.018%26sid%3Dliteratum%253Aachs%26aulast%3DHaikarainen%26aufirst%3DT.%26aulast%3DWaaler%26aufirst%3DJ.%26aulast%3DIgnatev%26aufirst%3DA.%26aulast%3DNkizinkiko%26aufirst%3DY.%26aulast%3DVenkannagari%26aufirst%3DH.%26aulast%3DObaji%26aufirst%3DE.%26aulast%3DKrauss%26aufirst%3DS.%26aulast%3DLehtio%26aufirst%3DL.%26atitle%3DDevelopment%2520and%2520structural%2520analysis%2520of%2520adenosine%2520site%2520binding%2520tankyrase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D328%26epage%3D333%26doi%3D10.1016%2Fj.bmcl.2015.12.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nkizinkiko, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suneel Kumar, B. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeankumar, V. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haikarainen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koivunen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madhuri, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yogeeswari, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkannagari, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obaji, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pihlajaniemi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sriram, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehtio, L.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent and selective nonplanar tankyrase inhibiting nicotinamide mimics</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">4139</span>– <span class="NLM_lpage">4149</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.06.063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.1016%2Fj.bmc.2015.06.063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=26183543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFehsr%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=4139-4149&author=Y.+Nkizinkikoauthor=B.+V.+Suneel+Kumarauthor=V.+U.+Jeankumarauthor=T.+Haikarainenauthor=J.+Koivunenauthor=C.+Madhuriauthor=P.+Yogeeswariauthor=H.+Venkannagariauthor=E.+Obajiauthor=T.+Pihlajaniemiauthor=D.+Sriramauthor=L.+Lehtio&title=Discovery+of+potent+and+selective+nonplanar+tankyrase+inhibiting+nicotinamide+mimics&doi=10.1016%2Fj.bmc.2015.06.063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of potent and selective nonplanar tankyrase inhibiting nicotinamide mimics</span></div><div class="casAuthors">Nkizinkiko, Yves; Suneel Kumar, B. V. S.; Jeankumar, Variam Ullas; Haikarainen, Teemu; Koivunen, Jarkko; Madhuri, Chanduri; Yogeeswari, Perumal; Venkannagari, Harikanth; Obaji, Ezeogo; Pihlajaniemi, Taina; Sriram, Dharmarajan; Lehtio, Lari</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4139-4149</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Diphtheria toxin-like ADP-ribosyltransferases catalyze a posttranslational modification, ADP-ribosylation and form a protein family of 17 members in humans.  Two of the family members, tankyrases 1 and 2, are involved in several cellular processes including mitosis and Wnt/β-catenin signaling pathway.  They are often over-expressed in cancer cells and have been linked with the survival of cancer cells making them potential therapeutic targets.  In this study, the authors identified nine tankyrase inhibitors through virtual and in vitro screening.  Crystal structures of tankyrase 2 with the compds. showed that they bind to the nicotinamide binding site of the catalytic domain.  Based on the co-crystal structures the authors designed and synthesized a series of tetrahydroquinazolin-4-one and pyridopyrimidin-4-one analogs and were subsequently able to improve the potency of a hit compd. almost 100-fold (from 11 μM to 150 nM).  The most potent compds. were selective towards tankyrases over a panel of other human ARTD enzymes.  They also inhibited Wnt/β-catenin pathway in a cell-based reporter assay demonstrating the potential usefulness of the identified new scaffolds for further development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpylPKok8psxrVg90H21EOLACvtfcHk0lgq-TX7GhsXVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFehsr%252FJ&md5=1e163b9b7620e0ff66c9d41915849ad0</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.06.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.06.063%26sid%3Dliteratum%253Aachs%26aulast%3DNkizinkiko%26aufirst%3DY.%26aulast%3DSuneel%2BKumar%26aufirst%3DB.%2BV.%26aulast%3DJeankumar%26aufirst%3DV.%2BU.%26aulast%3DHaikarainen%26aufirst%3DT.%26aulast%3DKoivunen%26aufirst%3DJ.%26aulast%3DMadhuri%26aufirst%3DC.%26aulast%3DYogeeswari%26aufirst%3DP.%26aulast%3DVenkannagari%26aufirst%3DH.%26aulast%3DObaji%26aufirst%3DE.%26aulast%3DPihlajaniemi%26aufirst%3DT.%26aulast%3DSriram%26aufirst%3DD.%26aulast%3DLehtio%26aufirst%3DL.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520selective%2520nonplanar%2520tankyrase%2520inhibiting%2520nicotinamide%2520mimics%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D4139%26epage%3D4149%26doi%3D10.1016%2Fj.bmc.2015.06.063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McGonigle, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolber-Simonds, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ackermann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Twine, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shie, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miu, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moniz, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomoto, K.</span></span> <span> </span><span class="NLM_article-title">E7449: A dual inhibitor of PARP1/2 and tankyrase1/2 inhibits growth of DNA repair deficient tumors and antagonizes Wnt signaling</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">41307</span>– <span class="NLM_lpage">41323</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.5846</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.18632%2Foncotarget.5846" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=26513298" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A280%3ADC%252BC28zmsFajsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=41307-41323&author=S.+McGonigleauthor=Z.+Chenauthor=J.+Wuauthor=P.+Changauthor=D.+Kolber-Simondsauthor=K.+Ackermannauthor=N.+C.+Twineauthor=J.+L.+Shieauthor=J.+T.+Miuauthor=K.+C.+Huangauthor=G.+A.+Monizauthor=K.+Nomoto&title=E7449%3A+A+dual+inhibitor+of+PARP1%2F2+and+tankyrase1%2F2+inhibits+growth+of+DNA+repair+deficient+tumors+and+antagonizes+Wnt+signaling&doi=10.18632%2Foncotarget.5846"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">E7449: A dual inhibitor of PARP1/2 and tankyrase1/2 inhibits growth of DNA repair deficient tumors and antagonizes Wnt signaling</span></div><div class="casAuthors">McGonigle Sharon; Chen Zhihong; Wu Jiayi; Kolber-Simonds Donna; Ackermann Karen; Twine Natalie C; Shie Jue-Lon; Miu Jingzang Tao; Huang Kuan-Chun; Nomoto Kenichi; Chang Paul; Chang Paul; Miu Jingzang Tao; Moniz George A; Moniz George A</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">41307-23</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Inhibition of Poly(ADP-ribose) Polymerase1 (PARP1) impairs DNA damage repair, and early generation PARP1/2 inhibitors (olaparib, niraparib, etc.) have demonstrated clinical proof of concept for cancer treatment.  Here, we describe the development of the novel PARP inhibitor E7449, a potent PARP1/2 inhibitor that also inhibits PARP5a/5b, otherwise known as tankyrase1 and 2 (TNKS1 and 2), important regulators of canonical Wnt/β-catenin signaling.  E7449 inhibits PARP enzymatic activity and additionally traps PARP1 onto damaged DNA; a mechanism previously shown to augment cytotoxicity.  Cells deficient in DNA repair pathways beyond homologous recombination were sensitive to E7449 treatment.  Chemotherapy was potentiated by E7449 and single agent had significant antitumor activity in BRCA-deficient xenografts.  Additionally, E7449 inhibited Wnt/β-catenin signaling in colon cancer cell lines, likely through TNKS inhibition.  Consistent with this possibility, E7449 stabilized axin and TNKS proteins resulting in β-catenin de-stabilization and significantly altered expression of Wnt target genes.  Notably, hair growth mediated by Wnt signaling was inhibited by E7449.  A pharmacodynamic effect of E7449 on Wnt target genes was observed in tumors, although E7449 lacked single agent antitumor activity in vivo, a finding typical for selective TNKS inhibitors.  E7449 antitumor activity was increased through combination with MEK inhibition.  Particularly noteworthy was the lack of toxicity, most significantly the lack of intestinal toxicity reported for other TNKS inhibitors.  E7449 represents a novel dual PARP1/2 and TNKS1/2 inhibitor which has the advantage of targeting Wnt/β-catenin signaling addicted tumors.  E7449 is currently in early clinical development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcScNmr1n8UDWbrIbt-tGZmxfW6udTcc2ebvBpr165wblLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28zmsFajsA%253D%253D&md5=8e0ce94993305253e4b5d76355583498</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.5846&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.5846%26sid%3Dliteratum%253Aachs%26aulast%3DMcGonigle%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DP.%26aulast%3DKolber-Simonds%26aufirst%3DD.%26aulast%3DAckermann%26aufirst%3DK.%26aulast%3DTwine%26aufirst%3DN.%2BC.%26aulast%3DShie%26aufirst%3DJ.%2BL.%26aulast%3DMiu%26aufirst%3DJ.%2BT.%26aulast%3DHuang%26aufirst%3DK.%2BC.%26aulast%3DMoniz%26aufirst%3DG.%2BA.%26aulast%3DNomoto%26aufirst%3DK.%26atitle%3DE7449%253A%2520A%2520dual%2520inhibitor%2520of%2520PARP1%252F2%2520and%2520tankyrase1%252F2%2520inhibits%2520growth%2520of%2520DNA%2520repair%2520deficient%2520tumors%2520and%2520antagonizes%2520Wnt%2520signaling%26jtitle%3DOncotarget%26date%3D2015%26volume%3D6%26spage%3D41307%26epage%3D41323%26doi%3D10.18632%2Foncotarget.5846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paine, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nathubhai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woon, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sunderland, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahon, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lloyd, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haikarainen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narwal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehtio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Threadgill, M. D.</span></span> <span> </span><span class="NLM_article-title">Exploration of the nicotinamide-binding site of the tankyrases, identifying 3-arylisoquinolin-1-ones as potent and selective inhibitors in vitro</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">5891</span>– <span class="NLM_lpage">5908</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.06.061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.1016%2Fj.bmc.2015.06.061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=26189030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFemu7vK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=5891-5908&author=H.+A.+Paineauthor=A.+Nathubhaiauthor=E.+C.+Woonauthor=P.+T.+Sunderlandauthor=P.+J.+Woodauthor=M.+F.+Mahonauthor=M.+D.+Lloydauthor=A.+S.+Thompsonauthor=T.+Haikarainenauthor=M.+Narwalauthor=L.+Lehtioauthor=M.+D.+Threadgill&title=Exploration+of+the+nicotinamide-binding+site+of+the+tankyrases%2C+identifying+3-arylisoquinolin-1-ones+as+potent+and+selective+inhibitors+in+vitro&doi=10.1016%2Fj.bmc.2015.06.061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Exploration of the nicotinamide-binding site of the tankyrases, identifying 3-arylisoquinolin-1-ones as potent and selective inhibitors in vitro</span></div><div class="casAuthors">Paine, Helen A.; Nathubhai, Amit; Woon, Esther C. Y.; Sunderland, Peter T.; Wood, Pauline J.; Mahon, Mary F.; Lloyd, Matthew D.; Thompson, Andrew S.; Haikarainen, Teemu; Narwal, Mohit; Lehtio, Lari; Threadgill, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5891-5908</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Tankyrases-1 and -2 (TNKS-1 and TNKS-2) have three cellular roles which make them important targets in cancer.  Using NAD+ as a substrate, they poly(ADP-ribosyl)ate TRF1 (regulating lengths of telomeres), NuMA (facilitating mitosis) and axin (in wnt/β-catenin signaling).  Using mol. modeling and the structure of the weak inhibitor 5-aminoiso quinolin-1-one, 3-aryl-5-substituted-isoquinolin-1-ones were designed as inhibitors to explore the structure-activity relationships (SARs) for binding and to define the shape of a hydrophobic cavity in the active site.  5-Amino-3-arylisoquinolinones were synthesized by Suzuki-Miyaura coupling of arylboronic acids to 3-bromo-1-methoxy-5-nitro-isoquinoline, redn. and O-demethylation.  3-Aryl-5-methylisoquinolin-1-ones, 3-aryl-5-fluoroisoquinolin-1-ones and 3-aryl-5-methoxyisoquinolin-1-ones were accessed by deprotonation of 3-substituted-N,N,2-trimethylbenzamides and quench with an appropriate benzonitrile.  SAR around the isoquinolinone core showed that aryl was required at the 3-position, optimally with a para-substituent.  Small meta-substituents were tolerated but groups in the ortho-positions reduced or abolished activity.  This was not due to lack of coplanarity of the rings, as shown by the potency of 4,5-dimethyl-3-phenylisoquinolin-1-one.  Me and methoxy were optimal at the 5-position.  SAR was rationalized by modeling and by crystal structures of examples with TNKS-2.  The 3-aryl unit was located in a large hydrophobic cavity and the para-substituents projected into a tunnel leading to the exterior.  Potency against TNKS-1 paralleled potency against TNKS-2.  Most inhibitors were highly selective for TNKSs over PARP-1 and PARP-2.  A range of highly potent and selective inhibitors is now available for cellular studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqorPYvLKQ94bVg90H21EOLACvtfcHk0lgq-TX7GhsXVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFemu7vK&md5=a0c5d0ca6be15f5a565e66ba201d0c57</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.06.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.06.061%26sid%3Dliteratum%253Aachs%26aulast%3DPaine%26aufirst%3DH.%2BA.%26aulast%3DNathubhai%26aufirst%3DA.%26aulast%3DWoon%26aufirst%3DE.%2BC.%26aulast%3DSunderland%26aufirst%3DP.%2BT.%26aulast%3DWood%26aufirst%3DP.%2BJ.%26aulast%3DMahon%26aufirst%3DM.%2BF.%26aulast%3DLloyd%26aufirst%3DM.%2BD.%26aulast%3DThompson%26aufirst%3DA.%2BS.%26aulast%3DHaikarainen%26aufirst%3DT.%26aulast%3DNarwal%26aufirst%3DM.%26aulast%3DLehtio%26aufirst%3DL.%26aulast%3DThreadgill%26aufirst%3DM.%2BD.%26atitle%3DExploration%2520of%2520the%2520nicotinamide-binding%2520site%2520of%2520the%2520tankyrases%252C%2520identifying%25203-arylisoquinolin-1-ones%2520as%2520potent%2520and%2520selective%2520inhibitors%2520in%2520vitro%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D5891%26epage%3D5908%26doi%3D10.1016%2Fj.bmc.2015.06.061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ferri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liscio, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asciutti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sardella, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macchiarulo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camaioni, E.</span></span> <span> </span><span class="NLM_article-title">Targeting Wnt-driven cancers: Discovery of novel tankyrase inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>142</i></span>,  <span class="NLM_fpage">506</span>– <span class="NLM_lpage">522</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.09.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.1016%2Fj.ejmech.2017.09.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=29107427" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslentbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2017&pages=506-522&author=M.+Ferriauthor=P.+Liscioauthor=A.+Carottiauthor=S.+Asciuttiauthor=R.+Sardellaauthor=A.+Macchiaruloauthor=E.+Camaioni&title=Targeting+Wnt-driven+cancers%3A+Discovery+of+novel+tankyrase+inhibitors&doi=10.1016%2Fj.ejmech.2017.09.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Wnt-driven cancers: Discovery of novel tankyrase inhibitors</span></div><div class="casAuthors">Ferri, Martina; Liscio, Paride; Carotti, Andrea; Asciutti, Stefania; Sardella, Roccaldo; Macchiarulo, Antonio; Camaioni, Emidio</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">506-522</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  Recent years have seen substantially heightened interest in the discovery of tankyrase inhibitors (TNKSi) as new promising anticancer agents.  In this framework, the aim of this review article is focused on the description of potent TNKSi also endowed with disruptor activity toward the Wnt/β-catenin signaling pathway.  Beginning with an overview of the most characterized TNKSi deriving from several drug design approaches and classifying them on the basis of the mol. interactions with the target, the authors discuss only those ones acting against Wnt cancer cell lines.  In addn., comprehensive structure property relationships (SPR) emerging from the hit evolution processes and preclin. results are provided.  The authors then review the most promising TNKSi hitherto reported in literature, acting in vivo models of Wnt-driven cancers.  Some out-looks on current issues and future directions in this field are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAs1ycCxVwl7Vg90H21EOLACvtfcHk0lg5pB2rkHoFMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslentbbJ&md5=9b4d843e6bb7ccdea56f9e9c8b70d18c</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.09.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.09.030%26sid%3Dliteratum%253Aachs%26aulast%3DFerri%26aufirst%3DM.%26aulast%3DLiscio%26aufirst%3DP.%26aulast%3DCarotti%26aufirst%3DA.%26aulast%3DAsciutti%26aufirst%3DS.%26aulast%3DSardella%26aufirst%3DR.%26aulast%3DMacchiarulo%26aufirst%3DA.%26aulast%3DCamaioni%26aufirst%3DE.%26atitle%3DTargeting%2520Wnt-driven%2520cancers%253A%2520Discovery%2520of%2520novel%2520tankyrase%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D142%26spage%3D506%26epage%3D522%26doi%3D10.1016%2Fj.ejmech.2017.09.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mizutani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yashiroda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muramatsu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chikada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsumura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirai, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukami, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seimiya, H.</span></span> <span> </span><span class="NLM_article-title">RK-287107, a potent and specific tankyrase inhibitor, blocks colorectal cancer cell growth in a preclinical model</span>. <i>Cancer Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">4003</span>– <span class="NLM_lpage">4014</span>, <span class="refDoi"> DOI: 10.1111/cas.13805</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.1111%2Fcas.13805" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=30238564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFKju7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2018&pages=4003-4014&author=A.+Mizutaniauthor=Y.+Yashirodaauthor=Y.+Muramatsuauthor=H.+Yoshidaauthor=T.+Chikadaauthor=T.+Tsumuraauthor=M.+Okueauthor=F.+Shiraiauthor=T.+Fukamiauthor=M.+Yoshidaauthor=H.+Seimiya&title=RK-287107%2C+a+potent+and+specific+tankyrase+inhibitor%2C+blocks+colorectal+cancer+cell+growth+in+a+preclinical+model&doi=10.1111%2Fcas.13805"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">RK-287107, a potent and specific tankyrase inhibitor, blocks colorectal cancer cell growth in a preclinical model</span></div><div class="casAuthors">Mizutani, Anna; Yashiroda, Yoko; Muramatsu, Yukiko; Yoshida, Haruka; Chikada, Tsubasa; Tsumura, Takeshi; Okue, Masayuki; Shirai, Fumiyuki; Fukami, Takehiro; Yoshida, Minoru; Seimiya, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4003-4014</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1349-7006</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Tankyrase poly(ADP-ribosyl)ates (PARylates) Axin, a neg. regulator of β-catenin.  This post-translational modification causes ubiquitin-dependent degrdn. of Axin, resulting in β-catenin accumulation.  Tankyrase inhibitors downregulate β-catenin and suppress the growth of APC-mutated colorectal cancer cells.  Herein, we report a novel tankyrase-specific inhibitor RK-287107, which inhibits tankyrase-1 and -2 four- and eight-fold more potently, resp., than G007-LK, a tankyrase inhibitor that has been previously reported as effective in mouse xenograft models.  RK-287107 causes Axin2 accumulation and downregulates β-catenin, T-cell factor/lymphoid enhancer factor reporter activity and the target gene expression in colorectal cancer cells harboring the shortly truncated APC mutations.  Consistently, RK-287107 inhibits the growth of APC-mutated (β-catenin-dependent) colorectal cancer COLO-320DM and SW403 cells but not the APC-wild (β-catenin-independent) colorectal cancer RKO cells.  I.p. or oral administration of RK-287107 suppresses COLO-320DM tumor growth in NOD-SCID mice.  Rates of tumor growth inhibition showed good correlation with the behavior of pharmacodynamic biomarkers, such as Axin2 accumulation and MYC downregulation.  These observations indicate that RK-287107 exerts a proof-of-concept antitumor effect, and thus may have potential for tankyrase-directed mol. cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7zgbenLgRqbVg90H21EOLACvtfcHk0lg5pB2rkHoFMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFKju7zI&md5=4e7bae4fa3689bd43abe0ea399024686</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1111%2Fcas.13805&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcas.13805%26sid%3Dliteratum%253Aachs%26aulast%3DMizutani%26aufirst%3DA.%26aulast%3DYashiroda%26aufirst%3DY.%26aulast%3DMuramatsu%26aufirst%3DY.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DChikada%26aufirst%3DT.%26aulast%3DTsumura%26aufirst%3DT.%26aulast%3DOkue%26aufirst%3DM.%26aulast%3DShirai%26aufirst%3DF.%26aulast%3DFukami%26aufirst%3DT.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DSeimiya%26aufirst%3DH.%26atitle%3DRK-287107%252C%2520a%2520potent%2520and%2520specific%2520tankyrase%2520inhibitor%252C%2520blocks%2520colorectal%2520cancer%2520cell%2520growth%2520in%2520a%2520preclinical%2520model%26jtitle%3DCancer%2520Sci.%26date%3D2018%26volume%3D109%26spage%3D4003%26epage%3D4014%26doi%3D10.1111%2Fcas.13805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buchstaller, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anlauf, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorsch, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leuthner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musil, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radtki, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritzert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohdich, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esdar, C.</span></span> <span> </span><span class="NLM_article-title">Discovery and optimization of 2-arylquinazolin-4-ones into a potent and selective tankyrase inhibitor modulating Wnt pathway activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">7897</span>– <span class="NLM_lpage">7909</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00656</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00656" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFWms7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=7897-7909&author=H.+P.+Buchstallerauthor=U.+Anlaufauthor=D.+Dorschauthor=D.+Kuhnauthor=M.+Lehmannauthor=B.+Leuthnerauthor=D.+Musilauthor=D.+Radtkiauthor=C.+Ritzertauthor=F.+Rohdichauthor=R.+Schneiderauthor=C.+Esdar&title=Discovery+and+optimization+of+2-arylquinazolin-4-ones+into+a+potent+and+selective+tankyrase+inhibitor+modulating+Wnt+pathway+activity&doi=10.1021%2Facs.jmedchem.9b00656"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Optimization of 2-Arylquinazolin-4-ones into a Potent and Selective Tankyrase Inhibitor Modulating Wnt Pathway Activity</span></div><div class="casAuthors">Buchstaller, Hans-Peter; Anlauf, Uwe; Dorsch, Dieter; Kuhn, Daniel; Lehmann, Martin; Leuthner, Birgitta; Musil, Djordje; Radtki, Daniela; Ritzert, Claudio; Rohdich, Felix; Schneider, Richard; Esdar, Christina</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7897-7909</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tankyrases 1 and 2 (TNKS1/2) are promising pharmacol. targets which recently gained interest for anticancer therapy in Wnt pathway dependent tumors.  2-Aryl-quinazolinones were identified and optimized into potent tankyrase inhibitors through SAR exploration around the quinazolinone core and the 4'-position of the Ph residue.  These efforts were supported by anal. of TNKS X-ray and Watermap structures and resulted in compd. 5k(I), a potent, selective tankyrase inhibitor with favorable pharmacokinetic properties.  The X-ray structure of I in complex with TNKS1 was solved and confirmed the design hypothesis.  Modulation of Wnt pathway activity was demonstrated with this compd. in a colorectal xenograft model in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrl6p_xrETB-bVg90H21EOLACvtfcHk0lg5pB2rkHoFMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFWms7bI&md5=7fcc6c91c6e614482386af2094675837</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00656%26sid%3Dliteratum%253Aachs%26aulast%3DBuchstaller%26aufirst%3DH.%2BP.%26aulast%3DAnlauf%26aufirst%3DU.%26aulast%3DDorsch%26aufirst%3DD.%26aulast%3DKuhn%26aufirst%3DD.%26aulast%3DLehmann%26aufirst%3DM.%26aulast%3DLeuthner%26aufirst%3DB.%26aulast%3DMusil%26aufirst%3DD.%26aulast%3DRadtki%26aufirst%3DD.%26aulast%3DRitzert%26aufirst%3DC.%26aulast%3DRohdich%26aufirst%3DF.%26aulast%3DSchneider%26aufirst%3DR.%26aulast%3DEsdar%26aufirst%3DC.%26atitle%3DDiscovery%2520and%2520optimization%2520of%25202-arylquinazolin-4-ones%2520into%2520a%2520potent%2520and%2520selective%2520tankyrase%2520inhibitor%2520modulating%2520Wnt%2520pathway%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D7897%26epage%3D7909%26doi%3D10.1021%2Facs.jmedchem.9b00656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nathubhai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haikarainen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koivunen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murthy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koumanov, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lloyd, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holman, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pihlajaniemi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tosh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehtio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Threadgill, M. D.</span></span> <span> </span><span class="NLM_article-title">Highly potent and isoform selective dual site binding tankyrase/Wnt signaling inhibitors that increase cellular glucose uptake and have antiproliferative activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">814</span>– <span class="NLM_lpage">820</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01574</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01574" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFSgu77O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=814-820&author=A.+Nathubhaiauthor=T.+Haikarainenauthor=J.+Koivunenauthor=S.+Murthyauthor=F.+Koumanovauthor=M.+D.+Lloydauthor=G.+D.+Holmanauthor=T.+Pihlajaniemiauthor=D.+Toshauthor=L.+Lehtioauthor=M.+D.+Threadgill&title=Highly+potent+and+isoform+selective+dual+site+binding+tankyrase%2FWnt+signaling+inhibitors+that+increase+cellular+glucose+uptake+and+have+antiproliferative+activity&doi=10.1021%2Facs.jmedchem.6b01574"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Highly Potent and Isoform Selective Dual Site Binding Tankyrase/Wnt Signaling Inhibitors That Increase Cellular Glucose Uptake and Have Antiproliferative Activity</span></div><div class="casAuthors">Nathubhai, Amit; Haikarainen, Teemu; Koivunen, Jarkko; Murthy, Sudarshan; Koumanov, Francoise; Lloyd, Matthew D.; Holman, Geoffrey D.; Pihlajaniemi, Taina; Tosh, David; Lehtio, Lari; Threadgill, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">814-820</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Compds. 13 and 14 were evaluated against eleven PARP isoforms to reveal that both 13 and 14 were more potent and isoform-selective towards inhibiting tankyrases (TNKSs) than the "std." inhibitor 1 (XAV939)5, i.e. IC50 = 100 pM vs. TNKS2 and IC50 = 6.5 μM vs. PARP1 for 14.  In cellular assays, 13 and 14 inhibited Wnt-signaling, enhanced insulin-stimulated glucose uptake and inhibited the proliferation of DLD-1 colorectal adenocarcinoma cells to a greater extent than 1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeH2cfPlBFBLVg90H21EOLACvtfcHk0ljlIUPs7i4zzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFSgu77O&md5=2eb1a9ae15a5b9402b730e67f1ba3d79</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01574%26sid%3Dliteratum%253Aachs%26aulast%3DNathubhai%26aufirst%3DA.%26aulast%3DHaikarainen%26aufirst%3DT.%26aulast%3DKoivunen%26aufirst%3DJ.%26aulast%3DMurthy%26aufirst%3DS.%26aulast%3DKoumanov%26aufirst%3DF.%26aulast%3DLloyd%26aufirst%3DM.%2BD.%26aulast%3DHolman%26aufirst%3DG.%2BD.%26aulast%3DPihlajaniemi%26aufirst%3DT.%26aulast%3DTosh%26aufirst%3DD.%26aulast%3DLehtio%26aufirst%3DL.%26aulast%3DThreadgill%26aufirst%3DM.%2BD.%26atitle%3DHighly%2520potent%2520and%2520isoform%2520selective%2520dual%2520site%2520binding%2520tankyrase%252FWnt%2520signaling%2520inhibitors%2520that%2520increase%2520cellular%2520glucose%2520uptake%2520and%2520have%2520antiproliferative%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D814%26epage%3D820%26doi%3D10.1021%2Facs.jmedchem.6b01574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez-Vega, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mina, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armenia, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatila, W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luna, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimitriadoy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kantheti, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saghafinia, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakravarty, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daian, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foltz, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shmulevich, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heins, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochoa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gross, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kundra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kandoth, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bahceci, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dervishi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dogrusoz, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laird, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Way, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greene, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iavarone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bivona, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazar, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammer, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giordano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwong, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McArthur, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tward, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frederick, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCormick, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyerson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Allen, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherniack, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciriello, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sander, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, N.</span></span> <span> </span><span class="NLM_article-title">Oncogenic signaling pathways in the cancer genome atlas</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>173</i></span>,  <span class="NLM_fpage">321</span>– <span class="NLM_lpage">337</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2018.03.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.1016%2Fj.cell.2018.03.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=29625050" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC1cXntFahsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=2018&pages=321-337&author=F.+Sanchez-Vegaauthor=M.+Minaauthor=J.+Armeniaauthor=W.+K.+Chatilaauthor=A.+Lunaauthor=K.+C.+Laauthor=S.+Dimitriadoyauthor=D.+L.+Liuauthor=H.+S.+Kanthetiauthor=S.+Saghafiniaauthor=D.+Chakravartyauthor=F.+Daianauthor=Q.+Gaoauthor=M.+H.+Baileyauthor=W.+W.+Liangauthor=S.+M.+Foltzauthor=I.+Shmulevichauthor=L.+Dingauthor=Z.+Heinsauthor=A.+Ochoaauthor=B.+Grossauthor=J.+Gaoauthor=H.+Zhangauthor=R.+Kundraauthor=C.+Kandothauthor=I.+Bahceciauthor=L.+Dervishiauthor=U.+Dogrusozauthor=W.+Zhouauthor=H.+Shenauthor=P.+W.+Lairdauthor=G.+P.+Wayauthor=C.+S.+Greeneauthor=H.+Liangauthor=Y.+Xiaoauthor=C.+Wangauthor=A.+Iavaroneauthor=A.+H.+Bergerauthor=T.+G.+Bivonaauthor=A.+J.+Lazarauthor=G.+D.+Hammerauthor=T.+Giordanoauthor=L.+N.+Kwongauthor=G.+McArthurauthor=C.+Huangauthor=A.+D.+Twardauthor=M.+J.+Frederickauthor=F.+McCormickauthor=M.+Meyersonauthor=E.+M.+Van+Allenauthor=A.+D.+Cherniackauthor=G.+Cirielloauthor=C.+Sanderauthor=N.+Schultz&title=Oncogenic+signaling+pathways+in+the+cancer+genome+atlas&doi=10.1016%2Fj.cell.2018.03.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Oncogenic signaling pathways in the cancer genome atlas</span></div><div class="casAuthors">Sanchez-Vega, Francisco; Mina, Marco; Armenia, Joshua; Chatila, Walid K.; Luna, Augustin; La, Konnor C.; Dimitriadoy, Sofia; Liu, David L.; Kantheti, Havish S.; Saghafinia, Sadegh; Chakravarty, Debyani; Daian, Foysal; Gao, Qingsong; Bailey, Matthew H.; Liang, Wen-Wei; Foltz, Steven M.; Shmulevich, Ilya; Ding, Li; Heins, Zachary; Ochoa, Angelica; Gross, Benjamin; Gao, Jianjiong; Zhang, Hongxin; Kundra, Ritika; Kandoth, Cyriac; Bahceci, Istemi; Dervishi, Leonard; Dogrusoz, Ugur; Zhou, Wanding; Shen, Hui; Laird, Peter W.; Way, Gregory P.; Greene, Casey S.; Liang, Han; Xiao, Yonghong; Wang, Chen; Iavarone, Antonio; Berger, Alice H.; Bivona, Trever G.; Lazar, Alexander J.; Hammer, Gary D.; Giordano, Thomas; Kwong, Lawrence N.; McArthur, Grant; Huang, Chenfei; Tward, Aaron D.; Frederick, Mitchell J.; McCormick, Frank; Meyerson, Matthew; Van Allen, Eliezer M.; Cherniack, Andrew D.; Ciriello, Giovanni; Sander, Chris; Schultz, Nikolaus</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">173</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">321-337.e10</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Genetic alterations in signaling pathways that control cell-cycle progression, apoptosis, and cell growth are common hallmarks of cancer, but the extent, mechanisms, and co-occurrence of alterations in these pathways differ between individual tumors and tumor types.  Using mutations, copy-no. changes, mRNA expression, gene fusions and DNA methylation in 9125 tumors profiled by The Cancer Genome Atlas (TCGA), we analyzed the mechanisms and patterns of somatic alterations in ten canonical pathways: cell cycle, Hippo, Myc, Notch, Nrf2, PI-3-Kinase/Akt, RTK-RAS, TGFβ signaling, p53 and β-catenin/Wnt.  We charted the detailed landscape of pathway alterations in 33 cancer types, stratified into 64 subtypes, and identified patterns of co-occurrence and mutual exclusivity.  Eighty-nine percent of tumors had at least one driver alteration in these pathways, and 57% percent of tumors had at least one alteration potentially targetable by currently available drugs.  Thirty percent of tumors had multiple targetable alterations, indicating opportunities for combination therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqv_ggbxuypEbVg90H21EOLACvtfcHk0ljlIUPs7i4zzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXntFahsrs%253D&md5=3677d3a77b12767c828f48eb80d71141</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2018.03.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2018.03.035%26sid%3Dliteratum%253Aachs%26aulast%3DSanchez-Vega%26aufirst%3DF.%26aulast%3DMina%26aufirst%3DM.%26aulast%3DArmenia%26aufirst%3DJ.%26aulast%3DChatila%26aufirst%3DW.%2BK.%26aulast%3DLuna%26aufirst%3DA.%26aulast%3DLa%26aufirst%3DK.%2BC.%26aulast%3DDimitriadoy%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DD.%2BL.%26aulast%3DKantheti%26aufirst%3DH.%2BS.%26aulast%3DSaghafinia%26aufirst%3DS.%26aulast%3DChakravarty%26aufirst%3DD.%26aulast%3DDaian%26aufirst%3DF.%26aulast%3DGao%26aufirst%3DQ.%26aulast%3DBailey%26aufirst%3DM.%2BH.%26aulast%3DLiang%26aufirst%3DW.%2BW.%26aulast%3DFoltz%26aufirst%3DS.%2BM.%26aulast%3DShmulevich%26aufirst%3DI.%26aulast%3DDing%26aufirst%3DL.%26aulast%3DHeins%26aufirst%3DZ.%26aulast%3DOchoa%26aufirst%3DA.%26aulast%3DGross%26aufirst%3DB.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DKundra%26aufirst%3DR.%26aulast%3DKandoth%26aufirst%3DC.%26aulast%3DBahceci%26aufirst%3DI.%26aulast%3DDervishi%26aufirst%3DL.%26aulast%3DDogrusoz%26aufirst%3DU.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DShen%26aufirst%3DH.%26aulast%3DLaird%26aufirst%3DP.%2BW.%26aulast%3DWay%26aufirst%3DG.%2BP.%26aulast%3DGreene%26aufirst%3DC.%2BS.%26aulast%3DLiang%26aufirst%3DH.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DIavarone%26aufirst%3DA.%26aulast%3DBerger%26aufirst%3DA.%2BH.%26aulast%3DBivona%26aufirst%3DT.%2BG.%26aulast%3DLazar%26aufirst%3DA.%2BJ.%26aulast%3DHammer%26aufirst%3DG.%2BD.%26aulast%3DGiordano%26aufirst%3DT.%26aulast%3DKwong%26aufirst%3DL.%2BN.%26aulast%3DMcArthur%26aufirst%3DG.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DTward%26aufirst%3DA.%2BD.%26aulast%3DFrederick%26aufirst%3DM.%2BJ.%26aulast%3DMcCormick%26aufirst%3DF.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DVan%2BAllen%26aufirst%3DE.%2BM.%26aulast%3DCherniack%26aufirst%3DA.%2BD.%26aulast%3DCiriello%26aufirst%3DG.%26aulast%3DSander%26aufirst%3DC.%26aulast%3DSchultz%26aufirst%3DN.%26atitle%3DOncogenic%2520signaling%2520pathways%2520in%2520the%2520cancer%2520genome%2520atlas%26jtitle%3DCell%26date%3D2018%26volume%3D173%26spage%3D321%26epage%3D337%26doi%3D10.1016%2Fj.cell.2018.03.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nusse, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clevers, H.</span></span> <span> </span><span class="NLM_article-title">Wnt/beta-catenin signaling, disease, and emerging therapeutic modalities</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>169</i></span>,  <span class="NLM_fpage">985</span>– <span class="NLM_lpage">999</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2017.05.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.1016%2Fj.cell.2017.05.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=28575679" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpt1agsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2017&pages=985-999&author=R.+Nusseauthor=H.+Clevers&title=Wnt%2Fbeta-catenin+signaling%2C+disease%2C+and+emerging+therapeutic+modalities&doi=10.1016%2Fj.cell.2017.05.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Wnt/β-catenin signaling, disease, and emerging therapeutic modalities</span></div><div class="casAuthors">Nusse, Roel; Clevers, Hans</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">985-999</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The WNT signal transduction cascade is a main regulator of development throughout the animal kingdom.  Wnts are also key drivers of most types of tissue stem cells in adult mammals.  Unsurprisingly, mutated Wnt pathway components are causative to multiple growth-related pathologies and to cancer.  Here, we describe the core Wnt/β-catenin signaling pathway, how it controls stem cells, and contributes to disease.  Finally, we discuss strategies for Wnt-based therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnL11nCbSs8LVg90H21EOLACvtfcHk0liO8cHdArFhPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpt1agsro%253D&md5=869cc558296677481527ac138f68fbb0</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2017.05.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2017.05.016%26sid%3Dliteratum%253Aachs%26aulast%3DNusse%26aufirst%3DR.%26aulast%3DClevers%26aufirst%3DH.%26atitle%3DWnt%252Fbeta-catenin%2520signaling%252C%2520disease%252C%2520and%2520emerging%2520therapeutic%2520modalities%26jtitle%3DCell%26date%3D2017%26volume%3D169%26spage%3D985%26epage%3D999%26doi%3D10.1016%2Fj.cell.2017.05.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krishnamurthy, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurzrock, R.</span></span> <span> </span><span class="NLM_article-title">Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors</span>. <i>Cancer Treat. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">50</span>– <span class="NLM_lpage">60</span>, <span class="refDoi"> DOI: 10.1016/j.ctrv.2017.11.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.1016%2Fj.ctrv.2017.11.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=29169144" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvValtbnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2018&pages=50-60&author=N.+Krishnamurthyauthor=R.+Kurzrock&title=Targeting+the+Wnt%2Fbeta-catenin+pathway+in+cancer%3A+Update+on+effectors+and+inhibitors&doi=10.1016%2Fj.ctrv.2017.11.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors</span></div><div class="casAuthors">Krishnamurthy, Nithya; Kurzrock, Razelle</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Treatment Reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">50-60</span>CODEN:
                <span class="NLM_cas:coden">CTREDJ</span>;
        ISSN:<span class="NLM_cas:issn">0305-7372</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The Wnt/beta-catenin pathway is a family of proteins that is implicated in many vital cellular functions like stem cell regeneration and organogenesis.  Several intra-cellular signal transduction pathways are induced by Wnt, notably the Wnt/beta-catenin dependent pathway or canonical pathway and the non-canonical or beta-catenin-independent pathway, the latter includes the Wnt/Ca2+ and Planar Cell Polarity pathway (PCP).  Wnt activation occurs at the intestinal crypt floor, and is crit. to optimal maintenance of stem cells.  Colorectal cancers show evidence of Wnt signaling pathway activation and this is assocd. with loss of function of the tumor regulator APC.  Wnt activation has been obsd. in breast, lung, and hematopoietic malignancies and contributes to tumor recurrence.  The Wnt pathway cross talks with the Notch and Sonic Hedgehog pathways, which has implications for therapeutic interventions in cancers.  There are significant challenges in targeting the Wnt pathway, including finding agents that are efficacious without damaging the system of normal somatic stem cell function in cellular repair and tissue homeostasis.  Here, we comprehensively review the Wnt pathway and its interactions with the Notch and Sonic Hedgehog pathways.  We present the state of the field in effectors and inhibitors of Wnt signaling, including updates on clin. trials in various cancers with inhibitors of Wnt, Notch, and Sonic Hedgehog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqHbcA6nGH3rVg90H21EOLACvtfcHk0liO8cHdArFhPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvValtbnF&md5=1a46da27b4932cbd31695e004a48b3c2</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.ctrv.2017.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ctrv.2017.11.002%26sid%3Dliteratum%253Aachs%26aulast%3DKrishnamurthy%26aufirst%3DN.%26aulast%3DKurzrock%26aufirst%3DR.%26atitle%3DTargeting%2520the%2520Wnt%252Fbeta-catenin%2520pathway%2520in%2520cancer%253A%2520Update%2520on%2520effectors%2520and%2520inhibitors%26jtitle%3DCancer%2520Treat.%2520Rev.%26date%3D2018%26volume%3D62%26spage%3D50%26epage%3D60%26doi%3D10.1016%2Fj.ctrv.2017.11.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lau, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callow, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waaler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boggs, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blake, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnuson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sambrone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schutten, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Firestein, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machon, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korinek, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merchant, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polakis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holsworth, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauss, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, M.</span></span> <span> </span><span class="NLM_article-title">A Novel Tankyrase small-molecule inhibitor suppresses APC mutation-driven colorectal tumor growth</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">3132</span>– <span class="NLM_lpage">3144</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-12-4562</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.1158%2F0008-5472.CAN-12-4562" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=23539443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsFejsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=3132-3144&author=T.+Lauauthor=E.+Chanauthor=M.+Callowauthor=J.+Waalerauthor=J.+Boggsauthor=R.+A.+Blakeauthor=S.+Magnusonauthor=A.+Sambroneauthor=M.+Schuttenauthor=R.+Firesteinauthor=O.+Machonauthor=V.+Korinekauthor=E.+Chooauthor=D.+Diazauthor=M.+Merchantauthor=P.+Polakisauthor=D.+D.+Holsworthauthor=S.+Kraussauthor=M.+Costa&title=A+Novel+Tankyrase+small-molecule+inhibitor+suppresses+APC+mutation-driven+colorectal+tumor+growth&doi=10.1158%2F0008-5472.CAN-12-4562"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Tankyrase Small-Molecule Inhibitor Suppresses APC Mutation-Driven Colorectal Tumor Growth</span></div><div class="casAuthors">Lau, Ted; Chan, Emily; Callow, Marinella; Waaler, Jo; Boggs, Jason; Blake, Robert A.; Magnuson, Steven; Sambrone, Amy; Schutten, Melissa; Firestein, Ron; Machon, Ondrej; Korinek, Vladimir; Choo, Edna; Diaz, Dolores; Merchant, Mark; Polakis, Paul; Holsworth, Daniel D.; Krauss, Stefan; Costa, Mike</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3132-3144</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Most colorectal cancers (CRC) are initiated by mutations of APC, leading to increased β-catenin-mediated signaling.  However, continued requirement of Wnt/P-catenin signaling for tumor progression in the context of acquired KRAS and other mutations is less well-established.  To attenuate Wnt/β-catenin signaling in tumors, we have developed potent and specific small-mol. tankyrase inhibitors, G007-LK and G244-LM, that reduce Wnt./p-catenin signaling by preventing poly(ADP-ribosyl)ation-dependent AXIN degrdn., thereby promoting β-catenin destabilization.  We show that novel tankyrase inhibitors completely block ligand-driven Wnt/β-catenin signaling in cell culture and display approx. 50% inhibition of APC mutation-driven signaling in most CRC cell lines.  It was previously unknown whether the level of AXIN protein stabilization by tankyrase inhibition is sufficient to impact tumor growth in the absence of normal APC activity.  Compd. G007-LK displays favorable pharmacokinetic properties and inhibits in vivo tumor growth in a subset of APC-mutant CRC xenograft models.  In the xenograft model most sensitive to tankyrase inhibitor, COLO-320DM, G007-LK inhibits cell-cycle progression, reduces colony formation, and induces differentiation, suggesting that β-catenin-dependent maintenance of an undifferentiated state may be blocked by tankyrase inhibition.  The full potential of the antitumor activity of G007-LK may be limited by intestinal toxicity assocd. with inhibition of Wnt/β-catenin signaling and cell proliferation in intestinal crypts.  These results establish proof-of-concept antitumor efficacy for tankyrase inhibitors in APC-mutant CRC models and uncover potential diagnostic and safety concerns to be overcome as tankyrase inhibitors are advanced into the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbDZ01XGjOaLVg90H21EOLACvtfcHk0lioO5U0ItqfRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsFejsbo%253D&md5=9f1d7b05b92ba8df593ccca9e7ea2cdf</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-12-4562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-12-4562%26sid%3Dliteratum%253Aachs%26aulast%3DLau%26aufirst%3DT.%26aulast%3DChan%26aufirst%3DE.%26aulast%3DCallow%26aufirst%3DM.%26aulast%3DWaaler%26aufirst%3DJ.%26aulast%3DBoggs%26aufirst%3DJ.%26aulast%3DBlake%26aufirst%3DR.%2BA.%26aulast%3DMagnuson%26aufirst%3DS.%26aulast%3DSambrone%26aufirst%3DA.%26aulast%3DSchutten%26aufirst%3DM.%26aulast%3DFirestein%26aufirst%3DR.%26aulast%3DMachon%26aufirst%3DO.%26aulast%3DKorinek%26aufirst%3DV.%26aulast%3DChoo%26aufirst%3DE.%26aulast%3DDiaz%26aufirst%3DD.%26aulast%3DMerchant%26aufirst%3DM.%26aulast%3DPolakis%26aufirst%3DP.%26aulast%3DHolsworth%26aufirst%3DD.%2BD.%26aulast%3DKrauss%26aufirst%3DS.%26aulast%3DCosta%26aufirst%3DM.%26atitle%3DA%2520Novel%2520Tankyrase%2520small-molecule%2520inhibitor%2520suppresses%2520APC%2520mutation-driven%2520colorectal%2520tumor%2520growth%26jtitle%3DCancer%2520Res.%26date%3D2013%26volume%3D73%26spage%3D3132%26epage%3D3144%26doi%3D10.1158%2F0008-5472.CAN-12-4562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martins-Neves, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paiva-Oliveira, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fontes-Ribeiro, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bovee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cleton-Jansen, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomes, C. M. F.</span></span> <span> </span><span class="NLM_article-title">IWR-1, a tankyrase inhibitor, attenuates Wnt/beta-catenin signaling in cancer stem-like cells and inhibits in vivo the growth of a subcutaneous human osteosarcoma xenograft</span>. <i>Cancer Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>414</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">15</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2017.11.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.1016%2Fj.canlet.2017.11.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=29126913" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVSiu7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=414&publication_year=2018&pages=1-15&author=S.+R.+Martins-Nevesauthor=D.+I.+Paiva-Oliveiraauthor=C.+Fontes-Ribeiroauthor=J.+Boveeauthor=A.+M.+Cleton-Jansenauthor=C.+M.+F.+Gomes&title=IWR-1%2C+a+tankyrase+inhibitor%2C+attenuates+Wnt%2Fbeta-catenin+signaling+in+cancer+stem-like+cells+and+inhibits+in+vivo+the+growth+of+a+subcutaneous+human+osteosarcoma+xenograft&doi=10.1016%2Fj.canlet.2017.11.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">IWR-1, a tankyrase inhibitor, attenuates Wnt/β-catenin signaling in cancer stem-like cells and inhibits in vivo the growth of a subcutaneous human osteosarcoma xenograft</span></div><div class="casAuthors">Martins-Neves, Sara R.; Paiva-Oliveira, Daniela I.; Fontes-Ribeiro, Carlos; Bovee, Judith V. M. G.; Cleton-Jansen, Anne-Marie; Gomes, Celia M. F.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">414</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-15</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Wnt/β-catenin or canonical Wnt signaling pathway regulates the self-renewal of cancer stem-like cells (CSCs) and is involved in tumor progression and chemotherapy resistance.  Previously, we reported that this pathway is activated in a subset of osteosarcoma CSCs and that doxorubicin induced stemness properties in differentiated cells through Wnt/β-catenin activation.  Here, we investigated whether pharmacol. Wnt/β-catenin inhibition, using a tankyrase inhibitor (IWR-1), might constitute a strategy to target CSCs and improve chemotherapy efficacy in osteosarcoma.  IWR-1 was specifically cytotoxic for osteosarcoma CSCs.  IWR-1 impaired spheres' self-renewal capacity by compromising landmark steps of the canonical Wnt signaling, namely translocation of β-catenin to the nucleus and subsequent TCF/LEF activation and expression of Wnt/β-catenin downstream targets.  IWR-1 also hampered the activity and expression of key stemness-related markers.  In vitro, IWR-1 induced apoptosis of osteosarcoma spheres and combined with doxorubicin elicited synergistic cytotoxicity, reversing spheres' resistance to this drug.  In vivo, IWR-1 co-administration with doxorubicin substantially decreased tumor progression, assocd. with specific down-regulation of TCF/LEF transcriptional activity, nuclear β-catenin and expression of the putative CSC marker Sox2.  We suggest that targeting the Wnt/β-catenin pathway can eliminate CSCs populations in osteosarcoma.  Combining conventional chemotherapy with Wnt/β-catenin inhibition may ameliorate therapeutic outcomes, by eradicating the aggressive osteosarcoma CSCs and reducing drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocG-gCNsSkwbVg90H21EOLACvtfcHk0lioO5U0ItqfRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVSiu7fK&md5=c3aa5ed1a5fa31daa1d180ed72394202</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2017.11.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2017.11.004%26sid%3Dliteratum%253Aachs%26aulast%3DMartins-Neves%26aufirst%3DS.%2BR.%26aulast%3DPaiva-Oliveira%26aufirst%3DD.%2BI.%26aulast%3DFontes-Ribeiro%26aufirst%3DC.%26aulast%3DBovee%26aufirst%3DJ.%26aulast%3DCleton-Jansen%26aufirst%3DA.%2BM.%26aulast%3DGomes%26aufirst%3DC.%2BM.%2BF.%26atitle%3DIWR-1%252C%2520a%2520tankyrase%2520inhibitor%252C%2520attenuates%2520Wnt%252Fbeta-catenin%2520signaling%2520in%2520cancer%2520stem-like%2520cells%2520and%2520inhibits%2520in%2520vivo%2520the%2520growth%2520of%2520a%2520subcutaneous%2520human%2520osteosarcoma%2520xenograft%26jtitle%3DCancer%2520Lett.%26date%3D2018%26volume%3D414%26spage%3D1%26epage%3D15%26doi%3D10.1016%2Fj.canlet.2017.11.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Solberg, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waaler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lund, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mygland, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauss, S.</span></span> <span> </span><span class="NLM_article-title">Tankyrase inhibition enhances the antiproliferative effect of PI3K and EGFR inhibition, mutually affecting beta-catenin and AKT signaling in colorectal cancer</span>. <i>Mol. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">543</span>– <span class="NLM_lpage">553</span>, <span class="refDoi"> DOI: 10.1158/1541-7786.MCR-17-0362</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.1158%2F1541-7786.MCR-17-0362" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=29222171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjslKrsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2018&pages=543-553&author=N.+T.+Solbergauthor=J.+Waalerauthor=K.+Lundauthor=L.+Myglandauthor=P.+A.+Olsenauthor=S.+Krauss&title=Tankyrase+inhibition+enhances+the+antiproliferative+effect+of+PI3K+and+EGFR+inhibition%2C+mutually+affecting+beta-catenin+and+AKT+signaling+in+colorectal+cancer&doi=10.1158%2F1541-7786.MCR-17-0362"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">TANKYRASE Inhibition Enhances the Antiproliferative Effect of PI3K and EGFR Inhibition, Mutually Affecting β-CATENIN and AKT Signaling in Colorectal Cancer</span></div><div class="casAuthors">Solberg, Nina T.; Waaler, Jo; Lund, Kaja; Mygland, Line; Olsen, Petter A.; Krauss, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">543-553</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Overactivation of the WNT/β-CATENIN signaling axis is a common denominator in colorectal cancer.  Currently, there is no available WNT inhibitor in clin. practice.  Although TANKYRASE (TNKS) inhibitors have been proposed as promising candidates, there are many colorectal cancer models that do not respond pos. to TNKS inhibition in vitro and in vivo.  Therefore, a combinatorial therapeutic approach combining a TNKS inhibitor (G007-LK) with PI3K (BKM120) and EGFR (erlotinib) inhibitors in colorectal cancer was investigated.  The data demonstrate that TNKS inhibition enhances the effect of PI3K and EGFR inhibition in the TNKS inhibitor-sensitive COLO320DM, and in the nonsensitive HCT-15 cell line.  In both cell lines, combined TNKS/PI3K/EGFR inhibition is more effective at reducing growth than a dual TNKS/MEK inhibition.  TNKS/PI3K/EGFR inhibition affected in a context-dependent manner components of the WNT/β-CATENIN, AKT/mTOR, EGFR, and RAS signaling pathways.  TNKS/PI3K/EGFR inhibition also efficiently reduced growth of both COLO320DM and HCT-15 tumor xenografts in vivo.  At the highest doses, tumor xenograft growth was halted without affecting the body wt. of the tested animals.  Implications: Combining TNKS inhibitors with PI3K and EGFR inhibition may expand the therapeutic arsenal against colorectal cancers.  Mol Cancer Res; 16(3); 543-53. ©2017 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7Sw_hfRxRmLVg90H21EOLACvtfcHk0lioO5U0ItqfRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjslKrsLw%253D&md5=bef581a05e452a6ea13d79b66dc65470</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1158%2F1541-7786.MCR-17-0362&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1541-7786.MCR-17-0362%26sid%3Dliteratum%253Aachs%26aulast%3DSolberg%26aufirst%3DN.%2BT.%26aulast%3DWaaler%26aufirst%3DJ.%26aulast%3DLund%26aufirst%3DK.%26aulast%3DMygland%26aufirst%3DL.%26aulast%3DOlsen%26aufirst%3DP.%2BA.%26aulast%3DKrauss%26aufirst%3DS.%26atitle%3DTankyrase%2520inhibition%2520enhances%2520the%2520antiproliferative%2520effect%2520of%2520PI3K%2520and%2520EGFR%2520inhibition%252C%2520mutually%2520affecting%2520beta-catenin%2520and%2520AKT%2520signaling%2520in%2520colorectal%2520cancer%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2018%26volume%3D16%26spage%3D543%26epage%3D553%26doi%3D10.1158%2F1541-7786.MCR-17-0362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waaler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mygland, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tveita, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strand, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solberg, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aizenshtadt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fauskanger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lund, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brinch, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lycke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dybing, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nygaard, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boe, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heintz, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hovig, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammarstrom, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corthay, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauss, S.</span></span> <span> </span><span class="NLM_article-title">Tankyrase inhibition sensitizes melanoma to PD-1 immune checkpoint blockade in syngeneic mouse models</span>. <i>Commun. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">196</span>, <span class="refDoi"> DOI: 10.1038/s42003-020-0916-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.1038%2Fs42003-020-0916-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=32332858" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BB3cXotlaqsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2020&pages=196&author=J.+Waalerauthor=L.+Myglandauthor=A.+Tveitaauthor=M.+F.+Strandauthor=N.+T.+Solbergauthor=P.+A.+Olsenauthor=A.+Aizenshtadtauthor=M.+Fauskangerauthor=K.+Lundauthor=S.+A.+Brinchauthor=M.+Lyckeauthor=E.+Dybingauthor=V.+Nygaardauthor=S.+L.+Boeauthor=K.+M.+Heintzauthor=E.+Hovigauthor=C.+Hammarstromauthor=A.+Corthayauthor=S.+Krauss&title=Tankyrase+inhibition+sensitizes+melanoma+to+PD-1+immune+checkpoint+blockade+in+syngeneic+mouse+models&doi=10.1038%2Fs42003-020-0916-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Tankyrase inhibition sensitizes melanoma to PD-1 immune checkpoint blockade in syngeneic mouse models</span></div><div class="casAuthors">Waaler, Jo; Mygland, Line; Tveita, Anders; Strand, Martin Frank; Solberg, Nina Therese; Olsen, Petter Angell; Aizenshtadt, Aleksandra; Fauskanger, Marte; Lund, Kaja; Brinch, Shoshy Alam; Lycke, Max; Dybing, Elisabeth; Nygaard, Vegard; Boee, Sigurd Laeines; Heintz, Karen-Marie; Hovig, Eivind; Hammarstrom, Clara; Corthay, Alexandre; Krauss, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Communications Biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">196</span>CODEN:
                <span class="NLM_cas:coden">CBOIDQ</span>;
        ISSN:<span class="NLM_cas:issn">2399-3642</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Abstr.: The development of immune checkpoint inhibitors represents a major breakthrough in cancer therapy.  Nevertheless, a substantial no. of patients fail to respond to checkpoint pathway blockade.  Evidence for WNT/β-catenin signaling-mediated immune evasion is found in a subset of cancers including melanoma.  Currently, there are no therapeutic strategies available for targeting WNT/β-catenin signaling.  Here we show that a specific small-mol. tankyrase inhibitor, G007-LK, decreases WNT/β-catenin and YAP signaling in the syngeneic murine B16-F10 and Clone M-3 melanoma models and sensitizes the tumors to anti-PD-1 immune checkpoint therapy.  Mechanistically, we demonstrate that the synergistic effect of tankyrase and checkpoint inhibitor treatment is dependent on loss of β-catenin in the tumor cells, anti-PD-1-stimulated infiltration of T cells into the tumor and induction of an IFNγ- and CD8+ T cell-mediated anti-tumor immune response.  Our study uncovers a combinatorial therapeutical strategy using tankyrase inhibition to overcome β-catenin-mediated resistance to immune checkpoint blockade in melanoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodvTrOGe9EiLVg90H21EOLACvtfcHk0liD69zCq278Jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXotlaqsL4%253D&md5=727d28f79bd8c9b5df056477837c3857</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fs42003-020-0916-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs42003-020-0916-2%26sid%3Dliteratum%253Aachs%26aulast%3DWaaler%26aufirst%3DJ.%26aulast%3DMygland%26aufirst%3DL.%26aulast%3DTveita%26aufirst%3DA.%26aulast%3DStrand%26aufirst%3DM.%2BF.%26aulast%3DSolberg%26aufirst%3DN.%2BT.%26aulast%3DOlsen%26aufirst%3DP.%2BA.%26aulast%3DAizenshtadt%26aufirst%3DA.%26aulast%3DFauskanger%26aufirst%3DM.%26aulast%3DLund%26aufirst%3DK.%26aulast%3DBrinch%26aufirst%3DS.%2BA.%26aulast%3DLycke%26aufirst%3DM.%26aulast%3DDybing%26aufirst%3DE.%26aulast%3DNygaard%26aufirst%3DV.%26aulast%3DBoe%26aufirst%3DS.%2BL.%26aulast%3DHeintz%26aufirst%3DK.%2BM.%26aulast%3DHovig%26aufirst%3DE.%26aulast%3DHammarstrom%26aufirst%3DC.%26aulast%3DCorthay%26aufirst%3DA.%26aulast%3DKrauss%26aufirst%3DS.%26atitle%3DTankyrase%2520inhibition%2520sensitizes%2520melanoma%2520to%2520PD-1%2520immune%2520checkpoint%2520blockade%2520in%2520syngeneic%2520mouse%2520models%26jtitle%3DCommun.%2520Biol.%26date%3D2020%26volume%3D3%26spage%3D196%26doi%3D10.1038%2Fs42003-020-0916-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mito, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagasu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kittaka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sone, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morita, Y.</span></span> <span> </span><span class="NLM_article-title">Pharmacological inhibition of tankyrase induces bone loss in mice by increasing osteoclastogenesis</span>. <i>Bone</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>106</i></span>,  <span class="NLM_fpage">156</span>– <span class="NLM_lpage">166</span>, <span class="refDoi"> DOI: 10.1016/j.bone.2017.10.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.1016%2Fj.bone.2017.10.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=29055830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslChs7nE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2018&pages=156-166&author=S.+Fujitaauthor=T.+Mukaiauthor=T.+Mitoauthor=S.+Kodamaauthor=A.+Nagasuauthor=M.+Kittakaauthor=T.+Soneauthor=Y.+Uekiauthor=Y.+Morita&title=Pharmacological+inhibition+of+tankyrase+induces+bone+loss+in+mice+by+increasing+osteoclastogenesis&doi=10.1016%2Fj.bone.2017.10.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological inhibition of tankyrase induces bone loss in mice by increasing osteoclastogenesis</span></div><div class="casAuthors">Fujita, Shunichi; Mukai, Tomoyuki; Mito, Takafumi; Kodama, Shoko; Nagasu, Akiko; Kittaka, Mizuho; Sone, Teruki; Ueki, Yasuyoshi; Morita, Yoshitaka</div><div class="citationInfo"><span class="NLM_cas:title">Bone (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">156-166</span>CODEN:
                <span class="NLM_cas:coden">BONEDL</span>;
        ISSN:<span class="NLM_cas:issn">1873-2763</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Tankyrase is a poly (ADP-ribose) polymerase that leads to ubiquitination and degrdn. of target proteins.  Since tankyrase inhibitors suppress the degrdn. of AXIN protein, a neg. regulator of the canonical Wnt pathway, they effectively act as Wnt inhibitors.  Small mol. tankyrase inhibitors are being investigated as drug candidates for cancer and fibrotic diseases, in which the Wnt pathways are aberrantly activated.  Tankyrase is also reported to degrade the adaptor protein SH3BP2 (SH3 domain-binding protein 2).  We have previously shown that SH3BP2 gain-of-function mutation enhances receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclastogenesis in murine bone marrow-derived macrophages (BMMs).  Although the interaction between tankyrase and SH3BP2 has been reported, it is not clear whether and how the inhibition of tankyrase affects bone cells and bone mass.  Here, we have demonstrated that tankyrase inhibitors (IWR-1, XAV939, and G007-LK) enhanced RANKL-induced osteoclast formation and function in murine BMMs and human peripheral blood mononuclear cells through the accumulation of SH3BP2, subsequent phosphorylation of SYK, and nuclear translocation of NFATc1.  Tankyrase inhibitors also enhanced osteoblast differentiation and maturation, represented by increased expression of osteoblast-assocd. genes accompanied by the accumulation of SH3BP2 protein and enhanced nuclear translocation of ABL, TAZ, and Runx2 in primary osteoblasts.  Most importantly, pharmacol. inhibition of tankyrase in mice significantly decreased tibia and lumbar vertebrae bone vols. in assocn. with increased nos. of osteoclasts.  Our findings uncover the role of tankyrase inhibition in bone cells and highlight the potential adverse effects of the inhibitor on bone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZ0uHmDycCArVg90H21EOLACvtfcHk0liD69zCq278Jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslChs7nE&md5=158b18c4cc176ef826a8cf2ca2a32009</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bone.2017.10.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bone.2017.10.017%26sid%3Dliteratum%253Aachs%26aulast%3DFujita%26aufirst%3DS.%26aulast%3DMukai%26aufirst%3DT.%26aulast%3DMito%26aufirst%3DT.%26aulast%3DKodama%26aufirst%3DS.%26aulast%3DNagasu%26aufirst%3DA.%26aulast%3DKittaka%26aufirst%3DM.%26aulast%3DSone%26aufirst%3DT.%26aulast%3DUeki%26aufirst%3DY.%26aulast%3DMorita%26aufirst%3DY.%26atitle%3DPharmacological%2520inhibition%2520of%2520tankyrase%2520induces%2520bone%2520loss%2520in%2520mice%2520by%2520increasing%2520osteoclastogenesis%26jtitle%3DBone%26date%3D2018%26volume%3D106%26spage%3D156%26epage%3D166%26doi%3D10.1016%2Fj.bone.2017.10.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Norum, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skarpen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brech, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuiper, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waaler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauss, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorlie, T.</span></span> <span> </span><span class="NLM_article-title">The tankyrase inhibitor G007-LK inhibits small intestine LGR5(+) stem cell proliferation without altering tissue morphology</span>. <i>Biol. Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">3</span>, <span class="refDoi"> DOI: 10.1186/s40659-017-0151-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.1186%2Fs40659-017-0151-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=29316982" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmslOqtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2018&pages=3&author=J.+H.+Norumauthor=E.+Skarpenauthor=A.+Brechauthor=R.+Kuiperauthor=J.+Waalerauthor=S.+Kraussauthor=T.+Sorlie&title=The+tankyrase+inhibitor+G007-LK+inhibits+small+intestine+LGR5%28%2B%29+stem+cell+proliferation+without+altering+tissue+morphology&doi=10.1186%2Fs40659-017-0151-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">The tankyrase inhibitor G007-LK inhibits small intestine LGR5+ stem cell proliferation without altering tissue morphology</span></div><div class="casAuthors">Norum, Jens Henrik; Skarpen, Ellen; Brech, Andreas; Kuiper, Raoul; Waaler, Jo; Krauss, Stefan; Soerlie, Therese</div><div class="citationInfo"><span class="NLM_cas:title">Biological Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3/1-3/13</span>CODEN:
                <span class="NLM_cas:coden">BESEEB</span>;
        ISSN:<span class="NLM_cas:issn">0717-6287</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: The WNT pathway regulates intestinal stem cells and is frequently disrupted in intestinal adenomas.  The pathway contains several potential biotargets for interference, including the poly-ADP ribosyltransferase enzymes tankyrase1 and 2.  LGR5 is a known WNT pathway target gene and marker of intestinal stem cells.  The LGR5+ stem cells are located in the crypt base and capable of regenerating all intestinal epithelial cell lineages.  Results: We treated Lgr5-EGFP-Ires-CreERT2;R26R-Confetti mice with the tankyrase inhibitor G007-LK for up to 3 wk to assess the effect on duodenal stem cell homeostasis and on the integrity of intestinal epithelium.  At the administered doses, G007-LK treatment inhibited WNT signalling in LGR5+ stem cells and reduced the no. and distribution of cells traced from duodenal LGR5+ stem cells.  However, the gross morphol. of the duodenum remained unaltered and G007-LK-treated mice showed no signs of wt. loss or any other visible morphol. changes.  The inhibitory effect on LGR5+ stem cell proliferation was reversible.  Conclusion: We show that the tankyrase inhibitor G007-LK is well tolerated by the mice, although proliferation of the LGR5+ intestinal stem cells was inhibited.  Our observations suggest the presence of a tankyrase inhibitor-resistant cell population in the duodenum, able to rescue tissue integrity in the presence of G007-LK-mediated inhibition of the WNT signalling dependent LGR5+ intestinal epithelial stem cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw_ndzjfN9-rVg90H21EOLACvtfcHk0liD69zCq278Jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmslOqtrw%253D&md5=e469fae6f5bfc912de008d41d403dbaa</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1186%2Fs40659-017-0151-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs40659-017-0151-6%26sid%3Dliteratum%253Aachs%26aulast%3DNorum%26aufirst%3DJ.%2BH.%26aulast%3DSkarpen%26aufirst%3DE.%26aulast%3DBrech%26aufirst%3DA.%26aulast%3DKuiper%26aufirst%3DR.%26aulast%3DWaaler%26aufirst%3DJ.%26aulast%3DKrauss%26aufirst%3DS.%26aulast%3DSorlie%26aufirst%3DT.%26atitle%3DThe%2520tankyrase%2520inhibitor%2520G007-LK%2520inhibits%2520small%2520intestine%2520LGR5%2528%252B%2529%2520stem%2520cell%2520proliferation%2520without%2520altering%2520tissue%2520morphology%26jtitle%3DBiol.%2520Res.%26date%3D2018%26volume%3D51%26spage%3D3%26doi%3D10.1186%2Fs40659-017-0151-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waaler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machon, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Kries, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundenes, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wedlich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gradl, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulsen, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machonova, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dembinski, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krauss, S.</span></span> <span> </span><span class="NLM_article-title">Novel synthetic antagonists of canonical Wnt signaling inhibit colorectal cancer cell growth</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">197</span>– <span class="NLM_lpage">205</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-10-1282</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.1158%2F0008-5472.CAN-10-1282" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=21199802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovFOh" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2011&pages=197-205&author=J.+Waalerauthor=O.+Machonauthor=J.+P.+von+Kriesauthor=S.+R.+Wilsonauthor=E.+Lundenesauthor=D.+Wedlichauthor=D.+Gradlauthor=J.+E.+Paulsenauthor=O.+Machonovaauthor=J.+L.+Dembinskiauthor=H.+Dinhauthor=S.+Krauss&title=Novel+synthetic+antagonists+of+canonical+Wnt+signaling+inhibit+colorectal+cancer+cell+growth&doi=10.1158%2F0008-5472.CAN-10-1282"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Synthetic Antagonists of Canonical Wnt Signaling Inhibit Colorectal Cancer Cell Growth</span></div><div class="casAuthors">Waaler, Jo; Machon, Ondrej; von Kries, Jens Peter; Wilson, Steven Ray; Lundenes, Elsa; Wedlich, Doris; Gradl, Dietmar; Paulsen, Jan Erik; Machonova, Olga; Dembinski, Jennifer L.; Dinh, Huyen; Krauss, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">197-205</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Canonical Wnt signaling is deregulated in several types of human cancer where it plays a central role in tumor cell growth and progression.  Here we report the identification of 2 new small mols. that specifically inhibit canonical Wnt pathway at the level of the destruction complex.  Specificity was verified in various cellular reporter systems, a Xenopus double-axis formation assay and a gene expression profile anal.  In human colorectal cancer (CRC) cells, the new compds. JW67 and JW74 rapidly reduced active β-catenin with a subsequent downregulation of Wnt target genes, including AXIN2, SP5, and NKD1.  Notably, AXIN2 protein levels were strongly increased after compd. exposure.  Long-term treatment with JW74 inhibited the growth of tumor cells in both a mouse xenograft model of CRC and in ApcMin mice (multiple intestinal neoplasia, Min).  Our findings rationalize further preclin. and clin. evaluation of these new compds. as novel modalities for cancer treatment.  Cancer Res; 71(1); 197-205.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpW6zbK2VV5PbVg90H21EOLACvtfcHk0ljpU_yFpglIUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovFOh&md5=e641536f7aea88b75d5cacc8b10458ab</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-10-1282&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-10-1282%26sid%3Dliteratum%253Aachs%26aulast%3DWaaler%26aufirst%3DJ.%26aulast%3DMachon%26aufirst%3DO.%26aulast%3Dvon%2BKries%26aufirst%3DJ.%2BP.%26aulast%3DWilson%26aufirst%3DS.%2BR.%26aulast%3DLundenes%26aufirst%3DE.%26aulast%3DWedlich%26aufirst%3DD.%26aulast%3DGradl%26aufirst%3DD.%26aulast%3DPaulsen%26aufirst%3DJ.%2BE.%26aulast%3DMachonova%26aufirst%3DO.%26aulast%3DDembinski%26aufirst%3DJ.%2BL.%26aulast%3DDinh%26aufirst%3DH.%26aulast%3DKrauss%26aufirst%3DS.%26atitle%3DNovel%2520synthetic%2520antagonists%2520of%2520canonical%2520Wnt%2520signaling%2520inhibit%2520colorectal%2520cancer%2520cell%2520growth%26jtitle%3DCancer%2520Res.%26date%3D2011%26volume%3D71%26spage%3D197%26epage%3D205%26doi%3D10.1158%2F0008-5472.CAN-10-1282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krauss, S.</span>; <span class="NLM_string-name">Nazare, M.</span>; <span class="NLM_string-name">Anumala, U.</span>; <span class="NLM_string-name">Lethio, L.</span>; <span class="NLM_string-name">Waaler, J.</span>; <span class="NLM_string-name">Holsworth, D.</span>; <span class="NLM_string-name">Wegert, A.</span>; <span class="NLM_string-name">Leenders, R.</span></span> <span> </span><span class="NLM_article-title">Triazole derivates as tankyrase inhibitors</span>. <span class="NLM_patent">WO/2018/118868</span>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=S.+Krauss&author=M.+Nazare&author=U.+Anumala&author=L.+Lethio&author=J.+Waaler&author=D.+Holsworth&author=A.+Wegert&author=R.+Leenders&title=Triazole+derivates+as+tankyrase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKrauss%26aufirst%3DS.%26atitle%3DTriazole%2520derivates%2520as%2520tankyrase%2520inhibitors%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sugane, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tobe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamaguchi, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimada, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeno, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyata, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimizuka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsukamoto, S.</span></span> <span> </span><span class="NLM_article-title">Atropisomeric 4-phenyl-4H-1,2,4-triazoles as selective glycine transporter 1 inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">5744</span>– <span class="NLM_lpage">5756</span>, <span class="refDoi"> DOI: 10.1021/jm400383w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400383w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVKqtLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5744-5756&author=T.+Suganeauthor=T.+Tobeauthor=W.+Hamaguchiauthor=I.+Shimadaauthor=K.+Maenoauthor=J.+Miyataauthor=T.+Suzukiauthor=T.+Kimizukaauthor=S.+Sakamotoauthor=S.+Tsukamoto&title=Atropisomeric+4-phenyl-4H-1%2C2%2C4-triazoles+as+selective+glycine+transporter+1+inhibitors&doi=10.1021%2Fjm400383w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Atropisomeric 4-Phenyl-4H-1,2,4-triazoles as Selective Glycine Transporter 1 Inhibitors</span></div><div class="casAuthors">Sugane, Takashi; Tobe, Takahiko; Hamaguchi, Wataru; Shimada, Itsuro; Maeno, Kyoichi; Miyata, Junji; Suzuki, Takeshi; Kimizuka, Tetsuya; Sakamoto, Shuichi; Tsukamoto, Shin-ichi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5744-5756</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of trisubstituted 4H-1,2,4-triazoles was synthesized and evaluated aiming to increase their activity and selectivity as glycine transporter 1 (GlyT1) inhibitors.  Structure-activity relationship exploration resulted in the identification of 3-[3-ethyl-5-(6-phenylpyridin-3-yl)-4H-1,2,4-triazol-4-yl]-2-methylbenzonitrile (I) with markedly higher selectivity for GlyT1.  Physiochem. studies revealed that the compd. I exists as a stable pair of atropisomers under physiol. conditions.  These atropisomers were successfully sepd. to obtain active enantiomer (R)-I, which displayed favorable pharmacokinetic properties, as well as pos. results in the mice Y-maze test.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqM-2SGK3g_mrVg90H21EOLACvtfcHk0ljpU_yFpglIUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVKqtLvN&md5=c3218bd9ccae1f172f6d995e089a1a74</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm400383w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400383w%26sid%3Dliteratum%253Aachs%26aulast%3DSugane%26aufirst%3DT.%26aulast%3DTobe%26aufirst%3DT.%26aulast%3DHamaguchi%26aufirst%3DW.%26aulast%3DShimada%26aufirst%3DI.%26aulast%3DMaeno%26aufirst%3DK.%26aulast%3DMiyata%26aufirst%3DJ.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DKimizuka%26aufirst%3DT.%26aulast%3DSakamoto%26aufirst%3DS.%26aulast%3DTsukamoto%26aufirst%3DS.%26atitle%3DAtropisomeric%25204-phenyl-4H-1%252C2%252C4-triazoles%2520as%2520selective%2520glycine%2520transporter%25201%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5744%26epage%3D5756%26doi%3D10.1021%2Fjm400383w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laplante, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fader, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fandrick, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fandrick, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hucke, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kemper, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, P. J.</span></span> <span> </span><span class="NLM_article-title">Assessing atropisomer axial chirality in drug discovery and development</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">7005</span>– <span class="NLM_lpage">7022</span>, <span class="refDoi"> DOI: 10.1021/jm200584g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200584g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFygu7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7005-7022&author=S.+R.+Laplanteauthor=L.+D.+Faderauthor=K.+R.+Fandrickauthor=D.+R.+Fandrickauthor=O.+Huckeauthor=R.+Kemperauthor=S.+P.+Millerauthor=P.+J.+Edwards&title=Assessing+atropisomer+axial+chirality+in+drug+discovery+and+development&doi=10.1021%2Fjm200584g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Assessing Atropisomer Axial Chirality in Drug Discovery and Development</span></div><div class="casAuthors">LaPlante, Steven R.; Fader, Lee D.; Fandrick, Keith R.; Fandrick, Daniel R.; Hucke, Oliver; Kemper, Ray; Miller, Stephen P. F.; Edwards, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7005-7022</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQ8uS-SDx68bVg90H21EOLACvtfcHk0ljpU_yFpglIUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFygu7zN&md5=6b44135b3871d2460fba4b3246b899e3</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm200584g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200584g%26sid%3Dliteratum%253Aachs%26aulast%3DLaplante%26aufirst%3DS.%2BR.%26aulast%3DFader%26aufirst%3DL.%2BD.%26aulast%3DFandrick%26aufirst%3DK.%2BR.%26aulast%3DFandrick%26aufirst%3DD.%2BR.%26aulast%3DHucke%26aufirst%3DO.%26aulast%3DKemper%26aufirst%3DR.%26aulast%3DMiller%26aufirst%3DS.%2BP.%26aulast%3DEdwards%26aufirst%3DP.%2BJ.%26atitle%3DAssessing%2520atropisomer%2520axial%2520chirality%2520in%2520drug%2520discovery%2520and%2520development%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7005%26epage%3D7022%26doi%3D10.1021%2Fjm200584g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Narwal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fallarero, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vuorela, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehtio, L.</span></span> <span> </span><span class="NLM_article-title">Homogeneous screening assay for human tankyrase</span>. <i>J. Biomol. Screening</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">593</span>– <span class="NLM_lpage">604</span>, <span class="refDoi"> DOI: 10.1177/1087057112436558</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.1177%2F1087057112436558" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=22357873" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC38XpvVShtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=593-604&author=M.+Narwalauthor=A.+Fallareroauthor=P.+Vuorelaauthor=L.+Lehtio&title=Homogeneous+screening+assay+for+human+tankyrase&doi=10.1177%2F1087057112436558"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Homogeneous screening assay for human tankyrase</span></div><div class="casAuthors">Narwal, Mohit; Fallarero, Adyary; Vuorela, Pia; Lehtio, Lari</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">593-604</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Tankyrase, a member of human PARP protein super-family, catalyzes a covalent post-translational modification of substrate proteins.  This modification, poly(ADP-ribos)ylation, leads to changes in protein interactions and modifies downstream signaling events.  Tankyrase 1 is a potential drug target due to its functions in telomere homeostasis and in Wnt signaling.  We describe here optimization and application of an activity-based homogenous assay for tankyrase inhibitors in a high-throughput screening format.  The method measures the consumption of substrate by the chem. conversion of the remaining NAD+ into a stable fluorescent condensation product.  Conditions were optimized to measure the enzymic auto-modification of a recombinant catalytic fragment of tankyrase 1.  The fluorescence assay is inexpensive, operationally easy and performs well according to the statistical anal. (Z'= 0.7).  A validatory screen with a natural product library confirmed suitability of the assay for finding new tankyrase inhibitors.  Flavone was the most potent (IC50=325 nM) hit from the natural compds.  A flavone deriv., apigenin, and iso-Pr gallate showed potency on the micromolar range, but displayed over 30-fold selectivity for tankyrase over the studied isoenzymes PARP1 and PARP2.  The assay is robust and will be useful for screening new tankyrase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdAQgc8t_53rVg90H21EOLACvtfcHk0lhpbKr2Ljjucg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpvVShtLg%253D&md5=e5736a4723ceff0fe1fc072ab9bac977</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1177%2F1087057112436558&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057112436558%26sid%3Dliteratum%253Aachs%26aulast%3DNarwal%26aufirst%3DM.%26aulast%3DFallarero%26aufirst%3DA.%26aulast%3DVuorela%26aufirst%3DP.%26aulast%3DLehtio%26aufirst%3DL.%26atitle%3DHomogeneous%2520screening%2520assay%2520for%2520human%2520tankyrase%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2012%26volume%3D17%26spage%3D593%26epage%3D604%26doi%3D10.1177%2F1087057112436558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Venkannagari, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fallarero, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feijs, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luscher, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehtio, L.</span></span> <span> </span><span class="NLM_article-title">Activity-based assay for human mono-ADP-ribosyltransferases ARTD7/PARP15 and ARTD10/PARP10 aimed at screening and profiling inhibitors</span>. <i>Eur. J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">148</span>– <span class="NLM_lpage">156</span>, <span class="refDoi"> DOI: 10.1016/j.ejps.2013.02.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.1016%2Fj.ejps.2013.02.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=23485441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmvF2gtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2013&pages=148-156&author=H.+Venkannagariauthor=A.+Fallareroauthor=K.+L.+Feijsauthor=B.+Luscherauthor=L.+Lehtio&title=Activity-based+assay+for+human+mono-ADP-ribosyltransferases+ARTD7%2FPARP15+and+ARTD10%2FPARP10+aimed+at+screening+and+profiling+inhibitors&doi=10.1016%2Fj.ejps.2013.02.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Activity-based assay for human mono-ADP-ribosyltransferases ARTD7/PARP15 and ARTD10/PARP10 aimed at screening and profiling inhibitors</span></div><div class="casAuthors">Venkannagari, Harikanth; Fallarero, Adyary; Feijs, Karla L. H.; Luscher, Bernhard; Lehtio, Lari</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">148-156</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Poly(ADP-ribose) polymerases (PARPs) or diphtheria toxin like ADP-ribosyl transferases (ARTDs) are enzymes that catalyze the covalent modification of proteins by attachment of ADP-ribose units to the target amino acid residues or to the growing chain of ADP-ribose.  A subclass of the ARTD superfamily consists of mono-ADP-ribosyl transferases that are thought to modify themselves and other substrate proteins by covalently adding only a single ADP-ribose moiety to the target.  Many of the ARTD enzymes are either established or potential drug targets and a functional activity assay for them will be a valuable tool to identify selective inhibitors for each enzyme.  Existing assays are not directly applicable for screening of inhibitors due to the different nature of the reaction and different target mols.  We modified and applied a fluorescence-based assay previously described for PARP1/ARTD1 and tankyrase/ARTD5 for screening of PARP10/ARTD10 and PARP15/ARTD7 inhibitors.  The assay measures the amt. of NAD+ present after chem. converting it to a fluorescent analog.  We demonstrate that by using an excess of a recombinant acceptor protein the performance of the activity-based assay is excellent for screening of compd. libraries.  The assay is homogenous and cost effective, making it possible to test relatively large compd. libraries.  This method can be used to screen inhibitors of mono-ARTDs and profile inhibitors of the enzyme class.  The assay was optimized for ARTD10 and ARTD7, but it can be directly applied to other mono-ARTDs of the ARTD superfamily.  Profiling of known ARTD inhibitors against ARTD10 and ARTD7 in a validatory screening identified the best inhibitors with submicromolar potencies.  Only few of the tested ARTD inhibitors were potent, implicating that there is a need to screen new compd. scaffolds.  This is needed to create small mols. that could serve as biol. probes and potential starting points for drug discovery projects against mono-ARTDs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDu0JDVu3v47Vg90H21EOLACvtfcHk0lhpbKr2Ljjucg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmvF2gtbo%253D&md5=f5c61569372452cabeb8b3c5100de258</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2013.02.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2013.02.012%26sid%3Dliteratum%253Aachs%26aulast%3DVenkannagari%26aufirst%3DH.%26aulast%3DFallarero%26aufirst%3DA.%26aulast%3DFeijs%26aufirst%3DK.%2BL.%26aulast%3DLuscher%26aufirst%3DB.%26aulast%3DLehtio%26aufirst%3DL.%26atitle%3DActivity-based%2520assay%2520for%2520human%2520mono-ADP-ribosyltransferases%2520ARTD7%252FPARP15%2520and%2520ARTD10%252FPARP10%2520aimed%2520at%2520screening%2520and%2520profiling%2520inhibitors%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2013%26volume%3D49%26spage%3D148%26epage%3D156%26doi%3D10.1016%2Fj.ejps.2013.02.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Venkannagari, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verheugd, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koivunen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haikarainen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obaji, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashok, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narwal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pihlajaniemi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luscher, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehtio, L.</span></span> <span> </span><span class="NLM_article-title">Small-molecule chemical probe rescues cells from mono-ADP-Ribosyltransferase ARTD10/PARP10-induced apoptosis and sensitizes cancer cells to DNA damage</span>. <i>Cell Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1251</span>– <span class="NLM_lpage">1260</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2016.08.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.1016%2Fj.chembiol.2016.08.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=27667561" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFGru73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2016&pages=1251-1260&author=H.+Venkannagariauthor=P.+Verheugdauthor=J.+Koivunenauthor=T.+Haikarainenauthor=E.+Obajiauthor=Y.+Ashokauthor=M.+Narwalauthor=T.+Pihlajaniemiauthor=B.+Luscherauthor=L.+Lehtio&title=Small-molecule+chemical+probe+rescues+cells+from+mono-ADP-Ribosyltransferase+ARTD10%2FPARP10-induced+apoptosis+and+sensitizes+cancer+cells+to+DNA+damage&doi=10.1016%2Fj.chembiol.2016.08.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Small-Molecule Chemical Probe Rescues Cells from Mono-ADP-Ribosyltransferase ARTD10/PARP10-Induced Apoptosis and Sensitizes Cancer Cells to DNA Damage</span></div><div class="casAuthors">Venkannagari, Harikanth; Verheugd, Patricia; Koivunen, Jarkko; Haikarainen, Teemu; Obaji, Ezeogo; Ashok, Yashwanth; Narwal, Mohit; Pihlajaniemi, Taina; Luscher, Bernhard; Lehtio, Lari</div><div class="citationInfo"><span class="NLM_cas:title">Cell Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1251-1260</span>CODEN:
                <span class="NLM_cas:coden">CCBEBM</span>;
        ISSN:<span class="NLM_cas:issn">2451-9448</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Members of the human diphtheria toxin-like ADP-ribosyltransferase (ARTD or PARP) family play important roles in regulating biol. activities by mediating either a mono-ADP-ribosylation (MARylation) of a substrate or a poly-ADP-ribosylation (PARylation).  ARTD10/PARP10 belongs to the MARylating ARTDs (mARTDs) subfamily, and plays important roles in biol. processes that range from cellular signaling, DNA repair, and cell proliferation to immune response.  Despite their biol. and disease relevance, no selective inhibitors for mARTDs are available.  Here we describe a small-mol. ARTD10 inhibitor, OUL35, a selective and potent inhibitor for this enzyme.  We characterize its selectivity profile, model its binding, and demonstrate activity in HeLa cells where OUL35 rescued cells from ARTD10 induced cell death.  Using OUL35 as a cell biol. tool we show that ARTD10 inhibition sensitizes the cells to the hydroxyurea-induced genotoxic stress.  Our study supports the proposed role of ARTD10 in DNA-damage repair and provides a tool compd. for selective inhibition of ARTD10-mediated MARylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJe0TpYzqU7rVg90H21EOLACvtfcHk0lhpbKr2Ljjucg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFGru73O&md5=101c3a4cde945ed863fa5df6a1efc84e</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2016.08.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2016.08.012%26sid%3Dliteratum%253Aachs%26aulast%3DVenkannagari%26aufirst%3DH.%26aulast%3DVerheugd%26aufirst%3DP.%26aulast%3DKoivunen%26aufirst%3DJ.%26aulast%3DHaikarainen%26aufirst%3DT.%26aulast%3DObaji%26aufirst%3DE.%26aulast%3DAshok%26aufirst%3DY.%26aulast%3DNarwal%26aufirst%3DM.%26aulast%3DPihlajaniemi%26aufirst%3DT.%26aulast%3DLuscher%26aufirst%3DB.%26aulast%3DLehtio%26aufirst%3DL.%26atitle%3DSmall-molecule%2520chemical%2520probe%2520rescues%2520cells%2520from%2520mono-ADP-Ribosyltransferase%2520ARTD10%252FPARP10-induced%2520apoptosis%2520and%2520sensitizes%2520cancer%2520cells%2520to%2520DNA%2520damage%26jtitle%3DCell%2520Chem.%2520Biol.%26date%3D2016%26volume%3D23%26spage%3D1251%26epage%3D1260%26doi%3D10.1016%2Fj.chembiol.2016.08.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murthy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desantis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verheugd, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maksimainen, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkannagari, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massari, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashok, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obaji, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nkizinkinko, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luscher, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabarrini, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehtio, L.</span></span> <span> </span><span class="NLM_article-title">4-(Phenoxy) and 4-(benzyloxy)benzamides as potent and selective inhibitors of mono-ADP-ribosyltransferase PARP10/ARTD10</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>156</i></span>,  <span class="NLM_fpage">93</span>– <span class="NLM_lpage">102</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.06.047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.1016%2Fj.ejmech.2018.06.047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=30006177" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1yju7%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=2018&pages=93-102&author=S.+Murthyauthor=J.+Desantisauthor=P.+Verheugdauthor=M.+M.+Maksimainenauthor=H.+Venkannagariauthor=S.+Massariauthor=Y.+Ashokauthor=E.+Obajiauthor=Y.+Nkizinkinkoauthor=B.+Luscherauthor=O.+Tabarriniauthor=L.+Lehtio&title=4-%28Phenoxy%29+and+4-%28benzyloxy%29benzamides+as+potent+and+selective+inhibitors+of+mono-ADP-ribosyltransferase+PARP10%2FARTD10&doi=10.1016%2Fj.ejmech.2018.06.047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">4-(Phenoxy) and 4-(benzyloxy)benzamides as potent and selective inhibitors of mono-ADP-ribosyltransferase PARP10/ARTD10</span></div><div class="casAuthors">Murthy, Sudarshan; Desantis, Jenny; Verheugd, Patricia; Maksimainen, Mirko M.; Venkannagari, Harikanth; Massari, Serena; Ashok, Yashwanth; Obaji, Ezeogo; Nkizinkinko, Yves; Luscher, Bernhard; Tabarrini, Oriana; Lehtio, Lari</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">93-102</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Human Diphtheria toxin-like ADP-ribosyltranferases (ARTD) 10 is an enzyme carrying out mono-ADP-ribosylation of a range of cellular proteins and affecting their activities.  It shuttles between cytoplasm and nucleus and influences signaling events in both compartments, such as nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) signaling and S phase DNA repair.  Furthermore, overexpression of ARTD10 induces cell death.  We recently reported on the discovery of a hit compd., OUL35 (compd. 1), with 330nM potency and remarkable selectivity towards ARTD10 over other enzymes in the human protein family.  Here we aimed at establishing a structure-activity relationship of the OUL35 scaffold, by evaluating an array of 4-phenoxybenzamide derivs.  By exploring modifications on the linker between the arom. rings, we identified also a 4-(benzyloxy)benzamide deriv., compd. 32, which is potent (IC50=230nM) and selective, and like OUL35 was able to rescue HeLa cells from ARTD10-induced cell death.  Evaluation of an enlarged series of derivs. produced detailed knowledge on the structural requirements for ARTD10 inhibition and allowed the discovery of further tool compds. with submicromolar cellular potency that will help in understanding the roles of ARTD10 in biol. systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrDFZOg0euI7Vg90H21EOLACvtfcHk0lhH2qzAld-48g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1yju7%252FM&md5=79a23a4fa33acfdcf2f1db44f98b218b</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.06.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.06.047%26sid%3Dliteratum%253Aachs%26aulast%3DMurthy%26aufirst%3DS.%26aulast%3DDesantis%26aufirst%3DJ.%26aulast%3DVerheugd%26aufirst%3DP.%26aulast%3DMaksimainen%26aufirst%3DM.%2BM.%26aulast%3DVenkannagari%26aufirst%3DH.%26aulast%3DMassari%26aufirst%3DS.%26aulast%3DAshok%26aufirst%3DY.%26aulast%3DObaji%26aufirst%3DE.%26aulast%3DNkizinkinko%26aufirst%3DY.%26aulast%3DLuscher%26aufirst%3DB.%26aulast%3DTabarrini%26aufirst%3DO.%26aulast%3DLehtio%26aufirst%3DL.%26atitle%3D4-%2528Phenoxy%2529%2520and%25204-%2528benzyloxy%2529benzamides%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520mono-ADP-ribosyltransferase%2520PARP10%252FARTD10%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D156%26spage%3D93%26epage%3D102%26doi%3D10.1016%2Fj.ejmech.2018.06.047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kabsch, W.</span></span> <span> </span><span class="NLM_article-title">Xds</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1107/S0907444909047337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.1107%2FS0907444909047337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=20124692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=125-132&author=W.+Kabsch&title=Xds&doi=10.1107%2FS0907444909047337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Software XDS for image rotation, recognition and crystal symmetry assignment</span></div><div class="casAuthors">Kabsch, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The usage and control of recent modifications of the program package XDS for the processing of rotation images are described in the context of previous versions.  New features include automatic detn. of spot size and reflecting range and recognition and assignment of crystal symmetry.  Moreover, the limitations of earlier package versions on the no. of correction/scaling factors and the representation of pixel contents have been removed.  Large program parts have been restructured for parallel processing so that the quality and completeness of collected data can be assessed soon after measurement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv5AyUw00DYbVg90H21EOLACvtfcHk0lhH2qzAld-48g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D&md5=1aa9a38aeb3ce95af4ffb7d8b8a142bd</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1107%2FS0907444909047337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909047337%26sid%3Dliteratum%253Aachs%26aulast%3DKabsch%26aufirst%3DW.%26atitle%3DXds%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D125%26epage%3D132%26doi%3D10.1107%2FS0907444909047337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storoni, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span> <span> </span><span class="NLM_article-title">Phaser crystallographic software</span>. <i>J. Appl. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">658</span>– <span class="NLM_lpage">674</span>, <span class="refDoi"> DOI: 10.1107/S0021889807021206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.1107%2FS0021889807021206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=19461840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2007&pages=658-674&author=A.+J.+McCoyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adamsauthor=M.+D.+Winnauthor=L.+C.+Storoniauthor=R.+J.+Read&title=Phaser+crystallographic+software&doi=10.1107%2FS0021889807021206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Phaser crystallographic software</span></div><div class="casAuthors">McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.; Winn, Martyn D.; Storoni, Laurent C.; Read, Randy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">658-674</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phaser is a program for phasing macromol. crystal structures by both mol. replacement and exptl. phasing methods.  The novel phasing algorithms implemented in Phaser have been developed using max. likelihood and multivariate statistics.  For mol. replacement, the new algorithms have proved to be significantly better than traditional methods in discriminating correct solns. from noise, and for single-wavelength anomalous dispersion exptl. phasing, the new algorithms, which account for correlations between F+ and F-, give better phases (lower mean phase error with respect to the phases given by the refined structure) than those that use mean F and anomalous differences ΔF.  One of the design concepts of Phaser was that it be capable of a high degree of automation.  To this end, Phaser (written in C++) can be called directly from Python, although it can also be called using traditional CCP4 keyword-style input.  Phaser is a platform for future development of improved phasing methods and their release, including source code, to the crystallog. community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPeVyjN_FMGbVg90H21EOLACvtfcHk0lhH2qzAld-48g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D&md5=c63b722ae97e0a74e6a5a079d388f09f</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1107%2FS0021889807021206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889807021206%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DStoroni%26aufirst%3DL.%2BC.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26atitle%3DPhaser%2520crystallographic%2520software%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2007%26volume%3D40%26spage%3D658%26epage%3D674%26doi%3D10.1107%2FS0021889807021206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K.</span></span> <span> </span><span class="NLM_article-title">Coot: model-building tools for molecular graphics</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2126</span>– <span class="NLM_lpage">2132</span>, <span class="refDoi"> DOI: 10.1107/S0907444904019158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.1107%2FS0907444904019158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=15572765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=2126-2132&author=P.+Emsleyauthor=K.+Cowtan&title=Coot%3A+model-building+tools+for+molecular+graphics&doi=10.1107%2FS0907444904019158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Coot: model-building tools for molecular graphics</span></div><div class="casAuthors">Emsley, Paul; Cowtan, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">2126-2132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">CCP4mg is a project that aims to provide a general-purpose tool for structural biologists, providing tools for x-ray structure soln., structure comparison and anal., and publication-quality graphics.  The map-fitting tools are available as a stand-alone package, distributed as 'Coot'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMisM42468k7Vg90H21EOLACvtfcHk0lhH2qzAld-48g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P&md5=1be390f3bb6fd584468499ad0921161e</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1107%2FS0907444904019158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904019158%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DCoot%253A%2520model-building%2520tools%2520for%2520molecular%2520graphics%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D2126%26epage%3D2132%26doi%3D10.1107%2FS0907444904019158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murshudov, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skubak, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lebedev, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pannu, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steiner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholls, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vagin, A. A.</span></span> <span> </span><span class="NLM_article-title">REFMAC5 for the refinement of macromolecular crystal structures</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">355</span>– <span class="NLM_lpage">367</span>, <span class="refDoi"> DOI: 10.1107/S0907444911001314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=10.1107%2FS0907444911001314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=21460454" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=355-367&author=G.+N.+Murshudovauthor=P.+Skubakauthor=A.+A.+Lebedevauthor=N.+S.+Pannuauthor=R.+A.+Steinerauthor=R.+A.+Nichollsauthor=M.+D.+Winnauthor=F.+Longauthor=A.+A.+Vagin&title=REFMAC5+for+the+refinement+of+macromolecular+crystal+structures&doi=10.1107%2FS0907444911001314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">REFMAC5 for the refinement of macromolecular crystal structures</span></div><div class="casAuthors">Murshudov, Garib N.; Skubak, Pavol; Lebedev, Andrey A.; Pannu, Navraj S.; Steiner, Roberto A.; Nicholls, Robert A.; Winn, Martyn D.; Long, Fei; Vagin, Alexei A.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">355-367</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">This paper describes various components of the macromol. crystallog. refinement program REFMAC5, which is distributed as part of the CCP4 suite.  REFMAC5 utilizes different likelihood functions depending on the diffraction data employed (amplitudes or intensities), the presence of twinning and the availability of SAD/SIRAS exptl. diffraction data.  To ensure chem. and structural integrity of the refined model, REFMAC5 offers several classes of restraints and choices of model parameterization.  Reliable models at resolns. at least as low as 4 Å can be achieved thanks to low-resoln. refinement tools such as secondary-structure restraints, restraints to known homologous structures, automatic global and local NCS restraints, 'jelly-body' restraints and the use of novel long-range restraints on at. displacement parameters (ADPs) based on the Kullback-Leibler divergence.  REFMAC5 addnl. offers TLS parameterization and, when high-resoln. data are available, fast refinement of anisotropic ADPs.  Refinement in the presence of twinning is performed in a fully automated fashion.  REFMAC5 is a flexible and highly optimized refinement package that is ideally suited for refinement across the entire resoln. spectrum encountered in macromol. crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5Jq-i2qIq5rVg90H21EOLACvtfcHk0liW7Fhqi_ydeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqtbk%253D&md5=f8f3202d246908500057ad7c71015b7b</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1107%2FS0907444911001314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444911001314%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DSkubak%26aufirst%3DP.%26aulast%3DLebedev%26aufirst%3DA.%2BA.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DSteiner%26aufirst%3DR.%2BA.%26aulast%3DNicholls%26aufirst%3DR.%2BA.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DLong%26aufirst%3DF.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26atitle%3DREFMAC5%2520for%2520the%2520refinement%2520of%2520macromolecular%2520crystal%2520structures%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D355%26epage%3D367%26doi%3D10.1107%2FS0907444911001314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6TKN" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6TKN','PDB','6TKN'); return false;">PDB: 6TKN</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6TG4" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6TG4','PDB','6TG4'); return false;">PDB: 6TG4</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6TKM" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6TKM','PDB','6TKM'); return false;">PDB: 6TKM</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6TKS" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6TKS','PDB','6TKS'); return false;">PDB: 6TKS</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NOB" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5NOB','PDB','5NOB'); return false;">PDB: 5NOB</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6TKP" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6TKP','PDB','6TKP'); return false;">PDB: 6TKP</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6TKQ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6TKQ','PDB','6TKQ'); return false;">PDB: 6TKQ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6TKR" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6TKR','PDB','6TKR'); return false;">PDB: 6TKR</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i49"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00208">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_71531"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c00208?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00208</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">General and specific synthetic procedures and spectra (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00208/suppl_file/jm0c00208_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Additional figures and tables for inhibition data and crystallography (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00208/suppl_file/jm0c00208_si_002.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00208/suppl_file/jm0c00208_si_003.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00208/suppl_file/jm0c00208_si_001.pdf">jm0c00208_si_001.pdf (2.1 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00208/suppl_file/jm0c00208_si_002.pdf">jm0c00208_si_002.pdf (6.9 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00208/suppl_file/jm0c00208_si_003.csv">jm0c00208_si_003.csv (2.73 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Atomic coordinates and structure factors have been deposited to Protein Data Bank with accession codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6TG4">6TG4</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6TKM">6TKM</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6TKN">6TKN</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6TKP">6TKP</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6TKQ">6TKQ</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6TKR">6TKR</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6TKS">6TKS</a>.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c00208&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-13%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c00208%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c00208" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                9MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679929e138623bec","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
